0001576427-26-000048.txt : 20260506 0001576427-26-000048.hdr.sgml : 20260506 20260506161136 ACCESSION NUMBER: 0001576427-26-000048 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 90 CONFORMED PERIOD OF REPORT: 20260331 FILED AS OF DATE: 20260506 DATE AS OF CHANGE: 20260506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Criteo S.A. CENTRAL INDEX KEY: 0001576427 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311] ORGANIZATION NAME: 07 Trade & Services EIN: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36153 FILM NUMBER: 26948492 BUSINESS ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 BUSINESS PHONE: 33175850939 MAIL ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 10-Q 1 crto-20260331.htm 10-Q crto-20260331
true000157642712/312026Q1falsehttp://fasb.org/us-gaap/2025#SellingAndMarketingExpensehttp://fasb.org/us-gaap/2025#SellingAndMarketingExpensehttp://fasb.org/us-gaap/2025#OperatingExpensesxbrli:sharesiso4217:USDiso4217:EURxbrli:sharesiso4217:USDxbrli:sharescrto:segmentxbrli:purecrto:trancheiso4217:EURcrto:market00015764272026-01-012026-03-310001576427crto:AmericanDepositarySharesMember2026-01-012026-03-310001576427us-gaap:CommonStockMember2026-01-012026-03-3100015764272026-05-0100015764272026-03-3100015764272025-12-3100015764272025-01-012025-03-310001576427us-gaap:CommonStockMember2024-12-310001576427us-gaap:TreasuryStockCommonMember2024-12-310001576427us-gaap:AdditionalPaidInCapitalMember2024-12-310001576427us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001576427us-gaap:RetainedEarningsMember2024-12-310001576427us-gaap:ParentMember2024-12-310001576427us-gaap:NoncontrollingInterestMember2024-12-3100015764272024-12-310001576427us-gaap:RetainedEarningsMember2025-01-012025-03-310001576427us-gaap:ParentMember2025-01-012025-03-310001576427us-gaap:NoncontrollingInterestMember2025-01-012025-03-310001576427us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001576427us-gaap:CommonStockMember2025-01-012025-03-310001576427us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001576427us-gaap:TreasuryStockCommonMember2025-01-012025-03-310001576427us-gaap:CommonStockMember2025-03-310001576427us-gaap:TreasuryStockCommonMember2025-03-310001576427us-gaap:AdditionalPaidInCapitalMember2025-03-310001576427us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001576427us-gaap:RetainedEarningsMember2025-03-310001576427us-gaap:ParentMember2025-03-310001576427us-gaap:NoncontrollingInterestMember2025-03-3100015764272025-03-3100015764272025-01-3100015764272025-01-312025-01-310001576427us-gaap:RestrictedStockUnitsRSUMember2025-01-312025-01-310001576427us-gaap:CommonStockMember2025-12-310001576427us-gaap:TreasuryStockCommonMember2025-12-310001576427us-gaap:AdditionalPaidInCapitalMember2025-12-310001576427us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001576427us-gaap:RetainedEarningsMember2025-12-310001576427us-gaap:ParentMember2025-12-310001576427us-gaap:NoncontrollingInterestMember2025-12-310001576427us-gaap:RetainedEarningsMember2026-01-012026-03-310001576427us-gaap:ParentMember2026-01-012026-03-310001576427us-gaap:NoncontrollingInterestMember2026-01-012026-03-310001576427us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001576427us-gaap:TreasuryStockCommonMember2026-01-012026-03-310001576427us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001576427us-gaap:CommonStockMember2026-03-310001576427us-gaap:TreasuryStockCommonMember2026-03-310001576427us-gaap:AdditionalPaidInCapitalMember2026-03-310001576427us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001576427us-gaap:RetainedEarningsMember2026-03-310001576427us-gaap:ParentMember2026-03-310001576427us-gaap:NoncontrollingInterestMember2026-03-3100015764272026-02-0600015764272026-02-062026-02-060001576427us-gaap:RestrictedStockUnitsRSUMember2026-02-062026-02-0600015764272025-01-012025-12-310001576427crto:RetailMediaMember2026-01-012026-03-310001576427crto:RetailMediaMember2025-01-012025-03-310001576427crto:PerformanceMediaMember2026-01-012026-03-310001576427crto:PerformanceMediaMember2025-01-012025-03-310001576427us-gaap:CashMemberus-gaap:FairValueInputsLevel1Member2026-03-310001576427us-gaap:CashMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576427us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2026-03-310001576427us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576427us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2026-03-310001576427us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576427us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2026-03-310001576427us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576427us-gaap:DebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-03-310001576427us-gaap:DebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576427us-gaap:CommercialPaperMember2026-03-310001576427us-gaap:CommercialPaperMember2025-12-310001576427crto:StructuredDebtSecuritiesMember2026-03-310001576427crto:StructuredDebtSecuritiesMember2025-12-310001576427us-gaap:CorporateDebtSecuritiesMember2026-03-310001576427us-gaap:CorporateDebtSecuritiesMember2025-12-310001576427crto:RetailMediaMember2025-12-310001576427crto:PerformanceMediaMember2025-12-310001576427crto:RetailMediaMember2026-03-310001576427crto:PerformanceMediaMember2026-03-310001576427crto:DoeVs.GoodRxHoldingsInc.Member2026-03-310001576427crto:IponwebMember2026-03-310001576427crto:IponwebMember2025-12-310001576427us-gaap:ResearchAndDevelopmentExpenseMember2026-01-012026-03-310001576427us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001576427crto:SalesAndOperationsExpenseMember2026-01-012026-03-310001576427crto:SalesAndOperationsExpenseMember2025-01-012025-03-310001576427us-gaap:GeneralAndAdministrativeExpenseMember2026-01-012026-03-310001576427us-gaap:GeneralAndAdministrativeExpenseMember2025-01-012025-03-310001576427us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310001576427us-gaap:RestrictedStockUnitsRSUMember2025-12-310001576427us-gaap:RestrictedStockUnitsRSUMember2026-03-310001576427crto:FinancialPerformanceSharesUnitsMember2026-01-012026-03-310001576427crto:FinancialPerformanceSharesUnitsMember2025-12-310001576427crto:FinancialPerformanceSharesUnitsMember2026-03-310001576427crto:TSRPerformanceSharesUnitsMember2026-01-012026-03-310001576427crto:TSRPerformanceSharesUnitsMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-01-012026-03-310001576427crto:TSRPerformanceSharesUnitsMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-01-012026-03-310001576427crto:TSRPerformanceSharesUnitsMember2025-12-310001576427crto:TSRPerformanceSharesUnitsMember2026-03-310001576427crto:FinancialPerformanceSharesUnitsPreviouslyModifiedTSRPSUsMember2026-01-012026-03-310001576427us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001576427us-gaap:EmployeeStockOptionMember2026-03-310001576427us-gaap:RestrictedStockMember2026-01-012026-03-310001576427us-gaap:RestrictedStockMember2025-01-012025-03-310001576427crto:CommissionNationaleDeLInformatiqueEtDesLibertesCNILMember2022-08-030001576427crto:CommissionNationaleDeLInformatiqueEtDesLibertesCNILMember2023-06-210001576427crto:DoeVs.GoodRxHoldingsInc.Member2025-09-300001576427crto:DoeVs.GoodRxHoldingsInc.Member2025-12-310001576427crto:CommerceGrowthMembercrto:RetailMediaMember2026-01-012026-03-310001576427crto:CommerceGrowthMembercrto:RetailMediaMember2025-01-012025-03-310001576427crto:OtherMembercrto:RetailMediaMember2026-01-012026-03-310001576427crto:OtherMembercrto:RetailMediaMember2025-01-012025-03-310001576427srt:AmericasMember2026-01-012026-03-310001576427srt:AmericasMember2025-01-012025-03-310001576427country:US2026-01-012026-03-310001576427country:US2025-01-012025-03-310001576427us-gaap:EMEAMember2026-01-012026-03-310001576427us-gaap:EMEAMember2025-01-012025-03-310001576427country:DE2026-01-012026-03-310001576427country:DE2025-01-012025-03-310001576427country:FR2026-01-012026-03-310001576427country:FR2025-01-012025-03-310001576427srt:AsiaPacificMember2026-01-012026-03-310001576427srt:AsiaPacificMember2025-01-012025-03-310001576427country:JP2026-01-012026-03-310001576427country:JP2025-01-012025-03-310001576427srt:AmericasMember2026-03-310001576427us-gaap:EMEAMember2026-03-310001576427srt:AsiaPacificMember2026-03-310001576427srt:AmericasMember2025-12-310001576427us-gaap:EMEAMember2025-12-310001576427srt:AsiaPacificMember2025-12-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
for the quarterly period ended March 31, 2026
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
for the transition period from _________ to _________
Commission file number: 001-36153
Criteo S.A.
(Exact name of registrant as specified in its charter)
France
Not Applicable
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
32 Rue Blanche
Paris
France
75009
(Address of principal executive offices) (Zip Code)

+33 1 75 85 09 39
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
American Depositary Shares, each representing one Ordinary Share,
nominal value €0.025 per share
CRTONasdaq Global Select Market
Ordinary Shares, nominal value €0.025 per share*Nasdaq Global Select Market*
* Not for trading, but only in connection with the registration of the American Depositary Shares.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes      No 







Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated Filer
Non-accelerated Filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).   Yes        No x
          As of May 1st, 2026, the registrant had 50,244,527 ordinary shares, nominal value €0.025 per share, outstanding.




TABLE OF CONTENTS












General
    Except where the context otherwise requires, all references in this Quarterly Report on Form 10-Q ("Form 10-Q") to the "Company," "Criteo," "we," "us," "our" or similar words or phrases are to Criteo S.A. and its subsidiaries, taken together. In this Form 10-Q, references to "$" and "US$" are to United States dollars. Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or "GAAP."
Trademarks
    “Criteo,” the Criteo logo and other trademarks or service marks of Criteo appearing in this Form 10-Q are the property of Criteo. Trade names, trademarks and service marks of other companies appearing in this Form 10-Q are the property of their respective holders.
Special Note Regarding Forward-Looking Statements
    This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are based on our management’s beliefs and assumptions and on information currently available to our management. All statements other than present and historical facts and conditions contained in this Form 10-Q, including statements regarding our future results of operations and financial position, business strategy, plans and objectives for future operations, are forward-looking statements and involve risks and uncertainties that could cause actual results to differ materially. When used in this Form 10-Q, the words “anticipate,” “believe,” “can,” “could,” “estimate,” “expect,” “intend,” “is designed to,” “may,” “might,” "objective," “plan,” “potential,” “predict,” "project," "seek," “should,” "will," "would," or the negative of these and similar expressions identify forward-looking statements.
    You should refer to Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2025, and to our subsequent quarterly reports on Form 10-Q, for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this Form 10-Q will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
    You should read this Form 10-Q and the documents that we reference in this Form 10-Q and have filed as exhibits to this Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.
     This Form 10-Q may contain market data and industry forecasts that were obtained from industry publications. These data and forecasts involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such information. We have not independently verified any third-party information. While we believe the market position, market opportunity and market size information included in this Form 10-Q is generally reliable, such information is inherently imprecise.





CRITEO S.A.
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED)
Notes
March 31, 2026December 31, 2025
(in thousands)
Assets
Current assets:
    Cash and cash equivalents4$319,981 $342,038 
Trade receivables, net of allowances of $23.2 million and $25.9 million at March 31, 2026 and December 31, 2025, respectively.
5448,275 582,102 
    Income taxes1312,985 14,233 
    Other taxes 61,100 57,050 
    Marketable securities - current portion428,348 23,242 
    Prepaid expenses and other current assets769,597 53,210 
    Total current assets940,286 1,071,875 
Property and equipment, net
155,502 139,330 
Intangible assets, net148,724 151,853 
Goodwill6532,525 535,761 
Right of use assets - operating leases9128,692 134,205 
Marketable securities - noncurrent portion422,996 23,500 
Noncurrent financial assets8,193 8,314 
Deferred tax assets88,355 90,689 
Other noncurrent assets746,777 45,680 
    Total noncurrent assets1,131,764 1,129,332 
Total assets$2,072,050 $2,201,207 
Liabilities and shareholders' equity
Current liabilities:
    Trade payables$448,472 $566,046 
    Contingencies - current portion1511,390 9,229 
    Income taxes1321,943 27,528 
    Financial liabilities - current portion10,626 11,360 
    Lease liability - operating - current portion934,475 33,085 
    Other taxes12,820 14,713 
    Employee - related payables119,297 114,416 
    Other current liabilities878,025 68,277 
    Total current liabilities737,048 844,654 
Deferred tax liabilities5,179 5,285 
Defined benefit plans105,725 5,707 
Lease liability - operating - noncurrent portion 999,221 105,277 
Contingencies - noncurrent portion1523,039 22,729 
Other noncurrent liabilities832,403 31,826 
    Total noncurrent liabilities165,567 170,824 
Total liabilities$902,615 $1,015,478 
Shareholders' equity:
Common shares, €0.025 par value, 55,659,895 and 55,659,895 shares authorized and issued, and 50,098,139 and 51,151,866 outstanding at March 31, 2026 and December 31, 2025, respectively.
$1,871 $1,871 
Treasury stock, 5,561,756 and 4,508,029 shares at cost as of March 31, 2026 and December 31, 2025, respectively.
(126,390)(120,853)
Additional paid-in capital698,717 706,321 
Accumulated other comprehensive loss(77,319)(68,879)
Retained earnings635,935 630,750 
Equity attributable to the shareholders of Criteo S.A.
1,132,814 1,149,210 
Noncontrolling interests36,621 36,519 
Total equity1,169,435 1,185,729 
Total equity and liabilities$2,072,050 $2,201,207 
The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.
2


CRITEO S.A.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

Three Months Ended
NotesMarch 31, 2026March 31, 2025
(in thousands, except per share data)
Revenue16$424,639 $451,434 
Cost of revenue:
Traffic acquisition costs174,271 187,062 
Other cost of revenue27,626 27,396 
Gross profit222,742 236,976 
Operating expenses:
Research and development expenses69,683 60,749 
Sales and operations expenses97,501 88,889 
General and administrative expenses45,158 39,171 
Total operating expenses212,342 188,809 
Income from operations10,400 48,167 
Financial and other income121,873 2,302 
Income before taxes
12,273 50,469 
Provision for income taxes133,693 10,458 
Net Income
$8,580 $40,011 
Net income available to shareholders of Criteo S.A.
$7,817 $37,928 
Net income available to noncontrolling interests$763 $2,083 
Weighted average shares outstanding used in computing per share amounts:
Basic1450,352,46553,979,157
Diluted1450,965,93357,195,898
Net income allocated to shareholders per share:
Basic14$0.16 $0.70 
Diluted14$0.15 $0.66 
The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.

3


CRITEO S.A.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE OPERATIONS (UNAUDITED)
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Net income
$8,580 $40,011 
Foreign currency translation differences, net of taxes(9,277)17,216 
Actuarial gains on employee benefits, net of taxes118 310 
Other comprehensive income (loss)
$(9,159)$17,526 
Total comprehensive income (loss)$(579)$57,537 
Attributable to shareholders of Criteo S.A.$(681)$53,858 
Attributable to noncontrolling interests
$102 $3,679 
The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.
4


CRITEO S.A.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)
Share capitalTreasury
Stock
Additional paid-in capitalAccumulated Other Comprehensive Income (Loss)Retained EarningsEquity - attributable to shareholders of Criteo S.A.Non controlling interestTotal equity
Common sharesShares
(in thousands, except share data)
Balance at December 31, 202457,744,839$1,931(3,467,417)$(125,298)$709,580$(108,768)$571,744$1,049,189$31,908$1,081,097
Net income
37,92837,9282,08340,011
Other comprehensive loss
15,93015,9301,59617,526
Issuance of ordinary shares110,05621,8431,8451,845
Change in treasury stocks(*)
(817,761)(34,102)(20,549)(1,517)(56,168)(56,168)
Share-Based Compensation16,61516,6154816,663
Other changes in equity(740)(740)2(738)
Balance at March 31, 202557,854,895$1,933(4,285,178)$(159,400)$707,489$(92,838)$607,415$1,064,599$35,637$1,100,236
(*) On January 31, 2025, Criteo's board of directors authorized an extension of the share repurchase program to up to $805.0 million of the Company's outstanding American Depositary Shares. The change in treasury stocks is comprised of 1,460,246 shares repurchased at a weighted average price of $38.50 offset by 642,485 treasury shares used for RSUs vesting.

Share capitalTreasury StockAdditional paid-in capitalAccumulated Other Comprehensive Income (Loss)Retained EarningsEquity - attributable to shareholders of Criteo S.A.Non controlling interestTotal equity
Common sharesShares
(in thousands, except share data)
Balance at December 31, 202555,659,895$1,871(4,508,029)$(120,853)$706,321$(68,879)$630,750$1,149,210$36,519$1,185,729
Net income
7,8177,8177638,580
Other comprehensive loss(8,440)(8,440)(719)(9,159)
Issuance of ordinary shares
Change in treasury stocks(*)
(1,053,727)(5,537)(22,604)(2,828)(30,969)(30,969)
Share-Based Compensation15,00015,0005915,059
Other changes in equity196196(1)195
Balance at March 31, 202655,659,895$1,871(5,561,756)$(126,390)$698,717$(77,319)$635,935$1,132,814$36,621$1,169,435
(*) On February 6, 2026, Criteo's board of directors authorized an increase of the share repurchase program to up to $959.0 million of the Company's outstanding American Depositary Shares. The change in treasury stocks is comprised of 1,596,328 shares repurchased at a weighted average price of $19.40 offset by 542,601 treasury shares used for RSUs vesting.







The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.
5


CRITEO S.A.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Cash flows from operating activities
Net income
$8,580 $40,011 
Noncash and nonoperating items40,266 42,630 
    - Amortization and provisions28,569 23,583 
    - Share based compensation expense
13,347 15,409 
 - Gain (loss) on disposal of and impairment of long-lived assets
(749)547 
    - Change in uncertain tax positions427  
    - Change in deferred taxes2,007 6,888 
    - Change in income taxes(3,692)(4,288)
    - Other357 491 
Changes in assets and liabilities:(639)(20,300)
    - Trade receivables131,986 163,943 
    - Trade payables(112,841)(174,331)
    - Other assets
(24,515)(8,460)
    - Other liabilities
3,828 (145)
    - Operating lease liabilities and right of use assets
903 (1,307)
Net cash provided by operating activities48,207 62,341 
Cash flows from investing activities
Acquisition of intangible assets, property and equipment
(32,848)(17,091)
Disposal of intangible assets, property and equipment641  
Purchases of investment securities(17,319)(11,449)
Maturities and sales of investment securities11,613 11,002 
Net cash used in investing activities(37,913)(17,538)
Cash flows from financing activities
Proceeds from exercise of stock options 1,845 
Repurchase of treasury stocks(30,969)(56,168)
Change in other financing activities(316)(471)
Net cash used in financing activities(31,285)(54,794)
Effect of exchange rates changes on cash and cash equivalents(1,066)5,219 
Net decrease in cash and cash equivalents and restricted cash(22,057)(4,772)
Net cash and cash equivalents and restricted cash at the beginning of the period342,359 290,943 
Net cash and cash equivalents and restricted cash at the end of the period$320,302 $286,171 
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated statement of financial position
Cash and cash equivalents$319,981 $285,850 
Restricted cash, included in other current assets$321 $321 
Total cash, cash equivalents, and restricted cash$320,302 $286,171 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for taxes, net of refunds$(4,951)$(5,920)
Cash paid for interest$(527)$(244)
Noncash investing and financing activities
Intangible assets, property and equipment acquired through payables$12,204 $1,621 
The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.
6


CRITEO S.A.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Criteo S.A. was initially incorporated as a société par actions simplifiée, or S.A.S., under the laws of the French Republic on November 3, 2005, for a period of 99 years and subsequently converted to a société anonyme, or S.A.
On October 29, 2025, the Company announced its intention to pursue a transfer of its legal domicile from France to Luxembourg via a cross-border conversion (the "Conversion") and replace its American Depositary Shares ("ADSs") structure with ordinary shares to be directly listed on Nasdaq. On January 7, 2026, the Company announced that, following the favorable opinion of its works council, its Board of Directors has approved the Conversion and the replacement of its American Depositary Shares structure with ordinary shares to be directly listed on Nasdaq. On February 27, 2026, a general meeting of the Company's shareholders was held at the Company's registered office at 32 Rue Blanche, 75009 Paris, France, at which the Company's shareholders approved all the proposals for the Conversion and certain related proposals. The Conversion is expected to be completed in the third quarter of 2026. Following the Conversion, Criteo intends to pursue a subsequent transfer of its domicile from Luxembourg to the United States, subject to the Company's Board of Directors' determination that such action is in the best interests of the Company and its shareholders.

We are a global technology company that enables marketers and media owners to drive better commerce outcomes. We leverage commerce data and AI to connect ecommerce, digital marketing and media monetization to reach consumers throughout their shopping journey. Our vision is to deliver full-funnel, cross-channel, self-service advertising that performs.
Our strategy is to help marketers and media owners activate 1st-party, privacy-safe data and drive better commerce outcomes through our platform, which includes a suite of products:
that offer marketers (brands, retailers, and agencies) the ability to easily reach consumers anywhere throughout their shopping journey and measure their advertising campaigns
that offer media owners (publishers and retailers) the ability to monetize their advertising and promotions inventory for commerce anywhere where consumers spend their time
that are underpinned by our advanced AI engine, analyzing large sets of commerce data in real-time to drive hyper personalization and budget efficiency.
In these notes, Criteo S.A. is referred to as the "Parent" company and together with its subsidiaries, collectively, as "Criteo," the "Company," the "Group," or "we".


7


Note 1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements (the "Unaudited Condensed Consolidated Financial Statements") have been prepared by Criteo in accordance with generally accepted accounting principles in the United States of America ("GAAP") and pursuant to the applicable rules and regulations of the Securities and Exchange Commission ("SEC"), including regarding interim financial reporting. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.

The unaudited condensed consolidated financial statements included herein reflect all normal recurring adjustments that are, in the opinion of management, necessary to state fairly the results for the interim periods presented. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year ending December 31, 2026.

Use of Estimates

The preparation of our Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the period. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates.
On an on-going basis, management evaluates its estimates, primarily those related to: (1) revenue recognition (2) income taxes, (3) assumptions used in the valuation of long-lived assets including intangible assets, and goodwill, and (4) assumptions surrounding the recognition and valuation of contingent liabilities and losses.

Significant Accounting Policies

There have been no other significant changes to our accounting policies described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Reclassifications

Certain prior year amounts, which are not material, have been reclassified to conform to current year presentation in the consolidated financial statements and notes.

Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, which requires disaggregated disclosure of income statement expenses. This standard is effective for annual periods beginning after December 15, 2026, with early adoption permitted. We do not expect the adoption of this standard to have a material impact on our consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software, which simplifies the capitalization guidance by removing the references to project stages, among other changes. The new standard is effective for annual periods beginning after December 15, 2027. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.
In December 2025, the FASB issued ASU 2025-10, Government Grants, Accounting for Government Grants received by Business Entities, which establishes guidance for business entities on how to recognize, measure, present and disclose government grants received. The new standard is effective for annual periods beginning after December 15, 2028. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.
8


Note 2. Restructuring and Other Exit Costs

The Company may periodically initiate restructuring actions designed to improve operational efficiency, optimize its cost structure, and better align its workforce and operations with business needs and strategic priorities. These actions may include workforce reductions and other organizational realignments intended to support the Company’s long-term objectives. The Company records employee severance and other termination costs that meet the requirements for recognition in accordance with the relevant guidance of ASC 420, Exit or Disposal Cost Obligations, or ASC 712, Compensation – Nonretirement Postemployment Benefits, as applicable.
A summary of our Restructuring and Other Exit costs activity is presented as follows:
Severance Liability
(in thousands)
Restructuring liability as of December 31, 2025
$3,043 
Restructuring charge5,688 
Amounts paid (3,841)
Restructuring liability as of March 31, 2026
$4,890 
During the fourth quarter of 2025, the Company commenced a cost-reduction plan intended to improve operating efficiency and better align its cost structure with revenue levels. In connection with this plan, the Company incurred approximately $3.0 million of restructuring costs during the year ended December 31, 2025 and approximately $5.7 million during the period ended March 31, 2026, primarily reflected within Sales and Operations expense.
Note 3. Segment information
The Company reports segment information based on the management approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company's reportable segments. The Company reports its results of operations through the following two segments: Retail Media and Performance Media.
Retail Media: This segment encompasses revenue generated from brands, agencies and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services.

Performance Media: This segment encompasses our targeting capabilities and supply and AdTech services.

The Company's chief operating decision maker ("CODM"), our Chief Executive Office ("CEO"), allocates resources to and assesses the performance of each operating segment using information about Contribution ex-TAC, which is Criteo's segment profitability measure and reflects our gross profit plus other costs of revenue.
The CODM only reviews revenues and corresponding TAC for each segment, and is not regularly provided any other expense nor financial information for our two segments.
The following table shows revenue by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 

9


The following table shows TAC by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$682 $708 
Performance Media173,589 186,354 
Total Traffic Acquisition Costs$174,271 $187,062 

The following table shows Contribution ex-TAC by reportable segment and its reconciliation to the Company’s Consolidated Statements of Operation:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Contribution ex-TAC
Retail Media$40,589 $58,790 
Performance Media209,779 205,582 
$250,368 $264,372 
Other cost of revenue
27,626 27,396 
Gross profit$222,742 $236,976 
Operating expenses
Research and development expenses69,683 60,749 
Sales and operations expenses97,501 88,889 
General and administrative expenses45,158 39,171 
Total Operating expenses$212,342 $188,809 
Income from operations$10,400 $48,167 
Financial and other income1,873 2,302 
Income before tax$12,273 $50,469 
10


Note 4. Financial instruments

Fair Value Measurements
The following tables summarize our assets measured at fair value on a recurring basis and the classification by level of input within the fair value hierarchy:
March 31, 2026December 31, 2025
(in thousands)
Cash and Cash Equivalents
Level 1
Cash$165,557 $160,252 
Money Market funds103,481 89,157 
Level 2
Commercial paper11,426 35,139 
Term deposits28,745 41,614 
Structured debt securities10,772 15,876 
Total$319,981 $342,038 

Investment Securities
The following table presents for each reporting period, the breakdown of investment securities held at cost basis:
March 31, 2026December 31, 2025
(in thousands)
Securities Held-to-maturity
Commercial paper$22,599 $17,366 
Structured debt securities17,247 17,625 
Corporate debt securities11,498 11,750 
Total$51,344 $46,742 

The gross unrealized gains or (loss) on our investment securities were not material as of March 31, 2026 and December 31, 2025.
For our investment securities, the fair value approximates the carrying amount, given the nature of the term deposit and the maturity of the expected cash flows.
The following table classifies our held-to-maturity securities by contractual maturities:
Held-to-maturity
March 31, 2026
(in thousands)
Due in one year$28,348 
Due in one to five years22,996 
Total$51,344 
.
Our investments in nonmarketable equity securities were not material as of March 31, 2026 and for the year ended December 31, 2025.

11


Note 5. Trade Receivables
The following table shows the breakdown in trade receivables net book value for the presented periods:
March 31, 2026December 31, 2025
(in thousands)
Trade accounts receivables$471,460 $607,983 
(Less) Allowance for doubtful accounts(23,185)(25,881)
Net carrying value at end of period$448,275 $582,102 

Note 6. Goodwill
Goodwill allocated to the two reportable segments and the changes in the carrying amount for the three months ended March 31, 2026 were as follows:
Retail MediaPerformance MediaTotal
(in thousands)
Balance at January 1, 2026
$151,828 $383,933 $535,761 
Currency translation adjustment(547)(2,689)(3,236)
Balance at March 31, 2026
$151,281 $381,244 $532,525 

Note 7. Other Current and Noncurrent Assets
The following table presents the components of prepaid expenses and other current assets, net, for the periods presented:
March 31, 2026December 31, 2025
(in thousands)
Prepayments to suppliers
$52,409 $39,294 
Other current assets
17,188 13,916 
Total
$69,597 $53,210 
Prepayments to suppliers include capitalized costs related to the implementation of cloud computing arrangements that are service contracts and are amortized on a straight-line basis over the term of the associated hosting arrangements. As of March 31, 2026 and December 31, 2025 the gross capitalized implementation costs were $24.7 million and $25.6 million, respectively, and amortization expense related to these costs was $2.1 million and $2.0 million for the three months ended March 31, 2026 and March 31, 2025, respectively.
Other current assets include an indemnification receivable of $5.5 million related to a legal matter, restricted cash, and other non-trade receivables. As of March 31, 2026 and December 31, 2025, restricted cash was $0.3 million and $0.3 million, respectively.
Other noncurrent assets as of March 31, 2026 and December 31, 2025 of $46.8 million and $45.7 million, respectively, are primarily comprised of the indemnification asset of $37.2 million, recorded against certain tax liabilities related to the Iponweb Acquisition.


12


Note 8. Other Current and Noncurrent Liabilities
Other current liabilities are presented in the following table:
March 31, 2026December 31, 2025
(in thousands)
Rebates$35,369 $36,844 
Customer prepayments and deferred revenue
6,620 8,420 
Accounts payable relating to capital expenditures30,004 18,126 
Other creditors6,032 4,888 
Total$78,025 $68,277 
Accounts payable relating to capital expenditures are primarily related to the purchase of data center equipment.
Other noncurrent liabilities are presented in the following table:
March 31, 2026December 31, 2025
(in thousands)
Uncertain tax positions$29,205 $28,675 
Other3,198 3,151 
Total$32,403 $31,826 

Note 9. Leases
The components of lease expense are as follows:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Lease expense
$10,335 $7,993 
Short term lease expense135 69 
Variable lease expense414 493 
Sublease income(154)(300)
Total operating lease expense$10,730 $8,255 

13


Note 10. Employee Benefits
Defined Benefit Plans
According to French law and the Syntec Collective Agreement, French employees are entitled to compensation paid on retirement, equal to up to twelve months of their salary based on term of employment.
The following table summarizes the changes in the projected benefit obligation:
Projected benefit obligation
(in thousands)
Accumulated postretirement benefit obligation at January 1, 2025
$4,709 
Service cost
785 
Interest cost
200 
Actuarial losses (gains)
(622)
Currency translation adjustment
635 
Accumulated postretirement benefit obligation at December 31, 2025
$5,707 
Service cost
198 
Interest cost
64 
Actuarial losses (gains)
(118)
Currency translation adjustment
(126)
Accumulated postretirement benefit obligation at March 31, 2026
$5,725 
The Company does not hold any plan assets for any of the periods presented.
The main assumptions used for the purposes of the actuarial valuations are listed below:
Three Months EndedYear Ended
March 31, 2026December 31, 2025
Discount rate (Corp AA)
4.6%4.5%
Expected rate of salary increase
7.0%7.0%
Expected rate of social charges
50.0%50.0%
Expected staff turnover
Company age-based tableCompany age-based table
Estimated retirement age
65 years old65 years old
Life table
TH-TF 2000-2002 shiftedTH-TF 2000-2002 shifted

Defined Contribution Plans
The Company also provides qualified defined contribution plans primarily in France, the United States, and the United Kingdom. The most significant of these plans is the 401(k) Plan, which covers eligible U.S. employees. Employees can contribute to the plans a specified percentage of their eligible compensation, subject to matching contributions from the Company on behalf of the eligible employee. The following table shows the Company's agreed contributions, reported in the Consolidated Statement of Operations for the period.
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Defined contribution plan expenses
$4,832 $4,242 

14


Note 11. Share based Compensation

Share based Compensation Expense

Share based compensation expense recorded in the consolidated statements of operations was as follows:

Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Research and Development
$6,598 $5,589 
Sales and Operations
2,956 5,421 
General and Administrative
5,505 5,654 
Total Share based compensation expense$15,059 $16,664 
Share based Compensation capitalized as internal-use software costs
(1,712)(1,255)
Total Share based compensation expense net of capitalization$13,347 $15,409 


Restricted Stock Units and Performance Stock Units

During the three months ended March 31, 2026, the Company granted new equity awards under our current equity compensation plans, which were comprised of restricted stock units (“RSU”), and performance-based awards for the Company’s senior executives ("PSU").

Restricted Stock Units

Restricted stock units generally vest over four years, subject to the holder’s continued service. The grant date fair value is determined by the Company's Nasdaq share price the day prior to the grant.

The following table summarizes the activities for our unvested RSUs for the period ended March 31, 2026:

Shares (RSU)Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
4,518,697 $33.15 
Granted692,386 17.93 
Vested(344,695)30.34 
Forfeited(127,651)34.86 
Outstanding as of March 31, 2026
4,738,737 $31.09 

As of March 31, 2026, the Company had unrecognized stock-based compensation relating to restricted stock units of approximately $76.6 million, which is expected to be recognized over a weighted-average period of 3.1 years.


15


Performance Stock Units

Performance stock units (PSUs) are subject to either internal financial performance conditions (Financial PSUs) or external market conditions (TSR PSUs).


Financial PSUs
Financial PSUs are subject to service and performance-based vesting conditions. These awards generally vest over three years, and the number of shares ultimately earned may range from % to 200% of target, depending on achievement of specified internal financial performance metrics. The grant-date fair value is generally based on the closing price of the Company’s Nasdaq share price on the date preceding grant.

The following table summarizes the activities for our unvested Financial PSUs for the period ended March 31, 2026 (1):

Shares (Financial PSU)
Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
442,139 $31.89 
Granted
392,985 24.74 
Performance share adjustment
4,658 29.37 
Vested(195,018)32.43 
Forfeited(15,615)31.31 
Outstanding as of March 31, 2026
629,149 $27.25 

As of March 31, 2026, the Company had unrecognized stock-based compensation related to performance stock units of approximately $11.1 million, which is expected to be recognized over a weighted-average period of 3.4 years.

TSR PSUs
TSR PSUs are subject to service and market-based vesting conditions and are earned based on the Company’s total shareholder return relative to the Nasdaq Composite Index. These awards are generally measured in two equal tranches over two years and three years performance periods, respectively, and the number of shares ultimately earned may range from % to 200% of target for each tranche, depending on relative TSR performance.

The following table summarizes the activities for our unvested TSR PSUs for the period ended March 31, 2026:

Shares
(TSR PSU)
Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
313,383 $54.41 
Granted
332,744 27.39 
Vested(23,699)51.28 
Forfeited(121,859)54.57 
Outstanding as of March 31, 2026
500,569 $36.56 


(1) The number of Financial PSUs granted during the three months ended March 31, 2026 includes 60,242 PSUs previously modified from TSR PSUs, for which financial performance targets were established in March 2026 for the 2026 performance tranche.
16


The grant-date fair value is approximately $9.1 million, over the respective vesting period. The grant-date fair value was determined based on a Monte-Carlo valuation model using the following key assumptions:
Expected volatility of the Company39.70 %
Expected volatility of the benchmark81.68 %
Risk-free rate3.71 %
Expected dividend yield %
As of March 31, 2026, the Company had unrecognized stock-based compensation related to performance stock units based on market conditions of $13.6 million, which is expected to be recognized over a weighted-average period of 2.6 years.

Nonemployee warrants

Nonemployee warrants generally vest over four years, subject to the holder’s continued service through the vesting date.

SharesWeighted-Average Grant date Fair Value Per ShareWeighted-Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2025
159,897 $18.31 2.6$1,300.0 
Granted 
Exercised 
Canceled 
Expired 
Outstanding as of March 31, 2026
159,897 $18.31 2.4$1,300.0 
Vested and exercisable - March 31, 2026
159,897 

The aggregate intrinsic value represents the difference between the exercise price of the nonemployee warrants and the fair market value of common stock on the date of exercise. During the period ended March 31, 2026, there were no exercises of nonemployee warrants.

No new nonemployee warrants were granted in the period ending March 31, 2026. As of March 31, 2026 all instruments have fully vested.
17


Stock Options

Stock options granted under the Company’s stock incentive plans generally vest over four years, subject to the holder’s continued service through the vesting date and expire no later than 10 years from the date of grant.

Options Outstanding
Number of Shares Underlying Outstanding OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2025
86,715 $17.35 4.0$276.0 
Options granted 
Options exercised 
Options forfeited 
Options canceled 
Options expired(86,715)
Outstanding as of March 31, 2026
 $ 0.0$ 
Vested and exercisable as of March 31, 2026
 

The aggregate intrinsic value represents the difference between the exercise price of the options and the fair market value of common stock on the date of exercise. The aggregate intrinsic value of the stock options exercised was $0.0 million and $0.9 million for the period ended March 31, 2026, and December 31, 2025, respectively.
No new stock options were granted in the period ending March 31, 2026. As of March 31, 2026, there is no remaining unrecognized stock-based compensation related to unvested stock options.
18


Note 12. Financial and Other Income and Expenses
The condensed consolidated statements of income line item “Financial and Other Income” can be broken down as follows:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Financial income from cash equivalents$2,654 $1,680 
Interest and fees(764)(430)
Foreign exchange income24 1,072 
Other financial expense(41)(20)
Total financial and other income $1,873 $2,302 

Note 13. Income Taxes
The tax provision for interim periods is determined using an estimate of our annual effective tax rate (“AETR”), adjusted for discrete items arising in the period. To calculate our estimated AETR, we estimate our income before taxes and the related tax expense or benefit for the full fiscal year (total of expected current and deferred tax provisions), excluding the effect of significant unusual or infrequently occurring items or comprehensive income items not recognized in the statement of income. Each quarter, we update our estimate of the annual effective tax rate, and if our estimated annual tax rate does change, we make a cumulative adjustment in that quarter. Our quarterly tax provision, and our quarterly estimate of our annual effective tax rate, are subject to significant volatility due to several factors, including our ability to accurately predict our income (loss) before provision for income taxes in multiple jurisdictions. Our effective tax rate in the future will depend on the portion of our profits earned within and outside of France.
In December 2021, the Organization for Economic Cooperation and Development (OECD) released Pillar Two Model Rules defining the global minimum tax, which calls for the taxation of a minimum rate of 15% for multinational companies with consolidated revenue above €750 million. Numerous jurisdictions have enacted or are in the process of enacting legislation to adopt a minimum effective tax rate. While the adoption of Pillar Two did not have a material impact on the three months ended March 31, 2026, the Company will continue to assess the ongoing impact as additional guidance becomes available.
The following table presents provision for income taxes:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Provision for Income taxes$3,693 $10,458 
For the three months ended March 31, 2026, the provision for income taxes differs from the nominal standard French rate of 25.0% primarily due to the application of the reduced income tax rate on the majority of the technology royalties income in France.
19



Note 14. Earnings Per Share
Basic Earnings Per Share
The components of Basic earnings per share ("EPS") for the periods presented were as follows:
Three Months Ended
March 31, 2026March 31, 2025
Net income attributable to shareholders of Criteo S.A.
$7,817 $37,928 
Weighted average number of shares outstanding of Criteo S.A.
50,352,465 53,979,157 
Basic earnings per share$0.16 $0.70 
Diluted Earnings Per Share
Diluted EPS considers the impact of potentially dilutive shares not yet issued from share-based compensation plans using the treasury stock method. There were no other potentially dilutive instruments outstanding as of March 31, 2026 and 2025. Consequently, all potential dilutive effects from shares are considered.
For each period presented, a contract to issue a certain number of shares (i.e., stock options and nonemployee warrants) was assessed as potentially dilutive if it was “in the money” (i.e., the exercise or settlement price is lower than the average market price).

Three Months Ended
March 31, 2026March 31, 2025
Net income attributable to shareholders of Criteo S.A.$7,817 $37,928 
Basic shares:
Weighted average number of shares outstanding of Criteo S.A.50,352,465 53,979,157 
Dilutive effect of:
RSUs and PSUs
613,468 3,079,762 
Stock options
 82,956 
Share warrants 54,023 
Diluted shares:
Weighted average number of shares outstanding used to determine diluted earnings per share50,965,933 57,195,898 
Diluted earnings per share$0.15 $0.66 
The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows:
Three Months Ended
March 31, 2026March 31, 2025
Restricted share awards1,995,016 33,092 
Weighted average number of anti-dilutive securities excluded from diluted earnings per share1,995,016 33,092 

20


Note 15. Commitments and contingencies
From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, results of operations, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
The amount of the provisions represents management’s latest estimate of the expected impact.
Legal and Regulatory matters
Following a complaint from Privacy International against a number of advertising technology companies with certain data protection authorities, including in France, France's Commission Nationale de l'Informatique et des Libertés (the "CNIL") opened a formal investigation in January 2020 against Criteo. In June 2023, the CNIL issued its decision, which retained alleged European Union's General Data Protection Regulation ("GDPR") violations but reduced the financial sanction against Criteo from the original amount of €60 million ($69.0 million) to €40 million ($46.0 million). Criteo issued the required sanction payment during the third quarter of 2023. The decision relates to past matters and does not include any obligation for Criteo to change its current practices. Criteo appealed this decision before the French Council of State (Conseil d’Etat). On March 4, 2026, the Conseil d'État rejected the appeal and affirmed the CNIL's decision in full.
As previously disclosed, the Company is party to a claim (Doe vs. GoodRx Holdings, Inc. et al. in the U.S. District Court for the Northern District of California) alleging violations of various state and federal laws. In the third quarter of 2025, the Company agreed to settle the matter for $7.0 million, subject to court approval. GoodRx agreed to indemnify the Company for $5.5 million, subject to court approval of the settlement with plaintiffs. In January 2026, the court denied approval of the proposed settlement. The Company continues to engage in discussions with the plaintiffs and GoodRx to address the Judge’s requests and re-file the settlement agreement. Based on management's assessment of the underlying facts and circumstances, including the status of settlement discussions and the indemnification arrangement with GoodRx, the Company recorded an estimated probable loss of $7.0 million in 2025. As of March 31, 2026, this amount is presented within “Contingencies-current portion”, and an indemnification receivable of $5.5 million is presented within “Prepaid expenses and other current assets”. The results of legal proceedings are inherently uncertain and it is reasonably possible that the ultimate loss may differ from the Company's estimate.
On July 9, 2025, a putative class action was filed against the Company, CVS and others in the U.S. District Court for the Central District of California, alleging violations of various laws regarding sensitive health and personal information. On October 27, 2025, the action was dismissed with respect to the Company. On November 7, 2025, a second amended putative class action complaint was filed against the Company, CVS and others in the U.S. District Court for the Central District of California, again alleging violations of various laws regarding sensitive health and personal information. The plaintiffs seek damages and injunctive relief. On January 30, 2026, the plaintiff filed a stipulation to dismiss the case, and the parties are currently engaged in mediation. While the Company continues to dispute the allegations of wrongdoing, as of the quarter ended March 31, 2026, the Company has recorded an accrual that reflects management's current best estimate of probable loss related to this matter. The ultimate outcome of this matter may differ from the amount accrued. The Company does not believe the resolution of this matter will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.
On October 17, 2025, AlmondNet, Inc. and Intent IQ, LLC filed a patent-infringement lawsuit in the U.S. District Court for the District of Delaware. The complaint was served to the Company on October 21, 2025. The plaintiffs seek damages and injunctive relief. We dispute the allegations of wrongdoing and intend to defend ourselves vigorously in these matters.
Non-income tax risks
For the three months ended March 31, 2026, the provision related to certain non-income tax matters recognized under ASC 450 – Contingencies, as of March 31, 2026 and December 31, 2025, respectively, was $23.0 million and $22.7 million.
These risks were initially identified and recognized as part of the Iponweb Acquisition in 2022. In accordance with the purchase agreement relating to the acquisition, the Company is indemnified against specific tax risks, and as
21


such, an indemnification asset has been recorded. The indemnification asset is recorded as part of "Other noncurrent assets" on the consolidated statement of financial position.
22


Note 16. Breakdown of Revenue and Noncurrent Assets
The following table presents the Company's revenue disaggregated by major product for the periods presented:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Commerce Growth356,583 365,296 
Other26,785 26,640 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 

The Company operates in three geographical markets:
Americas: North and South America;
Europe, Middle-East and Africa; and
Asia-Pacific.
The following table discloses our consolidated revenue for each geographical area for each of the reported periods. Revenue by geographical area is based mainly on the location of advertisers’ campaigns.
Revenue generated in other significant countries where we operate is presented in the following table:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Americas$158,629 $192,908 
United States140,414 174,499 
EMEA$175,330 $164,861 
Germany50,436 45,983 
France20,250 19,439 
Asia-Pacific$90,680 $93,665 
Japan56,239 54,151 
For each reported period, noncurrent assets (corresponding to the net book value of tangible and intangible assets) are presented in the table below. The geographical information includes such noncurrent assets from the locations of legal entities.
AmericasEMEAAsia-PacificTotal
(in thousands)
March 31, 2026$79,139 $210,336 $14,751 $304,226 
December 31, 2025$69,785 $207,109 $14,289 $291,183 
23


Note 17. Subsequent Events

The Company evaluated all subsequent events that occurred after March 31, 2026 through the date of issuance of the unaudited condensed consolidated financial statements and determined there are no significant events that require adjustments or disclosure.
24


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission ("SEC"), on February 26, 2026. In addition to our historical condensed consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Quarterly Report on Form 10-Q, particularly in Part II, Item 1A, "Risk Factors."

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States of America ("GAAP"), we present Contribution ex-TAC, and Adjusted EBITDA, which are non-GAAP financial measures. We define Contribution ex-TAC as a profitability measure akin to gross profit. It is calculated by deducting traffic acquisition costs from revenue and reconciled to gross profit through the exclusion of other costs of revenue. Contribution ex-TAC is presented in the section entitled "Contribution excluding Traffic Acquisition Costs", which includes a reconciliation to its most directly comparable GAAP financial measure, Gross Profit. We define Adjusted EBITDA as our consolidated earnings before financial income (expense), income taxes, depreciation and amortization, adjusted to eliminate the impact of equity related compensation, which includes employee equity awards compensation and director fees for share purchases, pension service costs, certain acquisition costs, certain restructuring and related costs, integration and transformation costs, and other nonrecurring or noncash items impacting net income that we do not consider indicative of our ongoing business performance. Adjusted EBITDA is presented in the section entitled "Adjusted EBITDA", which includes a reconciliation to its most directly comparable GAAP financial measure, Net Income. We also present revenues, traffic acquisition costs and Contribution ex-TAC on a constant currency basis; these measures exclude the impact of foreign currency fluctuations and are computed by applying the average exchange rates for the prior year to the current year figures. A reconciliation is provided in the section entitled "Constant Currency Reconciliation".

We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and allow for greater transparency with respect to key metrics used by management in operating our business. As required by the rules of the SEC, we provide reconciliations of the non-GAAP financial measures contained in this document to the most directly comparable measures under GAAP.
Overview
We are a global technology company driving superior commerce outcomes for marketers and media owners through the world’s leading Commerce Intelligence Platform. We operate in digital advertising, leveraging commerce data and AI to connect ecommerce, digital marketing and media monetization to reach consumers throughout their entire shopping journey. Our vision is to be the leading global commerce intelligence platform that connects the commerce ecosystem and uses AI to power full-funnel, cross-channel advertising and agentic commerce experiences. We have accelerated and deeply transformed the Company from a single-product to a multi-solution platform provider, fast diversifying our business into new solutions.
We report our financial results based on two reportable segments: Retail Media and Performance Media.
Retail Media: This segment encompasses revenue generated from brands, agencies and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services.

Performance Media: This segment encompasses our targeting capabilities and supply and AdTech services.



25


Current quarter financial highlights
For the three months ended March 31, 2026, revenue decreased by (6)% to $424.6 million, compared to the same period in the prior year, due to decreases in Retail Media and Performance Media. At constant currency, revenue decreased by (9)%.
Gross profit for the three months ended March 31, 2026 decreased by (6)% to $222.7 million, compared to the same period in the prior year, primarily due to lower revenue in Retail Media and in Performance Media.
Contribution ex-TAC for the three months ended March 31, 2026 decreased by (5)% to $250.4 million, compared to the same period in the prior year, due to a decrease in Retail Media, slightly offset by an increase in Performance Media. At constant currency, Contribution ex-TAC decreased by (9)%.
Net income for the three months ended March 31, 2026 decreased by (79)% to $8.6 million, primarily driven by higher operating expenses and lower gross profit.
Adjusted EBITDA for the three months ended March 31, 2026 decreased by (30)% to $64.9 million, compared to the same period in the prior year, primarily due to lower revenue and higher operating expenses.

Cash flows from operating activities was $48.2 million for the three months ended March 31, 2026, compared to $62.3 million in the same period in the prior year. This decrease primarily reflects lower net income, partially offset by a lower use of net working capital compared to the same period in the prior year.
Trends, Opportunities and Challenges
We believe our performance and future success depend on several factors that present significant opportunities but also pose risks and challenges, including those referred to in Part I, Item 1A of our risk factor section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Develop and Scale our Commerce Intelligence Platform

Our future growth depends upon our ability to retain and scale our existing clients and increase the usage of our platform. We believe that we are in a leading position in the Commerce Intelligence space as we have unique commerce data at scale, deep integrations with retailers, a large client base, differentiated technology and an R&D powerhouse. By unifying the Commerce ecosystem with a multi-retailer, multi-channel, multi-format approach and providing full funnel closed loop measurement to our clients, we believe we are well positioned to capture more ad budgets and market share.

Business and Macroeconomic Conditions

During 2026, geopolitical conditions and macroeconomic disruption have been increasingly volatile. In particular, we have experienced an impact on marketing budgets in the Middle East and in our Travel vertical. More broadly, macroeconomic uncertainty, including inflationary pressures and interest rate conditions across our markets, may negatively impact consumer spending behavior, advertising budgets, and our business performance.
These factors, among others, make it difficult for Criteo and our clients to accurately forecast future business activities.

We continue to monitor macroeconomic conditions closely and may take actions in response to such conditions to the extent they adversely affect our business.

Seasonality

In the advertising industry, companies commonly experience seasonal fluctuations in revenue, as many marketers allocate the largest portion of their budgets to the third and fourth quarter of the calendar year in order to coincide with increased back-to-school and holiday purchasing. Historically, the fourth quarter has reflected our highest level of advertising activity for the year. We generally expect the subsequent first quarter to reflect lower activity levels.

In addition, historical seasonality may not be predictive of future results given the potential for changes in advertising buying patterns and consumer activity due to the potential impacts of the evolving macroeconomic and geopolitical conditions discussed above.

26


We expect our revenue to continue to fluctuate based on seasonal factors that affect the advertising industry as a whole.

Privacy Trends and Government Regulations

We are subject to U.S. and international laws and regulations regarding privacy, data protection, digital advertising and the collection of user data. In addition, large Internet and technology companies such as Google and Apple are making their own decisions as to how to protect consumer privacy with measures resulting in signal loss, which impact the entire digital ecosystem. We have developed a multi-pronged addressability strategy to provide scalability and runtime interoperability of privacy-safe solutions for a more open, unified and efficient ecosystem.
27


Results of Operations for the Periods Ended March 31, 2026 and March 31, 2025 (Unaudited)
Revenue

Revenue breakdown by segment
Three Months Ended
March 31, 2026March 31, 2025%
 change
(in thousands, except percentages)
Revenue as reported424,639 451,434 (6)%
Conversion impact U.S. dollar/other currencies(15,166)
Revenue at constant currency $409,473 $451,434 (9)%
Retail Media revenue as reported 41,271 59,498 (31)%
Conversion impact U.S. dollar/other currencies(667)
Retail Media revenue at constant currency $40,604 $59,498 (32)%
Performance Media revenue as reported383,368 391,936 (2)%
Conversion impact U.S. dollar/other currencies(14,499)
Performance Media revenue at constant currency $368,869 $391,936 (6)%


Revenue for the three months ended March 31, 2026 decreased (6)%, or (9)% on a constant currency basis, to $409.5 million compared to the three months ended March 31, 2025, reflecting decreases in Performance Media and Retail Media.

In the three months ended March 31, 2026, 92% of revenue came from existing clients while 8% came from new client additions.
Retail Media revenue decreased (31)%, or (32)% on a constant currency basis, to $40.6 million for the three months ended March 31, 2026, reflecting the impact of previously communicated scope changes with two specific Retail Media clients, partially offset by continued strength in Retail Media onsite.

Performance Media revenue decreased (2)%, or (6)% on a constant currency basis, to $368.9 million for the three months ended March 31, 2026, primarily due to mixed performance across Commerce Growth verticals, partially mitigated by improving trends in AdTech services, and momentum in our Supply Side Platform.

Additionally, our $424.6 million of revenue for the three months ended March 31, 2026 was positively impacted by $15.2 million of currency fluctuations, particularly as a result of the appreciation of the Euro, the Pound Sterling and the Brazilian Real compared to the U.S. dollar.


28


Revenue breakdown by region
Three Months Ended
March 31, 2026March 31, 2025%
 change
(in thousands, except percentages)
Revenue as reported424,639 451,434 (6)%
Conversion impact U.S. dollar / other currencies(15,166)— 
Revenue at constant currency $409,473 $451,434 (9)%
Americas
Revenue as reported158,629 192,908 (18)%
Conversion impact U.S. dollar / other currencies(1,783)— 
Revenue at constant currency
$156,846 $192,908 (19)%
EMEA
Revenue as reported175,330 164,861 6%
Conversion impact U.S. dollar / other currencies(15,237)— 
Revenue at constant currency
$160,093 $164,861 (3)%
Asia-Pacific
Revenue as reported90,680 93,665 (3)%
Conversion impact U.S. dollar / other currencies1,854 — 
Revenue at constant currency$92,534 $93,665 (1)%

Our revenue in the Americas region decreased (18)%, or (19)% on a constant currency basis, to $156.8 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. This primarily reflects the continued impact of previously communicated scope changes with two specific Retail Media clients and soft Retail trends for Performance Media, in particular related to Fashion.

Our revenue in EMEA increased 6%, or (3)% on a constant currency basis, to $160.1 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, reflecting softness in Marketplaces and Retail for Performance Media, partially offset by continued traction in Retail Media.

Our revenue in the Asia-Pacific region decreased (3)%, or (1)% on a constant currency basis, to $92.5 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, reflecting soft Retail trends in Performance Media, partially offset by solid Travel and Marketplaces trends in the region.





29


Cost of Revenue
Three Months Ended
March 31, 2026March 31, 2025%
 change
(in thousands, except percentages)
Traffic acquisition costs 174,271187,062(7)%
Other cost of revenue 27,62627,396%
Total cost of revenue$201,897$214,458(6)%
% of revenue48 %48 %
Gross profit %52 %52 %
Three Months Ended
March 31, 2026March 31, 2025%
change
(in thousands, except percentages)
Retail Media
682 708 (4)%
Performance Media173,589 186,354 (7)%
Traffic Acquisition Costs$174,271 $187,062 (7)%

Total cost of revenue for the three months ended March 31, 2026 decreased $(12.6) million, or (6)%, compared to the three months ended March 31, 2025. This decrease was the result of a decrease of $(12.8) million, or (7)% (or (10)% on a constant currency basis) in traffic acquisition costs, and an increase of $0.2 million, or 1% in other cost of revenue.

Traffic acquisition costs decreased by (7)%, or (10)% at constant currency, compared to the three months ended March 31, 2025. This decrease was driven primarily by a 25% decline in the number of impressions we purchased in Performance Media, partially offset by a 24% increase (or 17% at constant currency) in the average CPM for inventory purchased.

Other cost of revenue increased by $0.2 million or, 1% for the three months ended March 31, 2026.





30


Contribution excluding Traffic Acquisition Costs

We define Contribution excluding Traffic Acquisition Costs, "Contribution ex-TAC", as a profitability measure akin to gross profit. It is calculated by deducting traffic acquisition costs from revenue and reconciled to gross profit through the exclusion of other costs of revenue. Contribution ex-TAC is not a measure calculated in accordance with U.S. GAAP. We have included Contribution ex-TAC because it is a key measure used by our management and board of directors to evaluate operating performance, generate future operating plans and make strategic decisions. In particular, we believe that this measure can provide useful measures for period-to-period comparisons of our business. Accordingly, we believe that Contribution ex-TAC provides useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management and board of directors. Our use of Contribution ex-TAC has limitations as an analytical tool, and you should not consider them in isolation or as a substitute for analysis of our financial results as reported under U.S. GAAP. Some of these limitations are: (a) other companies, including companies in our industry which have similar business arrangements, may address the impact of TAC differently; (b) other companies may report Contribution ex-TAC or similarly titled measures but calculate them differently, which reduces their usefulness as a comparative measure. Because of these and other limitations, you should consider Contribution ex-TAC alongside our other U.S. GAAP financial measures.

The below table provides a reconciliation of Contribution ex-TAC to gross profit:

Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Gross Profit$222,742 $236,976 
Other Cost of Revenue27,626 27,396 
Contribution ex-TAC $250,368 $264,372 

We consider Contribution ex-TAC as a key measure of our business activity. Our strategy focuses on maximizing our Contribution ex-TAC on an absolute basis over maximizing our near-term gross margin. We believe this focus builds sustainable long-term value for our business by fortifying a number of our competitive strengths, including access to advertising inventory, breadth and depth of data and continuous improvement of our Criteo AI Engine’s performance, allowing it to deliver more relevant advertisements at scale. As part of this focus, we continue to invest in building preferred relationships with direct publishers and pursue access to leading advertising exchanges.
The following table sets forth our revenue and Contribution ex-TAC by segment:
Three Months Ended
March 31, 2026March 31, 2025%
change
(amounts in thousands, except percentages)
Revenue
Retail Media$41,271 $59,498 (31)%
Performance Media383,368 391,936 (2)%
Total$424,639 $451,434 (6)%
Contribution ex-TAC
Retail Media$40,589 $58,790 (31)%
Performance Media209,779 205,582 2%
Total$250,368 $264,372 (5)%

Contribution ex-TAC decreased $(14.0) million, or (5)% for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The decrease in Contribution ex-TAC was due to a decrease in Retail Media, reflecting the impact of previously communicated scope changes with two specific Retail Media clients, partially offset by continued strength in Retail Media onsite and an increase in Performance Media.
31


Constant Currency Reconciliation
Information in this Form 10-Q with respect to results presented on a constant currency basis was calculated by applying prior period average exchange rates to current period results. Management reviews and analyzes business results excluding the effect of foreign currency translation because they believe this better represents our underlying business trends. Below is a table which reconciles the actual results presented in this section with the results presented on a constant currency basis:
Three Months Ended
March 31, 2026March 31, 2025%
change
(amounts in thousands, except percentages)
Revenue as reported$424,639 $451,434 (6)%
Conversion impact U.S. dollar/other currencies(15,166)— 
Revenue at constant currency$409,473 $451,434 (9)%
Traffic acquisition costs as reported$174,271 $187,062 (7)%
Conversion impact U.S. dollar/other currencies(5,692)— 
Traffic Acquisition Costs at constant currency$168,579 $187,062 (10)%
Contribution ex-TAC as reported$250,368 $264,372 (5)%
Conversion impact U.S. dollar/other currencies(9,474)— 
Contribution ex-TAC at constant currency$240,894 $264,372 (9)%
Other cost of revenue as reported$27,626 $27,396 1%
Gross Profit as reported$222,742 $236,976 (6)%



32


Research and Development Expenses
Three Months Ended
March 31, 2026March 31, 2025%
change
(in thousands, except percentages)
Research and development expenses$69,683 $60,749 15%
% of revenue16 %13 %
Research and development expenses for the three months ended March 31, 2026, increased $8.9 million or 15% compared to the three months ended March 31, 2025. This increase was driven by higher headcount costs and related impact of the appreciation of the euro compared to the U.S. dollar, higher amortization expense related to internally developed intangible assets and higher third-party services.

Sales and Operations Expenses
Three Months Ended
March 31, 2026March 31, 2025%
change
(in thousands, except percentages)
Sales and operations expenses$97,501 $88,889 10%
% of revenue23 %20 %
Sales and operations expenses for the three months ended March 31, 2026 increased $8.6 million or 10% compared to the three months ended March 31, 2025. This increase was driven by higher restructuring and other headcount costs and related impact of the appreciation of the euro compared to the U.S. dollar, higher bad debt expense, partially offset by lower share-based compensation.

General and Administrative Expenses
Three Months Ended
March 31, 2026March 31, 2025%
change
(in thousands, except percentages)
General and administrative expenses$45,158 $39,171 15%
% of revenue11 %%
General and administrative expenses for the three months ended March 31, 2026, increased $6.0 million or 15%, compared to the three months ended March 31, 2025. This increase was mainly driven by an accrual for a litigation matter, higher transformation costs, and higher headcount related costs.
33


Financial and Other Income
Three Months Ended
March 31, 2026March 31, 2025%
change
(in thousands, except percentages)
Financial and other income
$1,873 $2,302 (19)%
% of revenue0.4 %%
Financial and other income for the three months ended March 31, 2026, decreased by $(0.4) million or (19)% compared to the three months ended March 31, 2025. This decrease was due to a lower positive impact of foreign exchange, including end of year noncash changes in fair value of financial instruments and higher interest expense, partially offset by higher interest income.

Provision for Income Taxes
Three Months Ended
March 31, 2026March 31, 2025%
change
(in thousands, except percentages)
Provision for Income taxes$3,693 $10,458 (65)%
% of revenue%%
Provision for income tax expense for the three months ended March 31, 2026, decreased $(6.8) million or (65)% compared to the three months ended March 31, 2025. The decrease was driven by a decrease of profit before tax.
The provision for income taxes differs from the nominal standard French rate of 25.0% primarily due to the application of the reduced income tax rate on the majority of the technology royalties income in France.

34


Adjusted EBITDA
We define Adjusted EBITDA as our consolidated earnings before financial income (expense), income taxes, depreciation and amortization, adjusted to eliminate the impact of equity related compensation, which includes employee equity awards compensation and director fees for share purchases, pension service costs, certain acquisition costs, certain restructuring and related costs, integration and transformation costs, and other nonrecurring or noncash items impacting net income that we do not consider indicative of our ongoing business performance. Adjusted EBITDA is not a measure calculated in accordance with GAAP. We have included Adjusted EBITDA because it is a key measure used by our management and board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short-term and long-term operational plans. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management and board of directors. Our use of Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our financial results as reported under GAAP. Some of these limitations are: (a) although depreciation and amortization are noncash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements; (b) Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; (c) Adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation; (d) Adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us; and (e) other companies, including companies in our industry, may calculate Adjusted EBITDA or similarly titled measures differently, which reduces their usefulness as a comparative measure. Because of these and other limitations, you should consider Adjusted EBITDA alongside our GAAP financial results, including net income.
Three Months Ended
March 31, 2026March 31, 2025
(in thousands, except percentages)
Net Income
$8,580 $40,011 
Adjustments:
Financial income
(1,873)(1,948)
Provision for income taxes3,693 10,458 
Equity awards compensation expense13,822 15,880 
Pension service costs198 183 
Depreciation and amortization expense28,367 25,693 
Restructuring, integration and transformation costs10,162 1,871 
Other noncash or nonrecurring events (2)
1,950 — 
Total net adjustments56,319 52,137 
Adjusted EBITDA (1)
$64,899 $92,148 
(1) Refer to the "Non-GAAP Financial Measures" section for the definition of this Non-GAAP metric.
(2) Includes costs related to nonrecurring litigation matters.








35


The following table presents our Net Income and Adjusted EBITDA on a comparative basis:
Three Months Ended
March 31, 2026March 31, 2025% change
(in thousands, except percentages)
Net Income
$8,580 $40,011 (79)%
Adjusted EBITDA$64,899 $92,148 (30)%
Net income decreased $(31.4) million, or (79)%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025, and adjusted EBITDA decreased $(27.2) million, or (30)%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The decrease in net income and adjusted EBITDA was primarily due to higher operating expenses and lower gross profit.
36


Liquidity and Capital Resources
Our cash and cash equivalents, and restricted cash at March 31, 2026 were held for working capital and general corporate purposes, which could include acquisitions, and amounted to $320.3 million as of March 31, 2026. The $(22.1) million decrease in cash and cash equivalents, and restricted cash compared to December 31, 2025, primarily resulted from a decrease of $(31.3) million in cash used for financing activities, a decrease of $(37.9) million in cash used for investing activities, partially offset by an increase of $48.2 million in cash provided by operating activities over the period. Our policy is to invest any cash in excess of our immediate requirements in investments designed to preserve the principal balance and provide liquidity. Accordingly, our cash and cash equivalents are invested primarily in demand deposit accounts that are currently providing only a minimal return.
As disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, on September 27, 2022, the Company entered into a new five year Revolving Credit Facility (as amended, the "RCF") that allows immediate access to an additional €407.0 million ($468.0 million) of liquidity. The RCF, combined with $320.0 million of cash and cash equivalents, $51.3 million of marketable securities, and $49.4 million of treasury shares available for M&A, provides total financial liquidity of $888.7 million as of March 31, 2026. Subsequent to March 31, 2026, the Company cancelled 1.9 million of M&A treasury shares in April, representing approximately $39 million.
Overall, we believe that our current financial liquidity, combined with our expected cash flow generation in 2026, enables financial flexibility.
Share repurchase programs
For the three months ended March 31, 2026, we have repurchased $31.0 million of shares. During the year ended December 31, 2025, we completed a $152.1 million share repurchase.
All above programs have been implemented under our multi-year authorization granted by our board of directors. In February 2026, this authorization was extended to a total amount of up to $959.0 million. Other than these repurchase programs, we intend to retain all available funds and any future earnings to fund our growth.
Off-Balance Sheet Arrangements
We do not have any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities that are established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. We therefore believe that we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in these relationships.
Operating and Capital Expenditure Requirements
For the three months ended March 31, 2026 and 2025, our net capital expenditures were $(32.2) million and $(17.1) million, respectively, primarily related to the acquisition of servers and other data center equipment, and capitalized software development costs. We expect our capital expenditures to be at mid-teens percent of Contribution ex-TAC for 2026, as we plan to continue to build, reshape and maintain additional data center equipment capacity in all regions and we keep investing in our Commerce Intelligence Platform.
Our future working capital requirements will depend on many factors, including the rate of our revenue growth, the amount and timing of our investments in personnel and capital equipment, and the timing and extent of our introduction of new products and product enhancements.
We believe our existing cash balances will be sufficient to meet our anticipated cash requirements through at least the next 12 months.
If our cash and cash equivalents balances and cash flows from operating activities are insufficient to satisfy our liquidity requirements, we may need to raise additional funds through equity, equity-linked or debt financing to support our operations, and such financings may not be available to us on acceptable terms, or at all.
37


We may also seek to raise additional funds in the future to support potential acquisitions of businesses, technologies, assets or products.
If we are unable to raise additional funds when needed, our operations and ability to execute our business strategy could be adversely affected. If we raise additional funds through the incurrence of indebtedness, such indebtedness would have rights that are senior to holders of our equity securities and could contain covenants that restrict our operations. Any additional equity financing will be dilutive to our shareholders.
Historical Cash Flows
The following table sets forth our cash flows for the three months ended March 31, 2026 and March 31, 2025:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Cash flows provided by operating activities $48,207 $62,341 
Cash used in investing activities
$(37,913)$(17,538)
Cash used in financing activities
$(31,285)$(54,794)
Operating Activities
Cash provided by operating activities has typically been generated from net income and by changes in our operating assets and liabilities, particularly in the areas of accounts receivable and accounts payable and accrued expenses, adjusted for certain noncash and nonoperating expense items such as depreciation, amortization, equity awards compensation, deferred tax assets and income taxes.
For the three months ended March 31, 2026, net cash provided by operating activities was $48.2 million, consisting mostly of net income adjusted for certain noncash and nonoperating items, including amortization and provision expense of $28.6 million, and share based compensation expense of $13.3 million, partially offset by $(0.6) million of changes in working capital. The decrease in cash flows from operating activities during the three months ended March 31, 2026, compared to the same period in 2025, was primarily due to lower net income, partially offset by improved working capital.
Investing Activities
For the three months ended March 31, 2026, net cash used for investing activities was $37.9 million, primarily driven by capitalized software development costs and the acquisition of servers and other data center equipment.
Cash used for investing activities increased during the three months ended March 31, 2026, compared to the same period in 2025, due to higher purchases in data center equipment and higher software development costs.
Financing Activities
For the three months ended March 31, 2026, net cash used for financing activities was $31.3 million, due to the repurchasing of shares of $31.0 million. The decrease in cash used for financing activities during the three months ended March 31, 2026, compared to the same period in 2025, was mostly due to a decrease in the amount of shares repurchased.
Critical Accounting Policies and Estimates
There have been no material changes to our critical accounting policies and estimates from the information provided in Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Recently Issued Pronouncements
38


See "Recently Issued Accounting Standards" under Note 1, "Summary of Significant Accounting Policies," of the Notes to Unaudited Condensed Consolidated Financial Statements for a discussion of certain accounting standards that have been issued during 2026.
39


Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market Risk
We are mainly exposed to foreign currency exchange rate fluctuations. There have been no material changes to our exposure to market risk during the three months ended March 31, 2026.
    
For a description of our foreign exchange risk, please see "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - B. Liquidity and Capital Resources" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
A hypothetical 10% increase or decrease of the Pound Sterling, the Brazilian real, the Japanese yen or the Euro against the U.S. dollar would have impacted the Condensed Consolidated Statements of Income as follows:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
GBP/USD +10%-10%+10%-10%
Net income (loss) impact $(16)$16 $481 $(481)
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
BRL/USD +10%-10%+10%-10%
Net income (loss) impact $21 $(21)$39 $(39)
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
JPY/USD +10%-10%+10%-10%
Net income (loss) impact $224 $(224)$613 $(613)
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
EUR/USD +10%-10%+10%-10%
Net income (loss) impact $720 $(720)$534 $(534)

Credit Risk and Trade Receivables
For a description of our trade receivables, please see "Note 5. Trade Receivables" in the Notes to the Unaudited Condensed Consolidated Financial Statements.

40


Item 4. Controls and Procedures
Disclosure Controls and Procedures
Based on their evaluation as of March 31, 2026, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective to provide reasonable assurance that (i) the information required to be disclosed in our reports filed or submitted under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and (ii) such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting identified in management's evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitation on Effectiveness of Controls and Procedures
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Criteo have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies and procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

41


PART II
Item 1.    Legal Proceedings
For a discussion of our legal proceedings, refer to Note 15. Commitments and contingencies.
Item 1A. Risk Factors
You should carefully consider the risks described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025. These risks and uncertainties are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, also may become important factors that affect us. If any such risks materialize, our business, financial condition and results of operations could be materially harmed and the trading price of our American Depositary Shares could decline. These risks are not exclusive and additional risks and uncertainties that we are unaware of, or that we currently believe are not material, also may become important factors that affect us. The following risk factor is provided to update the risk factors previously disclosed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 26, 2026. Except as presented below, there have been no material changes to the Risk Factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Regulatory, legislative or self-regulatory developments regarding internet or online matters could adversely affect our ability to conduct our business.

Governmental authorities around the world have enacted, considered or are considering legislation or regulations that could significantly restrict our ability to collect, process, use, transfer and pool data collected from and about consumers and devices. Trade associations and industry self-regulatory groups have also promulgated best practices and other industry standards relating to targeted advertising.

In the EU, the two main pillars of the data protection legal framework remain the E-Privacy Directive and the GDPR. The E-Privacy Directive mandates that the placing or reading of information in a user's device, such as through a cookie and other tracking technologies, requires such user’s express consent. The European Data Protection Board has also published guidelines expanding the list of what is a tracking technology under the E-Privacy Directive, limiting our possibility to rely on certain technologies such as racking links and URL.

Under GDPR, data protection authorities have the power to impose administrative fines of up to a maximum of €20 million or 4% of the data controller’s or data processor’s total worldwide turnover from the preceding financial year. High sanctions are also applicable under the E-Privacy Directive.

Further, on October 1, 2020, the French data protection authority (the Commission Nationale de l'Informatique et des Libertés, or the “CNIL”) issued the final version of its guidelines on the use of cookies and other trackers and its final recommendations on modalities for obtaining users’ consent to store or read non-essential cookies and similar technologies on their devices. The recommendations provide that, when required, consent must be indicated by a clear and positive action of the data subject, such as by clicking on an “accept all” button on the first layer of the consent management platform. The CNIL also noted that it should be as easy to refuse consent to the use of cookies as it is to accept consent, and an equivalent “refuse all” button should be present on the first layer of the consent management platform. Further, the ability to withdraw consent must be always readily available. Companies had until March 2021 to ensure compliance with these guidelines. The CNIL has launched investigations and sanctioned companies for lack of compliance with its guidelines on cookies. The European Center for Digital Rights (“NOYB”) has also filed several complaints with data protection authorities for failure to comply with GDPR requirements.

In January 2020, the CNIL opened a formal investigation into Criteo. In June 2023, the CNIL issued its decision, which retained alleged GDPR violations but reduced the financial sanction against Criteo from the original amount of 60 million ($69.0 million) to €40 million ($46.0 million). Criteo made the required sanction payment in the third quarter of 2023. The decision relates to past matters and does not include any obligation for Criteo to change its current practices. Criteo appealed this decision before the Conseil d’Etat. On March 4, 2026, the Conseil d’Etat rejected Criteo’s appeal and confirmed the CNIL’s decision in full. Refer to Note 15 Commitments and contingencies, for more information.

42



In November 2025, the European Commission proposed a broad package of amendments to the GDPR intended to modernize and align the EU’s data protection framework with other digital regulations. The proposals would, among other things, clarify the definition of personal data, introduce new legal bases for the development and operation of AI systems, adjust breach-notification thresholds and timelines, and consolidate certain E-Privacy and cookie-related provisions directly into the GDPR. In particular, the draft would permit the use of standardized, browser- or device-level consent signals to express user preferences, potentially reducing our clients’, publisher and retailer partners’ ability to manage consent collection through their own interfaces. If adopted, these reforms could alter the scope of lawful processing, affect how we collect and use data for advertising and measurement, and increase operational and compliance complexity. The timing, final content, and enforcement approach of these reforms remain uncertain, and any resulting changes could materially impact our business, financial condition, or results of operations.

In 2018, the State of California adopted the CCPA, which went into effect on January 1, 2020, and requires covered companies to, among other things, provide new disclosures to California consumers and afford such consumers new abilities to opt out of the sale of their personal information. The California Privacy Rights Act (the “CPRA”), which both amends and expands the scope of the CCPA and creates additional privacy rights and protections for California consumers with respect to their personal information and additional obligations on businesses became effective January 1, 2023. California’s privacy regulations continue to evolve with new rules on data broker registration, automated decision-making and cybersecurity audits, and enforcement activity is accelerating.

In September 2025, the California Privacy Protection Agency approved final regulations under the CCPA that significantly expand business obligations and consumer rights in California, including mandatory risk-assessments and annual cybersecurity audits for certain businesses; new rules governing the use of automated decision-making technology in connection with “significant decisions” about consumers; and enhanced disclosures, consent/opt-out mechanisms and documentation requirements in connection with consumer privacy rights. These new regulations will begin to take effect on January 1, 2026, with phased compliance deadlines. Because the ultimate reach and enforcement of these obligations are still evolving, the implementation of these rules could require significant changes to our data-collection, processing, governance, audit and compliance frameworks.

In addition, other states in the U.S. are quickly adopting state enacted privacy laws. Currently, more than 20 states in the U.S have passed consumer and privacy laws. Although many of these laws are modeled in part on the CCPA and CPRA, they vary in important respects, including definitions of “sale” or “sharing,” requirements for targeted advertising opt-outs, data-protection impact assessments, and enforcement mechanisms. This patchwork of state privacy laws increases the complexity of our compliance obligations, may require modifications to our data-handling practices, systems, and consumer interfaces. We cannot predict the full effect of these laws and regulations on our business, but adapting our business to comply with them could involve substantial resources and expense, regulatory exposure, and may cause us to divert resources from other aspects of our business, all of which may adversely affect our business.

Clarifications of and changes to these existing and proposed laws, regulations, judicial interpretations and industry standards can be costly to comply with, and sometimes contradictory, and we may be unable to pass along those costs to our clients in the form of increased fees, which may negatively affect our operating results. Such changes can also delay or impede the development of new solutions, result in negative publicity and reputational harm, require significant management time and attention, increase our risk of non-compliance and subject us to claims or other remedies, including fines or demands that we modify or cease existing business practices. Additionally, any perception of our practices or solutions as an invasion of privacy, whether such practices or solutions are consistent with current or future regulations and industry practices, may subject us to public criticism, private class actions, reputational harm or claims by regulators, which could disrupt our business and expose us to increased liability. Finally, our legal and financial exposure often depends in part on our clients’, publisher and retailer partners’ or other third parties' adherence to and compliance with privacy laws and regulations and their use of our services in ways consistent with users’ expectations.

If our clients or publisher and retail partners fail to adhere to our contracts in this regard, or a court or governmental agency determines that we have not adequately, accurately or completely described our own solutions, services and data collection, use and sharing practices in our own disclosures to consumers, then we and our clients and publisher and retailer partners may be subject to potentially adverse publicity, damages and investigation or other regulatory activity in connection with our privacy practices or those of our clients.
43



Beyond privacy, AI regulation is emerging as a major compliance frontier. Given our long history developing, using, and innovating through AI with the Criteo AI Engine, this could increase costs or restrict opportunities. Compliance with existing, expanding, or new laws and regulations regarding AI or use of data to train AI, including the EU AI Act adopted on July 12, 2024 and other data protection laws, may involve significant costs or require changes in products or business practices that could adversely affect our results of operations. In November 2025, the European Commission published the Digital Omnibus on AI Regulation Proposal, which would amend the AI Act by introducing flexible timelines for compliance with high-risk AI obligations, expanding the supervisory role of the European Artificial Intelligence Office, allowing sensitive data processing for bias mitigation and adjusting registration burdens and proportionality requirements. These reforms may require us to modify how we access, train or deploy foundation models or general-purpose AI, undertake additional documentation, governance, oversight and monitoring, and align with evolving definitions of what constitutes an AI “system” or “provider.”
Any failure to adapt could adversely affect our product development, business practices, competitive positioning and results of operations. Additionally, our ability to innovate may be affected if we are unable to access foundation models and general-purpose AI ("GPAI") in the same manner as our non-EU competitors as these GPAI providers may choose to avoid the EU market due to its regulatory complexity.
44


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the issuer and Affiliated Purchasers
The following table provides certain information with respect to our purchases of our ADSs during the first fiscal quarter of 2026:
Period
Total Number of Shares Purchased(1)
Average Price Paid per Share(2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(1)
January 1 to 31, 2026698,046 $20.44 698,046 $206,862,142 
February 1 to 28, 2026733,282 $18.44 733,282 $193,331,696 
March 1 to 31, 2026165,000 $19.15 165,000 $190,170,521 
Total1,596,328 1,596,328 
(1) On February 6, 2026, the Board of Directors authorized an increase of the previously authorized share repurchase program from up to $805.0 million to up to $959.0 million of the Company’s outstanding American Depositary Shares.
(2) Weighted average price paid per share excludes any broker commissions paid.
Item 5. Other Information
Trading Plans
During the three months ended March 31, 2026, no directors or Section 16 officers of the Company adopted or terminated any Rule 10b5-1 trading arrangement or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.

45


Item 6. Exhibits
Exhibit Index
Incorporated by Reference
ExhibitDescriptionSchedule/ FormFile
Number
ExhibitFile
Date
8-K001-361533.14/28/2026
101.INS
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Extension Calculation Link base Document
101.DEF
XBRL Taxonomy Extension Definition Link base Document
101.LAB
XBRL Taxonomy Extension Labels Linkbase Document
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File, formatted in Inline XBRL and contained in Exhibit 101.
#    Filed herewith.
*    Furnished herewith.
46


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 CRITEO S.A.
 (Registrant)
By:
/s/ Sarah Glickman
Date: May 6, 2026Name:Sarah Glickman
Title: Chief Financial Officer
 (Principal financial officer and duly authorized signatory)
47
EX-31.1 2 exhibit311ceocertificateq1.htm EX-31.1 Document

Exhibit 31.1
Certification by the Chief Executive Officer pursuant to
Securities Exchange Act Rules 13a-14(a) and 15d-14(a)
as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Michael Komasinski, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Criteo S.A.;
2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.     The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.     The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 6, 2026            
/s/ Michael Komasinski
Michael Komasinski
Chief Executive Officer
(Principal Executive Officer)


EX-31.2 3 exhibit312cfocertificateq1.htm EX-31.2 Document

Exhibit 31.2
Certification by the Chief Financial Officer pursuant to
Securities Exchange Act Rules 13a-14(a) and 15d-14(a)
as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Sarah Glickman, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Criteo S.A.;
2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.     The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.     The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 6, 2026                
/s/ Sarah Glickman
Sarah Glickman
Chief Financial Officer


EX-32.1 4 exhibit321ceocfocertificat.htm EX-32.1 Document

Exhibit 32.1
Certification by the Chief Executive Officer and Chief Financial Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Michael Komasinski, Chief Executive Officer of Criteo S.A. (the “Company”), and Sarah Glickman, Chief Financial Officer of the Company, each hereby certifies that, to the best of his/her knowledge:
1.    The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2026, to which this Certification is attached as Exhibit 32.1 (the “Quarterly Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and
2.    The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 6, 2026
/s/ Michael Komasinski/s/ Sarah Glickman
Michael KomasinskiSarah Glickman
Chief Executive OfficerChief Financial Officer



This certification accompanies the Quarterly Report, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Quarterly Report), irrespective of any general incorporation language contained in such filing.


EX-101.SCH 5 crto-20260331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952157 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Restructuring and Other Exit Costs link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Segment information link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Financial instruments link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Trade Receivables link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Other Current and Noncurrent Assets link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Other Current and Noncurrent Liabilities link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Employee Benefits link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Share-based Compensation link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - Financial and Other Income and Expenses link:presentationLink link:calculationLink link:definitionLink 9952170 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 9952171 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 9952172 - Disclosure - Commitments and contingencies link:presentationLink link:calculationLink link:definitionLink 9952173 - Disclosure - Breakdown of Revenue and Noncurrent Assets link:presentationLink link:calculationLink link:definitionLink 9952174 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 9955511 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9955512 - Disclosure - Restructuring and Other Exit Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 9955513 - Disclosure - Segment information (Tables) link:presentationLink link:calculationLink link:definitionLink 9955514 - Disclosure - Financial instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 9955515 - Disclosure - Trade Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 9955516 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 9955517 - Disclosure - Other Current and Noncurrent Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9955518 - Disclosure - Other Current and Noncurrent Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9955519 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9955520 - Disclosure - Employee Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 9955521 - Disclosure - Share-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9955522 - Disclosure - Financial and Other Income and Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 9955523 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9955524 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9955525 - Disclosure - Breakdown of Revenue and Noncurrent Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9955526 - Disclosure - Restructuring and Other Exit Costs - Summary of restructuring activities included in other current liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955527 - Disclosure - Restructuring and Other Exit Costs - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955528 - Disclosure - Segment information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955529 - Disclosure - Segment information - Schedule of Segment Reporting Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955530 - Disclosure - Financial instruments - Fair Value Assets Measured on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9955531 - Disclosure - Financial instruments - Schedule of Breakdown of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9955532 - Disclosure - Financial instruments - Schedule of Marketable Securities by Contractual Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9955533 - Disclosure - Trade Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 9955534 - Disclosure - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9955535 - Disclosure - Other Current and Noncurrent Assets - Breakdown in other current assets (Details) link:presentationLink link:calculationLink link:definitionLink 9955536 - Disclosure - Other Current and Noncurrent Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955537 - Disclosure - Other Current and Noncurrent Liabilities - Schedule of Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955538 - Disclosure - Other Current and Noncurrent Liabilities - Schedule of Other Noncurrent Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955539 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9955540 - Disclosure - Employee Benefits - Schedule of Accumulated and Projected Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9955541 - Disclosure - Employee Benefits - Schedule of Assumptions Used for Actuarial Valuations (Details) link:presentationLink link:calculationLink link:definitionLink 9955542 - Disclosure - Employee Benefits - Schedule of Defined Contribution Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9955543 - Disclosure - Share-based Compensation - Equity Awards Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9955544 - Disclosure - Share-based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955545 - Disclosure - Share-based Compensation - RSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9955546 - Disclosure - Share-based Compensation - PSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9955547 - Disclosure - Share-based Compensation - Performance Stock Units Total Shareholder Return Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9955548 - Disclosure - Share-based Compensation - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 9955549 - Disclosure - Share-based Compensation - Options Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9955550 - Disclosure - Financial and Other Income and Expenses - Schedule of Financial Income (Details) link:presentationLink link:calculationLink link:definitionLink 9955551 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9955552 - Disclosure - Earnings Per Share - Schedule of Basic Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9955553 - Disclosure - Earnings Per Share - Schedule of Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9955554 - Disclosure - Earnings Per Share - Anti-Dilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9955555 - Disclosure - Commitments and contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9955556 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue by Product and Services (Details) link:presentationLink link:calculationLink link:definitionLink 9955557 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955558 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue Generated in Other Significant Countries (Details) link:presentationLink link:calculationLink link:definitionLink 9955559 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Non-Current Assets by Geographical Area and Country (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 crto-20260331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 crto-20260331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 crto-20260331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Award Timing Predetermined Award Timing Predetermined [Flag] Gain (loss) on disposal of and impairment of long-lived assets Gain (Loss) on Disposal of and Impairment of Long-Lived Assets Gain (Loss) on Disposal of and Impairment of Long-Lived Assets Entity File Number Entity File Number Additional paid-in capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Leases [Abstract] Schedule of Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Shares Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right Schedule of Investment Securities, Held at Cost Fair Value, by Balance Sheet Grouping [Table Text Block] Structured debt securities Debt Securities [Member] Goodwill [Line Items] Goodwill [Line Items] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Beginning balance (in shares) Ending balance (in shares) Class of Warrant or Right, Outstanding Basic (in USD per share) Basic earnings per share (in USD per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Weighted-Average Grant date Fair Value Per Share Class Of Warrant Or Right, Weighted Average Grant Date Fair Value [Abstract] Class Of Warrant Or Right, Weighted Average Grant Date Fair Value Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Commercial paper Commercial Paper [Member] Other current assets Other Assets, Miscellaneous, Current Trade payables Increase (Decrease) in Accounts Payable, Trade Other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Schedule of Segment Reporting Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Treasury shares used for vesting (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Adjustment to Compensation, Amount Adjustment to Compensation Amount Performance share adjustment (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment, Weighted Average Grant Date Fair Value Share based compensation expense Share-Based Payment Arrangement, Noncash Expense Total share-based payment expense Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value Employee Stock Option Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Disposal of intangible assets, property and equipment Proceeds from Sale of Productive Assets Antidilutive Securities [Axis] Antidilutive Securities [Axis] Equity attributable to the shareholders of Criteo S.A. Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Total Share based compensation expense Share-Based Payment Arrangement, Expense Common shares authorized (in shares) Common Stock, Shares Authorized Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Issuance of ordinary shares (in shares) Stock Issued During Period, Shares, New Issues Current assets: Assets, Current [Abstract] Forfeited, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total equity and liabilities Liabilities and Equity Other liabilities Increase (Decrease) in Other Current Liabilities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Liabilities and shareholders' equity Liabilities and Equity [Abstract] Cover page. Cover [Abstract] Expected rate of social charges Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate of Social Charges Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate of Social Charges Cash and Cash Equivalents, Fair Value Disclosure Cash and Cash Equivalents, Fair Value Disclosure General and Administrative General and Administrative Expense [Member] Net income available to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Accounting Policies [Abstract] Accounting Policies [Abstract] Restricted share awards Restricted Stock [Member] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Treasury Stock Treasury Stock, Common [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Retirement Benefits [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Revenue from External Customers and Long-Lived Assets by Geographical Areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Other noncurrent liabilities Total Other Liabilities, Noncurrent Other taxes Accrual for Taxes Other than Income Taxes, Current Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Share based Compensation capitalized as internal-use software costs Share-Based Payment Arrangement, Amount Capitalized Share-Based Payment Arrangement, Performance Shares, Activity Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Attributable to shareholders of Criteo S.A. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Name Measure Name Restructuring liability, beginning balance Restructuring liability, ending balance Restructuring Reserve Number of geographical markets in which entity operates Number of Countries in which Entity Operates Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Lease liability - operating - current portion Operating Lease, Liability, Current Deferred tax liabilities Deferred Income Tax Liabilities, Net Document Fiscal Period Focus Document Fiscal Period Focus Expected rate of salary increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Weighted-average exercise price (in US dollar per share) Class Of Warrant Or Right, Outstanding, Weighted Average Grant Date Fair Value Class Of Warrant Or Right, Outstanding, Weighted Average Grant Date Fair Value Award Timing Method Award Timing Method [Text Block] Weighted-Average Remaining Contractual Term (Years) Class Of Warrant Or Right, Weighted Average Remaining Contractual Term [Abstract] Class Of Warrant Or Right, Weighted Average Remaining Contractual Term Litigation Case [Domain] Litigation Case [Domain] Award Type [Axis] Award Type [Axis] Total assets Assets Schedule of Nonvested Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Trading Symbol Trading Symbol Vested (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Geographical [Domain] Geographical [Domain] Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Effect of exchange rates changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Restricted stock units (RSUs) Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Securities Held-to-maturity Total Debt Securities, Held-to-Maturity, Fair Value Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Other Non-current Assets [Line Items] Other Non-current Assets [Line Items] Other Non-current Assets Schedule of Investment Securities, Held-to-Maturity Debt Securities, Held-to-Maturity [Table Text Block] Beginning balance, options (in shares) Ending balance, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Common shares outstanding (in shares) Common Stock, Shares, Outstanding Financial liabilities - current portion Financial Liabilities, Current Financial Liabilities, Current Schedule of Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Document Information [Table] Document Information [Table] PEO PEO [Member] Trade Receivables Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Financial income from cash equivalents Investment Income, Interest Noncash investing and financing activities Noncash Investing and Financing Items [Abstract] Income taxes Accrued Income Taxes, Current United States UNITED STATES Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Retained Earnings Retained Earnings [Member] Due in one to five years Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Prepaid expenses and other current assets Total Prepaid Expense and Other Assets, Current Shares (RSU) Shares (Financial PSU) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Net cash and cash equivalents and restricted cash at the beginning of the period Net cash and cash equivalents and restricted cash at the end of the period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Provision for income taxes Provision for Income taxes Income Tax Expense (Benefit) Purchases of investment securities Payments to Acquire Marketable Securities Other Other [Member] Other Document Information [Line Items] Document Information [Line Items] Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Due in one year Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Equity - attributable to shareholders of Criteo S.A. Parent [Member] Net Income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Other assets Increase (Decrease) in Other Current Assets Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] Restructuring and Other Exit Costs Restructuring and Related Activities Disclosure [Text Block] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Customer prepayments and deferred revenue Contract with Customer, Refund Liability, Current Change in income taxes Increase (Decrease) in Income Taxes Proceeds from exercise of stock options Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Share warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative expenses General and Administrative Expense Long-lived assets Long-Lived Assets Unrecognized stock-based compensation, stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Aggregate intrinsic value Class Of Warrant Or Right, Aggregate Intrinsic Value Class Of Warrant Or Right, Aggregate Intrinsic Value Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Schedule of Stock Options Roll Forward Schedule of Stock Options Roll Forward [Table Text Block] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Total operating lease expense Lease, Cost Goodwill Goodwill balance, beginning of the period Goodwill balance, end of the period Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Loss contingency, estimate of possible loss Loss Contingency, Estimate of Possible Loss Schedule of Components of Lease Expense Lease, Cost [Table Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Money Market funds Money Market Funds [Member] Basic shares: Weighted Average Number of Shares Outstanding, Basic [Abstract] Other Current and Noncurrent Liabilities Other Liabilities Disclosure [Text Block] Equity Components [Axis] Equity Components [Axis] Defined benefit plans Liability, Defined Benefit Pension Plan, Noncurrent Sublease income Sublease Income Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Employee Benefits Compensation and Employee Benefit Plans [Text Block] Expired, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Change in uncertain tax positions Increase (Decrease) In Unrecognized Tax Benefits Increase (Decrease) In Unrecognized Tax Benefits Warrants term (in years) Warrants and Rights Outstanding, Term Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Entity Address, Country Entity Address, Country Other Performance Measure, Amount Other Performance Measure, Amount Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Total current liabilities Liabilities, Current Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Individual: Individual [Axis] Vesting [Axis] Vesting [Axis] Defined contribution plan expenses Defined Contribution Plan, Cost Restricted cash, included in other current assets Restricted Cash Schedule of Accumulated and Projected Benefit Obligations Schedule of Accumulated and Projected Benefit Obligations [Table Text Block] Research and Development Research and Development Expense [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Minimum percentage increase to target shares Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Percentage Increase To Target Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Percentage Increase To Target Shares Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Right of use assets - operating leases Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Maximum percentage increase to target shares Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Percentage Increase To Target Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Percentage Increase To Target Shares Entity Interactive Data Current Entity Interactive Data Current Lease expense Operating Lease, Cost Stock-based compensation, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Exercised, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Vested and exercisable (in shares) Class Of Warrant Or Right, Vested And Expected to Vest, Exercisable, Number Class Of Warrant Or Right, Vested And Expected to Vest, Exercisable, Number Segment information Breakdown of Revenue and Noncurrent Assets Segment Reporting Disclosure [Text Block] Schedule of Goodwill [Table] Goodwill [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Marketable securities - noncurrent portion Marketable Securities, Noncurrent Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Expired (in shares) Class Of Warrant Or Right, Expired During Period Class Of Warrant Or Right, Expired During Period Deferred tax assets Deferred Income Tax Assets, Net Acquisition of intangible assets, property and equipment Payments to Acquire Productive Assets Other noncurrent assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key PEO Name PEO Name Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Expected volatility of the Company Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Company Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Company Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Tranche 1 Share-Based Payment Arrangement, Tranche One [Member] Financial instruments Financial Instruments Disclosure [Text Block] Segments [Axis] Segments [Axis] Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Class of Stock [Domain] Class of Stock [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized stock-based compensation, nonvested awards Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Trade accounts receivables Accounts Receivable, before Allowance for Credit Loss, Current Share-based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Granted (in shares) Class Of Warrant Or Right, Granted During Period Class Of Warrant Or Right, Granted During Period Underlying Security Market Price Change Underlying Security Market Price Change, Percent Vesting [Domain] Vesting [Domain] Forfeited (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Term deposits Bank Time Deposits [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Change in treasury stocks Treasury Stock, Value, Acquired, Cost Method Research and development expenses Research and Development Expense Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Trade receivables, allowances (Less) Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Revenue from External Customers by Products and Services Revenue from External Customers by Products and Services [Table Text Block] Lease liability - operating - noncurrent portion Operating Lease, Liability, Noncurrent Share options (in shares) Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Options Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Options Retail Media Retail Media [Member] Retail Media Americas Americas [Member] Canceled, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Cancellations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Cancellations in Period Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Aggregate Intrinsic Value (in thousands) Class Of Warrant Or Right, Aggregate Instrinsic Value [Abstract] Class Of Warrant Or Right, Aggregate Instrinsic Value TSR Performance Shares Units (TSR PSU) TSR Performance Shares Units [Member] TSR Performance Shares Units Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Schedule of Financial and Other Income (Expense) Schedule of Other Nonoperating Income (Expense) [Table Text Block] Prepayments to suppliers Prepayments To Suppliers Prepayments To Suppliers Capitalized computer software, amortization Capitalized Computer Software, Amortization Currency translation adjustment Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Schedule of Basic Earnings Per Share Schedule Of Earnings Per Share, Basic [Table Text Block] Schedule Of Earnings Per Share, Basic [Table Text Block] RSUs and PSUs (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period American Depositary Shares American Depositary Shares [Member] American Depositary Shares [Member] Document Quarterly Report Document Quarterly Report Doe vs. GoodRx Holdings, Inc. Doe Vs. GoodRx Holdings, Inc. [Member] Doe Vs. GoodRx Holdings, Inc. Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Number of operating segments Number of Operating Segments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Weighted-average remaining contractual term, options outstanding (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Germany GERMANY Granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Interest cost Defined Benefit Plan, Interest Cost Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Commerce Growth Commerce Growth [Member] Commerce Growth Employees warrants exercised (in shares) Exercised (in shares) Class Of Warrant Or Right, Exercised During Period Class Of Warrant Or Right, Exercised During Period Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Aggregate intrinsic value, options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Summary of restructuring activities included in other current liabilities Restructuring and Related Costs [Table Text Block] Change in other financing activities Proceeds from (Payment for) Other Financing Activity Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] Goodwill Goodwill Disclosure [Text Block] Noncontrolling interests Equity, Attributable to Noncontrolling Interest Equity Awards Adjustments Equity Awards Adjustments [Member] Other Other Noncash Income (Expense) Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Outstanding at beginning of period (in USD per share) Outstanding at end of period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Amounts paid Payments for Restructuring Weighted average shares outstanding used in computing per share amounts: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Changes in assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital Other Other Accrued Liabilities, Noncurrent Share-Based Compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Treasury stock, 5,561,756 and 4,508,029 shares at cost as of March 31, 2026 and December 31, 2025, respectively. Treasury Stock, Value Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Sales and operations expenses Selling and Marketing Expense Country Region Country Region Financial Instruments [Domain] Financial Instruments [Domain] Weighted-average remaining contractual term outstanding Class Of Warrant Or Right, Vested And Exercisable, Weighted Average Remaining Contractual Term Class Of Warrant Or Right, Vested And Exercisable, Weighted Average Remaining Contractual Term Litigation Case [Axis] Litigation Case [Axis] Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] EMEA EMEA [Member] Total noncurrent assets Assets, Noncurrent Schedule of Diluted Earnings Per Share Schedule Of Earnings Per Share, Diluted [Table Text Block] Schedule Of Earnings Per Share, Diluted [Table Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Accumulated postretirement benefit obligation at beginning of period Accumulated postretirement benefit obligation at end of period Defined Benefit Plan, Benefit Obligation Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Operating lease liabilities and right of use assets Increase (Decrease) In Operating Lease Liabilities (Assets) Increase (Decrease) In Operating Lease Liabilities (Assets) Cost of revenue: Cost of Revenue [Abstract] Company Selected Measure Name Company Selected Measure Name Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Number of tranches Number of Tranches Number of Tranches Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Total Share based compensation expense net of capitalization Share-Based Payment Arrangement, Expensed and Capitalized, Amount Common shares, €0.025 par value, 55,659,895 and 55,659,895 shares authorized and issued, and 50,098,139 and 51,151,866 outstanding at March 31, 2026 and December 31, 2025, respectively. Common Stock, Value, Issued Contingencies - noncurrent portion Loss Contingency, Accrual, Noncurrent Goodwill [Roll Forward] Goodwill [Roll Forward] Commitments and contingencies Commitments and Contingencies Disclosure [Text Block] Tranche 2 Share-Based Payment Arrangement, Tranche Two [Member] Diluted (in shares) Weighted average number of shares outstanding used to determine diluted earnings per share (in shares) Weighted Average Number of Shares Outstanding, Diluted No Trading Symbol Flag No Trading Symbol Flag Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Other Non-current Assets [Table] Other Non-current Assets [Table] Other Non-current Assets Commission Nationale de l'Informatique et des Libertés (CNIL) Commission Nationale De l'Informatique Et Des Libertés (CNIL) [Member] Commission Nationale De l'Informatique Et Des Libertés (CNIL) Business Combination [Axis] Business Combination [Axis] Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Entity Small Business Entity Small Business Capitalized stock-based compensation relating to internally developed software Capitalized Computer Software, Gross Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Non controlling interest Noncontrolling Interest [Member] Document Transition Report Document Transition Report Underlying Securities Award Underlying Securities Amount Schedule of Defined Contribution Plan Defined Contribution Plan Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Canceled (in shares) Class Of Warrant Or Right, Canceled During Period Class Of Warrant Or Right, Canceled During Period Income Taxes Income Tax Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Short term lease expense Short-Term Lease, Cost Financial and Other Income and Expenses Other Nonoperating Income and Expense [Text Block] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Treasury stock acquired, average cost per share (in dollars per share) Shares Acquired, Average Cost Per Share Document Type Document Type Earnings per share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Actuarial gains on employee benefits, net of taxes Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Product and Service [Axis] Product and Service [Axis] Variable lease expense Variable Lease, Cost Revenue Total Revenue Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Name Forgone Recovery, Individual Name Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total current assets Assets, Current Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Loss contingency accrual Loss Contingency Accrual Authorized amount of share repurchase program Share Repurchase Program, Authorized, Amount Performance share adjustment (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment Financial Performance Shares Units Previously Modified TSR PSUs Financial Performance Shares Units Previously Modified TSR PSUs [Member] Financial Performance Shares Units Previously Modified TSR PSUs Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Currency translation adjustment Goodwill, Foreign Currency Translation, Gain (Loss) Aggregate intrinsic value of the share options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value France FRANCE Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Marketable securities - current portion Marketable Securities, Current Share Based Compensation Performance Shares Award Total Shareholder Return Unvested Activity Share Based Compensation Performance Shares Award Total Shareholder Return Unvested Activity [Table Text Block] Share Based Compensation Performance Shares Award Total Shareholder Return Unvested Activity Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities: Liabilities, Current [Abstract] Weighted-Average Remaining Contractual Term (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Geographical [Axis] Geographical [Axis] Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Foreign exchange income Gain (Loss), Foreign Currency Transaction, before Tax Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Asia-Pacific Asia Pacific [Member] Diluted (in USD per share) Diluted earnings per share (in USD per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Trade receivables, net of allowances of $23.2 million and $25.9 million at March 31, 2026 and December 31, 2025, respectively. Net carrying value at end of period Accounts Receivable, after Allowance for Credit Loss, Current Title of 12(b) Security Title of 12(b) Security Structured debt securities Structured Debt Securities [Member] Structured Debt Securities Schedule of Assumptions Used for Actuarial Valuations Defined Benefit Plan, Assumptions [Table Text Block] Noncurrent financial assets Nontrade Receivables, Noncurrent Other taxes Prepaid Other Taxes And Other Taxes Receivable Prepaid Other Taxes And Other Taxes Receivable Treasury stock (in shares) Treasury stock, beginning balance (in shares) Treasury stock, ending balance (in shares) Treasury Stock, Common, Shares Net income allocated to shareholders per share: Earnings Per Share [Abstract] Financial and other income Financial and other income Total financial and other income Nonoperating Income (Expense) Gross profit Gross Profit Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Noncash and nonoperating items Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item Actuarial losses (gains) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Iponweb Iponweb [Member] Iponweb Other changes in equity Stockholders' Equity, Other Indemnification asset Business Combination, Indemnification Asset, Acquisition Date, Amount Dilutive effect of: Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract] Cash paid for taxes, net of refunds Income Taxes Paid, Net Change in treasury stocks (in shares) Change in treasury stocks (in shares) Treasury Stock, Shares, Acquired Award Timing Disclosures [Line Items] Service cost Defined Benefit Plan, Service Cost Employee - related payables Employee-related Liabilities, Current Income taxes Prepaid Income Taxes Prepaid Income Taxes Amortization and provisions Depreciation, Depletion, Amortization And Provisions For Various Depreciation, Depletion, Amortization And Provisions For Various Schedule of Other Current Liabilities Other Current Liabilities [Table Text Block] Net income available to shareholders of Criteo S.A. Net income attributable to shareholders of Criteo S.A. Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Shareholders' equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Other Current and Noncurrent Assets Other Current Assets [Text Block] Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Restructuring charge Restructuring Charges Repurchase of treasury stocks Payments for Repurchase of Common Stock Adoption Date Trading Arrangement Adoption Date Significant Accounting Policies Reclassification, Comparability Adjustment [Policy Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Trade receivables Increase (Decrease) in Accounts Receivable Entity Current Reporting Status Entity Current Reporting Status Receivables [Abstract] Receivables [Abstract] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Income from operations Operating Income (Loss) Japan JAPAN Retained earnings Retained Earnings (Accumulated Deficit) Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Contingencies - current portion Loss Contingency, Accrual, Current Current Fiscal Year End Date Current Fiscal Year End Date Class of Stock [Axis] Class of Stock [Axis] Other cost of revenue Other Cost of Operating Revenue Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Schedule of Breakdown in Trade Receivables Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Other financial expense Other Nonoperating Income (Expense) Weighted-Average Grant date Fair Value Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Table] Statement [Table] Change in deferred taxes Deferred Income Tax Expense (Benefit) Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash Cash [Member] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Financial PSU (PSUs) Financial PSU Financial Performance Shares Units [Member] Financial Performance Shares Units Aggregate Intrinsic Value (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value Maturities and sales of investment securities Proceeds from Sale and Maturity of Marketable Securities Reconciliation of cash, cash equivalents, and restricted cash to the consolidated statement of financial position Cash and Cash Equivalents [Abstract] Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Diluted shares: Weighted Average Number of Shares Outstanding, Diluted [Abstract] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Amendment Flag Amendment Flag Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Measure: Measure [Axis] Accounts payable relating to capital expenditures Accounts Payable, Capital Expenditures Accounts Payable, Capital Expenditures Contribution ex-TAC Gross Profit And Other Costs Of Revenue Gross Profit And Other Costs Of Revenue Schedule of Stockholders' Equity Note, Warrants or Rights Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Fair Value, Assets Measured on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Basic (in shares) Weighted average number of shares outstanding of Criteo S.A. (in shares) Weighted Average Number of Shares Outstanding, Basic Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Traffic acquisition costs Cost of Product and Service Sold Loss contingency, receivable Loss Contingency, Receivable Vested and exercisable, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility of the benchmark Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Benchmark Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Benchmark Weighted-average exercise price, options outstanding (in US dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Trade payables Accounts Payable, Trade, Current Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common shares par value (in euro per share) Common Stock, Par or Stated Value Per Share Common shares issued (in shares) Common Stock, Shares, Issued Granted, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Use of Estimates Use of Estimates, Policy [Policy Text Block] Interest and fees Interest Expense, Nonoperating Schedule of Goodwill Schedule of Goodwill [Table Text Block] Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Subsequent Events Subsequent Events [Text Block] Foreign currency translation differences, net of taxes Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Total noncurrent liabilities Liabilities, Noncurrent Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Performance Media Performance Media [Member] Performance Media Intangible assets, property and equipment acquired through payables Capital Expenditures Incurred but Not yet Paid Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Operating expenses Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Other current liabilities Total Other Liabilities, Current Sales and Operations Sales And Operations Expense [Member] Sales And Operations Expense [Member] Discount rate (Corp AA) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Other creditors Other Sundry Liabilities, Current Issuance of ordinary shares Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Uncertain tax positions Uncertain Tax Liability Uncertain Tax Liability Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalents Cash and Cash Equivalent Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Ordinary Shares Share capital Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Corporate debt securities Corporate Debt Securities [Member] Net decrease in cash and cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Rebates Notes Payable, Current EX-101.PRE 9 crto-20260331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover Page - shares
3 Months Ended
Mar. 31, 2026
May 01, 2026
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 001-36153  
Entity Registrant Name Criteo S.A.  
Entity Incorporation, State or Country Code I0  
Entity Address, Address Line One 32 Rue Blanche  
Entity Address, City or Town Paris  
Entity Address, Country FR  
Entity Address, Postal Zip Code 75009  
Country Region 33  
City Area Code 75  
Local Phone Number 85 09 39  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   50,244,527
Entity Central Index Key 0001576427  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Amendment Flag false  
American Depositary Shares    
Document Information [Line Items]    
Title of 12(b) Security American Depositary Shares, each representing one Ordinary Share,nominal value €0.025 per share  
Trading Symbol CRTO  
Security Exchange Name NASDAQ  
Ordinary Shares    
Document Information [Line Items]    
Title of 12(b) Security Ordinary Shares, nominal value €0.025 per share  
Security Exchange Name NASDAQ  
No Trading Symbol Flag true  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 319,981 $ 342,038
Trade receivables, net of allowances of $23.2 million and $25.9 million at March 31, 2026 and December 31, 2025, respectively. 448,275 582,102
Income taxes 12,985 14,233
Other taxes 61,100 57,050
Marketable securities - current portion 28,348 23,242
Prepaid expenses and other current assets 69,597 53,210
Total current assets 940,286 1,071,875
Property and equipment, net 155,502 139,330
Intangible assets, net 148,724 151,853
Goodwill 532,525 535,761
Right of use assets - operating leases 128,692 134,205
Marketable securities - noncurrent portion 22,996 23,500
Noncurrent financial assets 8,193 8,314
Deferred tax assets 88,355 90,689
Other noncurrent assets 46,777 45,680
Total noncurrent assets 1,131,764 1,129,332
Total assets 2,072,050 2,201,207
Current liabilities:    
Trade payables 448,472 566,046
Contingencies - current portion 11,390 9,229
Income taxes 21,943 27,528
Financial liabilities - current portion 10,626 11,360
Lease liability - operating - current portion 34,475 33,085
Other taxes 12,820 14,713
Employee - related payables 119,297 114,416
Other current liabilities 78,025 68,277
Total current liabilities 737,048 844,654
Deferred tax liabilities 5,179 5,285
Defined benefit plans 5,725 5,707
Lease liability - operating - noncurrent portion 99,221 105,277
Contingencies - noncurrent portion 23,039 22,729
Other noncurrent liabilities 32,403 31,826
Total noncurrent liabilities 165,567 170,824
Total liabilities 902,615 1,015,478
Shareholders' equity:    
Common shares, €0.025 par value, 55,659,895 and 55,659,895 shares authorized and issued, and 50,098,139 and 51,151,866 outstanding at March 31, 2026 and December 31, 2025, respectively. 1,871 1,871
Treasury stock, 5,561,756 and 4,508,029 shares at cost as of March 31, 2026 and December 31, 2025, respectively. (126,390) (120,853)
Additional paid-in capital 698,717 706,321
Accumulated other comprehensive loss (77,319) (68,879)
Retained earnings 635,935 630,750
Equity attributable to the shareholders of Criteo S.A. 1,132,814 1,149,210
Noncontrolling interests 36,621 36,519
Total equity 1,169,435 1,185,729
Total equity and liabilities $ 2,072,050 $ 2,201,207
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) (Parenthetical)
$ in Thousands
Mar. 31, 2026
€ / shares
Mar. 31, 2026
USD ($)
shares
Dec. 31, 2025
€ / shares
Dec. 31, 2025
USD ($)
shares
Statement of Financial Position [Abstract]        
Trade receivables, allowances | $   $ 23,185   $ 25,881
Common shares par value (in euro per share) | € / shares € 0.025   € 0.025  
Common shares authorized (in shares)   55,659,895   55,659,895
Common shares issued (in shares)   55,659,895   55,659,895
Common shares outstanding (in shares)   50,098,139   51,151,866
Treasury stock (in shares)   5,561,756   4,508,029
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 424,639 $ 451,434
Cost of revenue:    
Traffic acquisition costs 174,271 187,062
Other cost of revenue 27,626 27,396
Gross profit 222,742 236,976
Operating expenses:    
Research and development expenses 69,683 60,749
Sales and operations expenses 97,501 88,889
General and administrative expenses 45,158 39,171
Total operating expenses 212,342 188,809
Income from operations 10,400 48,167
Financial and other income 1,873 2,302
Income before taxes 12,273 50,469
Provision for income taxes 3,693 10,458
Net Income 8,580 40,011
Net income available to shareholders of Criteo S.A. 7,817 37,928
Net income available to noncontrolling interests $ 763 $ 2,083
Weighted average shares outstanding used in computing per share amounts:    
Basic (in shares) 50,352,465 53,979,157
Diluted (in shares) 50,965,933 57,195,898
Net income allocated to shareholders per share:    
Basic (in USD per share) $ 0.16 $ 0.70
Diluted (in USD per share) $ 0.15 $ 0.66
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net income $ 8,580 $ 40,011
Foreign currency translation differences, net of taxes (9,277) 17,216
Actuarial gains on employee benefits, net of taxes 118 310
Other comprehensive income (loss) (9,159) 17,526
Total comprehensive income (loss) (579) 57,537
Attributable to shareholders of Criteo S.A. (681) 53,858
Attributable to noncontrolling interests $ 102 $ 3,679
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Equity - attributable to shareholders of Criteo S.A.
Share capital
Treasury Stock
Additional paid-in capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Non controlling interest
Beginning balance (in shares) at Dec. 31, 2024     57,744,839          
Beginning balance at Dec. 31, 2024 $ 1,081,097 $ 1,049,189 $ 1,931 $ (125,298) $ 709,580 $ (108,768) $ 571,744 $ 31,908
Treasury stock, beginning balance (in shares) at Dec. 31, 2024       (3,467,417)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 40,011 37,928         37,928 2,083
Other comprehensive income (loss) 17,526 15,930       15,930   1,596
Issuance of ordinary shares (in shares)     110,056          
Issuance of ordinary shares 1,845 1,845 $ 2   1,843      
Change in treasury stocks (in shares) [1]       (817,761)        
Change in treasury stocks [1] (56,168) (56,168)   $ (34,102) (20,549)   (1,517)  
Share-Based Compensation 16,663 16,615     16,615     48
Other changes in equity (738) (740)         (740) 2
Ending balance (in shares) at Mar. 31, 2025     57,854,895          
Ending balance at Mar. 31, 2025 1,100,236 1,064,599 $ 1,933 $ (159,400) 707,489 (92,838) 607,415 35,637
Treasury stock, ending balance (in shares) at Mar. 31, 2025       (4,285,178)        
Beginning balance (in shares) at Dec. 31, 2025     55,659,895          
Beginning balance at Dec. 31, 2025 $ 1,185,729 1,149,210 $ 1,871 $ (120,853) 706,321 (68,879) 630,750 36,519
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 (4,508,029)     (4,508,029)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 8,580 7,817         7,817 763
Other comprehensive income (loss) (9,159) (8,440)       (8,440)   (719)
Issuance of ordinary shares 0              
Change in treasury stocks (in shares) [2]       (1,053,727)        
Change in treasury stocks [2] (30,969) (30,969)   $ (5,537) (22,604)   (2,828)  
Share-Based Compensation 15,059 15,000     15,000     59
Other changes in equity 195 196         196 (1)
Ending balance (in shares) at Mar. 31, 2026     55,659,895          
Ending balance at Mar. 31, 2026 $ 1,169,435 $ 1,132,814 $ 1,871 $ (126,390) $ 698,717 $ (77,319) $ 635,935 $ 36,621
Treasury stock, ending balance (in shares) at Mar. 31, 2026 (5,561,756)     (5,561,756)        
[1] On January 31, 2025, Criteo's board of directors authorized an extension of the share repurchase program to up to $805.0 million of the Company's outstanding American Depositary Shares. The change in treasury stocks is comprised of 1,460,246 shares repurchased at a weighted average price of $38.50 offset by 642,485 treasury shares used for RSUs vesting.
[2] On February 6, 2026, Criteo's board of directors authorized an increase of the share repurchase program to up to $959.0 million of the Company's outstanding American Depositary Shares. The change in treasury stocks is comprised of 1,596,328 shares repurchased at a weighted average price of $19.40 offset by 542,601 treasury shares used for RSUs vesting.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
Feb. 06, 2026
Jan. 31, 2025
Authorized amount of share repurchase program $ 959.0 $ 805.0
Change in treasury stocks (in shares) 1,596,328 1,460,246
Treasury stock acquired, average cost per share (in dollars per share) $ 19.40 $ 38.50
Restricted stock units (RSUs)    
Treasury shares used for vesting (in shares) 542,601 642,485
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net income $ 8,580 $ 40,011
Noncash and nonoperating items 40,266 42,630
Amortization and provisions 28,569 23,583
Share based compensation expense 13,347 15,409
Gain (loss) on disposal of and impairment of long-lived assets (749) 547
Change in uncertain tax positions 427 0
Change in deferred taxes 2,007 6,888
Change in income taxes (3,692) (4,288)
Other 357 491
Changes in assets and liabilities: (639) (20,300)
Trade receivables 131,986 163,943
Trade payables (112,841) (174,331)
Other assets (24,515) (8,460)
Other liabilities 3,828 (145)
Operating lease liabilities and right of use assets 903 (1,307)
Net cash provided by operating activities 48,207 62,341
Cash flows from investing activities    
Acquisition of intangible assets, property and equipment (32,848) (17,091)
Disposal of intangible assets, property and equipment 641 0
Purchases of investment securities (17,319) (11,449)
Maturities and sales of investment securities 11,613 11,002
Net cash used in investing activities (37,913) (17,538)
Cash flows from financing activities    
Proceeds from exercise of stock options 0 1,845
Repurchase of treasury stocks (30,969) (56,168)
Change in other financing activities (316) (471)
Net cash used in financing activities (31,285) (54,794)
Effect of exchange rates changes on cash and cash equivalents (1,066) 5,219
Net decrease in cash and cash equivalents and restricted cash (22,057) (4,772)
Net cash and cash equivalents and restricted cash at the beginning of the period 342,359 290,943
Net cash and cash equivalents and restricted cash at the end of the period 320,302 286,171
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated statement of financial position    
Cash and Cash Equivalents 319,981 285,850
Restricted cash, included in other current assets 321 321
Total cash, cash equivalents, and restricted cash 320,302 286,171
Supplemental disclosures of cash flow information    
Cash paid for taxes, net of refunds (4,951) (5,920)
Cash paid for interest (527) (244)
Noncash investing and financing activities    
Intangible assets, property and equipment acquired through payables $ 12,204 $ 1,621
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation

The accompanying unaudited condensed consolidated financial statements (the "Unaudited Condensed Consolidated Financial Statements") have been prepared by Criteo in accordance with generally accepted accounting principles in the United States of America ("GAAP") and pursuant to the applicable rules and regulations of the Securities and Exchange Commission ("SEC"), including regarding interim financial reporting. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.

The unaudited condensed consolidated financial statements included herein reflect all normal recurring adjustments that are, in the opinion of management, necessary to state fairly the results for the interim periods presented. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year ending December 31, 2026.

Use of Estimates

The preparation of our Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the period. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates.
On an on-going basis, management evaluates its estimates, primarily those related to: (1) revenue recognition (2) income taxes, (3) assumptions used in the valuation of long-lived assets including intangible assets, and goodwill, and (4) assumptions surrounding the recognition and valuation of contingent liabilities and losses.

Significant Accounting Policies

There have been no other significant changes to our accounting policies described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Reclassifications

Certain prior year amounts, which are not material, have been reclassified to conform to current year presentation in the consolidated financial statements and notes.

Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, which requires disaggregated disclosure of income statement expenses. This standard is effective for annual periods beginning after December 15, 2026, with early adoption permitted. We do not expect the adoption of this standard to have a material impact on our consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software, which simplifies the capitalization guidance by removing the references to project stages, among other changes. The new standard is effective for annual periods beginning after December 15, 2027. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.
In December 2025, the FASB issued ASU 2025-10, Government Grants, Accounting for Government Grants received by Business Entities, which establishes guidance for business entities on how to recognize, measure, present and disclose government grants received. The new standard is effective for annual periods beginning after December 15, 2028. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring and Other Exit Costs
3 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Restructuring and Other Exit Costs Restructuring and Other Exit Costs
The Company may periodically initiate restructuring actions designed to improve operational efficiency, optimize its cost structure, and better align its workforce and operations with business needs and strategic priorities. These actions may include workforce reductions and other organizational realignments intended to support the Company’s long-term objectives. The Company records employee severance and other termination costs that meet the requirements for recognition in accordance with the relevant guidance of ASC 420, Exit or Disposal Cost Obligations, or ASC 712, Compensation – Nonretirement Postemployment Benefits, as applicable.
A summary of our Restructuring and Other Exit costs activity is presented as follows:
Severance Liability
(in thousands)
Restructuring liability as of December 31, 2025
$3,043 
Restructuring charge5,688 
Amounts paid (3,841)
Restructuring liability as of March 31, 2026
$4,890 
During the fourth quarter of 2025, the Company commenced a cost-reduction plan intended to improve operating efficiency and better align its cost structure with revenue levels. In connection with this plan, the Company incurred approximately $3.0 million of restructuring costs during the year ended December 31, 2025 and approximately $5.7 million during the period ended March 31, 2026, primarily reflected within Sales and Operations expense.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.26.1
Segment information
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment information Segment information
The Company reports segment information based on the management approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company's reportable segments. The Company reports its results of operations through the following two segments: Retail Media and Performance Media.
Retail Media: This segment encompasses revenue generated from brands, agencies and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services.

Performance Media: This segment encompasses our targeting capabilities and supply and AdTech services.

The Company's chief operating decision maker ("CODM"), our Chief Executive Office ("CEO"), allocates resources to and assesses the performance of each operating segment using information about Contribution ex-TAC, which is Criteo's segment profitability measure and reflects our gross profit plus other costs of revenue.
The CODM only reviews revenues and corresponding TAC for each segment, and is not regularly provided any other expense nor financial information for our two segments.
The following table shows revenue by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 
The following table shows TAC by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$682 $708 
Performance Media173,589 186,354 
Total Traffic Acquisition Costs$174,271 $187,062 

The following table shows Contribution ex-TAC by reportable segment and its reconciliation to the Company’s Consolidated Statements of Operation:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Contribution ex-TAC
Retail Media$40,589 $58,790 
Performance Media209,779 205,582 
$250,368 $264,372 
Other cost of revenue
27,626 27,396 
Gross profit$222,742 $236,976 
Operating expenses
Research and development expenses69,683 60,749 
Sales and operations expenses97,501 88,889 
General and administrative expenses45,158 39,171 
Total Operating expenses$212,342 $188,809 
Income from operations$10,400 $48,167 
Financial and other income1,873 2,302 
Income before tax$12,273 $50,469 
Breakdown of Revenue and Noncurrent Assets
The following table presents the Company's revenue disaggregated by major product for the periods presented:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Commerce Growth356,583 365,296 
Other26,785 26,640 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 

The Company operates in three geographical markets:
Americas: North and South America;
Europe, Middle-East and Africa; and
Asia-Pacific.
The following table discloses our consolidated revenue for each geographical area for each of the reported periods. Revenue by geographical area is based mainly on the location of advertisers’ campaigns.
Revenue generated in other significant countries where we operate is presented in the following table:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Americas$158,629 $192,908 
United States140,414 174,499 
EMEA$175,330 $164,861 
Germany50,436 45,983 
France20,250 19,439 
Asia-Pacific$90,680 $93,665 
Japan56,239 54,151 
For each reported period, noncurrent assets (corresponding to the net book value of tangible and intangible assets) are presented in the table below. The geographical information includes such noncurrent assets from the locations of legal entities.
AmericasEMEAAsia-PacificTotal
(in thousands)
March 31, 2026$79,139 $210,336 $14,751 $304,226 
December 31, 2025$69,785 $207,109 $14,289 $291,183 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.26.1
Financial instruments
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Financial instruments Financial instruments
Fair Value Measurements
The following tables summarize our assets measured at fair value on a recurring basis and the classification by level of input within the fair value hierarchy:
March 31, 2026December 31, 2025
(in thousands)
Cash and Cash Equivalents
Level 1
Cash$165,557 $160,252 
Money Market funds103,481 89,157 
Level 2
Commercial paper11,426 35,139 
Term deposits28,745 41,614 
Structured debt securities10,772 15,876 
Total$319,981 $342,038 

Investment Securities
The following table presents for each reporting period, the breakdown of investment securities held at cost basis:
March 31, 2026December 31, 2025
(in thousands)
Securities Held-to-maturity
Commercial paper$22,599 $17,366 
Structured debt securities17,247 17,625 
Corporate debt securities11,498 11,750 
Total$51,344 $46,742 

The gross unrealized gains or (loss) on our investment securities were not material as of March 31, 2026 and December 31, 2025.
For our investment securities, the fair value approximates the carrying amount, given the nature of the term deposit and the maturity of the expected cash flows.
The following table classifies our held-to-maturity securities by contractual maturities:
Held-to-maturity
March 31, 2026
(in thousands)
Due in one year$28,348 
Due in one to five years22,996 
Total$51,344 
.
Our investments in nonmarketable equity securities were not material as of March 31, 2026 and for the year ended December 31, 2025.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.26.1
Trade Receivables
3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Trade Receivables Trade Receivables
The following table shows the breakdown in trade receivables net book value for the presented periods:
March 31, 2026December 31, 2025
(in thousands)
Trade accounts receivables$471,460 $607,983 
(Less) Allowance for doubtful accounts(23,185)(25,881)
Net carrying value at end of period$448,275 $582,102 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Goodwill
Goodwill allocated to the two reportable segments and the changes in the carrying amount for the three months ended March 31, 2026 were as follows:
Retail MediaPerformance MediaTotal
(in thousands)
Balance at January 1, 2026
$151,828 $383,933 $535,761 
Currency translation adjustment(547)(2,689)(3,236)
Balance at March 31, 2026
$151,281 $381,244 $532,525 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Assets
3 Months Ended
Mar. 31, 2026
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Current and Noncurrent Assets Other Current and Noncurrent Assets
The following table presents the components of prepaid expenses and other current assets, net, for the periods presented:
March 31, 2026December 31, 2025
(in thousands)
Prepayments to suppliers
$52,409 $39,294 
Other current assets
17,188 13,916 
Total
$69,597 $53,210 
Prepayments to suppliers include capitalized costs related to the implementation of cloud computing arrangements that are service contracts and are amortized on a straight-line basis over the term of the associated hosting arrangements. As of March 31, 2026 and December 31, 2025 the gross capitalized implementation costs were $24.7 million and $25.6 million, respectively, and amortization expense related to these costs was $2.1 million and $2.0 million for the three months ended March 31, 2026 and March 31, 2025, respectively.
Other current assets include an indemnification receivable of $5.5 million related to a legal matter, restricted cash, and other non-trade receivables. As of March 31, 2026 and December 31, 2025, restricted cash was $0.3 million and $0.3 million, respectively.
Other noncurrent assets as of March 31, 2026 and December 31, 2025 of $46.8 million and $45.7 million, respectively, are primarily comprised of the indemnification asset of $37.2 million, recorded against certain tax liabilities related to the Iponweb Acquisition.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Liabilities
3 Months Ended
Mar. 31, 2026
Other Liabilities Disclosure [Abstract]  
Other Current and Noncurrent Liabilities Other Current and Noncurrent Liabilities
Other current liabilities are presented in the following table:
March 31, 2026December 31, 2025
(in thousands)
Rebates$35,369 $36,844 
Customer prepayments and deferred revenue
6,620 8,420 
Accounts payable relating to capital expenditures30,004 18,126 
Other creditors6,032 4,888 
Total$78,025 $68,277 
Accounts payable relating to capital expenditures are primarily related to the purchase of data center equipment.
Other noncurrent liabilities are presented in the following table:
March 31, 2026December 31, 2025
(in thousands)
Uncertain tax positions$29,205 $28,675 
Other3,198 3,151 
Total$32,403 $31,826 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.26.1
Leases
3 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Leases Leases
The components of lease expense are as follows:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Lease expense
$10,335 $7,993 
Short term lease expense135 69 
Variable lease expense414 493 
Sublease income(154)(300)
Total operating lease expense$10,730 $8,255 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Employee Benefits
3 Months Ended
Mar. 31, 2026
Retirement Benefits [Abstract]  
Employee Benefits Employee Benefits
Defined Benefit Plans
According to French law and the Syntec Collective Agreement, French employees are entitled to compensation paid on retirement, equal to up to twelve months of their salary based on term of employment.
The following table summarizes the changes in the projected benefit obligation:
Projected benefit obligation
(in thousands)
Accumulated postretirement benefit obligation at January 1, 2025
$4,709 
Service cost
785 
Interest cost
200 
Actuarial losses (gains)
(622)
Currency translation adjustment
635 
Accumulated postretirement benefit obligation at December 31, 2025
$5,707 
Service cost
198 
Interest cost
64 
Actuarial losses (gains)
(118)
Currency translation adjustment
(126)
Accumulated postretirement benefit obligation at March 31, 2026
$5,725 
The Company does not hold any plan assets for any of the periods presented.
The main assumptions used for the purposes of the actuarial valuations are listed below:
Three Months EndedYear Ended
March 31, 2026December 31, 2025
Discount rate (Corp AA)
4.6%4.5%
Expected rate of salary increase
7.0%7.0%
Expected rate of social charges
50.0%50.0%
Expected staff turnover
Company age-based tableCompany age-based table
Estimated retirement age
65 years old65 years old
Life table
TH-TF 2000-2002 shiftedTH-TF 2000-2002 shifted

Defined Contribution Plans
The Company also provides qualified defined contribution plans primarily in France, the United States, and the United Kingdom. The most significant of these plans is the 401(k) Plan, which covers eligible U.S. employees. Employees can contribute to the plans a specified percentage of their eligible compensation, subject to matching contributions from the Company on behalf of the eligible employee. The following table shows the Company's agreed contributions, reported in the Consolidated Statement of Operations for the period.
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Defined contribution plan expenses
$4,832 $4,242 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation Share based Compensation
Share based Compensation Expense

Share based compensation expense recorded in the consolidated statements of operations was as follows:

Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Research and Development
$6,598 $5,589 
Sales and Operations
2,956 5,421 
General and Administrative
5,505 5,654 
Total Share based compensation expense$15,059 $16,664 
Share based Compensation capitalized as internal-use software costs
(1,712)(1,255)
Total Share based compensation expense net of capitalization$13,347 $15,409 


Restricted Stock Units and Performance Stock Units

During the three months ended March 31, 2026, the Company granted new equity awards under our current equity compensation plans, which were comprised of restricted stock units (“RSU”), and performance-based awards for the Company’s senior executives ("PSU").

Restricted Stock Units

Restricted stock units generally vest over four years, subject to the holder’s continued service. The grant date fair value is determined by the Company's Nasdaq share price the day prior to the grant.

The following table summarizes the activities for our unvested RSUs for the period ended March 31, 2026:

Shares (RSU)Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
4,518,697 $33.15 
Granted692,386 17.93 
Vested(344,695)30.34 
Forfeited(127,651)34.86 
Outstanding as of March 31, 2026
4,738,737 $31.09 

As of March 31, 2026, the Company had unrecognized stock-based compensation relating to restricted stock units of approximately $76.6 million, which is expected to be recognized over a weighted-average period of 3.1 years.
Performance Stock Units

Performance stock units (PSUs) are subject to either internal financial performance conditions (Financial PSUs) or external market conditions (TSR PSUs).


Financial PSUs
Financial PSUs are subject to service and performance-based vesting conditions. These awards generally vest over three years, and the number of shares ultimately earned may range from —% to 200% of target, depending on achievement of specified internal financial performance metrics. The grant-date fair value is generally based on the closing price of the Company’s Nasdaq share price on the date preceding grant.

The following table summarizes the activities for our unvested Financial PSUs for the period ended March 31, 2026 (1):

Shares (Financial PSU)
Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
442,139 $31.89 
Granted
392,985 24.74 
Performance share adjustment
4,658 29.37 
Vested(195,018)32.43 
Forfeited(15,615)31.31 
Outstanding as of March 31, 2026
629,149 $27.25 

As of March 31, 2026, the Company had unrecognized stock-based compensation related to performance stock units of approximately $11.1 million, which is expected to be recognized over a weighted-average period of 3.4 years.

TSR PSUs
TSR PSUs are subject to service and market-based vesting conditions and are earned based on the Company’s total shareholder return relative to the Nasdaq Composite Index. These awards are generally measured in two equal tranches over two years and three years performance periods, respectively, and the number of shares ultimately earned may range from —% to 200% of target for each tranche, depending on relative TSR performance.

The following table summarizes the activities for our unvested TSR PSUs for the period ended March 31, 2026:

Shares
(TSR PSU)
Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
313,383 $54.41 
Granted
332,744 27.39 
Vested(23,699)51.28 
Forfeited(121,859)54.57 
Outstanding as of March 31, 2026
500,569 $36.56 


(1) The number of Financial PSUs granted during the three months ended March 31, 2026 includes 60,242 PSUs previously modified from TSR PSUs, for which financial performance targets were established in March 2026 for the 2026 performance tranche.
The grant-date fair value is approximately $9.1 million, over the respective vesting period. The grant-date fair value was determined based on a Monte-Carlo valuation model using the following key assumptions:
Expected volatility of the Company39.70 %
Expected volatility of the benchmark81.68 %
Risk-free rate3.71 %
Expected dividend yield— %
As of March 31, 2026, the Company had unrecognized stock-based compensation related to performance stock units based on market conditions of $13.6 million, which is expected to be recognized over a weighted-average period of 2.6 years.

Nonemployee warrants

Nonemployee warrants generally vest over four years, subject to the holder’s continued service through the vesting date.

SharesWeighted-Average Grant date Fair Value Per ShareWeighted-Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2025
159,897 $18.31 2.6$1,300.0 
Granted— 
Exercised— 
Canceled— 
Expired— 
Outstanding as of March 31, 2026
159,897 $18.31 2.4$1,300.0 
Vested and exercisable - March 31, 2026
159,897 

The aggregate intrinsic value represents the difference between the exercise price of the nonemployee warrants and the fair market value of common stock on the date of exercise. During the period ended March 31, 2026, there were no exercises of nonemployee warrants.

No new nonemployee warrants were granted in the period ending March 31, 2026. As of March 31, 2026 all instruments have fully vested.
Stock Options

Stock options granted under the Company’s stock incentive plans generally vest over four years, subject to the holder’s continued service through the vesting date and expire no later than 10 years from the date of grant.

Options Outstanding
Number of Shares Underlying Outstanding OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2025
86,715 $17.35 4.0$276.0 
Options granted— 
Options exercised— 
Options forfeited— 
Options canceled— 
Options expired(86,715)
Outstanding as of March 31, 2026
— $— 0.0$— 
Vested and exercisable as of March 31, 2026
— 

The aggregate intrinsic value represents the difference between the exercise price of the options and the fair market value of common stock on the date of exercise. The aggregate intrinsic value of the stock options exercised was $0.0 million and $0.9 million for the period ended March 31, 2026, and December 31, 2025, respectively.
No new stock options were granted in the period ending March 31, 2026. As of March 31, 2026, there is no remaining unrecognized stock-based compensation related to unvested stock options.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.26.1
Financial and Other Income and Expenses
3 Months Ended
Mar. 31, 2026
Other Income and Expenses [Abstract]  
Financial and Other Income and Expenses Financial and Other Income and Expenses
The condensed consolidated statements of income line item “Financial and Other Income” can be broken down as follows:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Financial income from cash equivalents$2,654 $1,680 
Interest and fees(764)(430)
Foreign exchange income24 1,072 
Other financial expense(41)(20)
Total financial and other income $1,873 $2,302 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes
3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The tax provision for interim periods is determined using an estimate of our annual effective tax rate (“AETR”), adjusted for discrete items arising in the period. To calculate our estimated AETR, we estimate our income before taxes and the related tax expense or benefit for the full fiscal year (total of expected current and deferred tax provisions), excluding the effect of significant unusual or infrequently occurring items or comprehensive income items not recognized in the statement of income. Each quarter, we update our estimate of the annual effective tax rate, and if our estimated annual tax rate does change, we make a cumulative adjustment in that quarter. Our quarterly tax provision, and our quarterly estimate of our annual effective tax rate, are subject to significant volatility due to several factors, including our ability to accurately predict our income (loss) before provision for income taxes in multiple jurisdictions. Our effective tax rate in the future will depend on the portion of our profits earned within and outside of France.
In December 2021, the Organization for Economic Cooperation and Development (OECD) released Pillar Two Model Rules defining the global minimum tax, which calls for the taxation of a minimum rate of 15% for multinational companies with consolidated revenue above €750 million. Numerous jurisdictions have enacted or are in the process of enacting legislation to adopt a minimum effective tax rate. While the adoption of Pillar Two did not have a material impact on the three months ended March 31, 2026, the Company will continue to assess the ongoing impact as additional guidance becomes available.
The following table presents provision for income taxes:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Provision for Income taxes$3,693 $10,458 
For the three months ended March 31, 2026, the provision for income taxes differs from the nominal standard French rate of 25.0% primarily due to the application of the reduced income tax rate on the majority of the technology royalties income in France.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Earnings per share Earnings Per Share
Basic Earnings Per Share
The components of Basic earnings per share ("EPS") for the periods presented were as follows:
Three Months Ended
March 31, 2026March 31, 2025
Net income attributable to shareholders of Criteo S.A.
$7,817 $37,928 
Weighted average number of shares outstanding of Criteo S.A.
50,352,465 53,979,157 
Basic earnings per share$0.16 $0.70 
Diluted Earnings Per Share
Diluted EPS considers the impact of potentially dilutive shares not yet issued from share-based compensation plans using the treasury stock method. There were no other potentially dilutive instruments outstanding as of March 31, 2026 and 2025. Consequently, all potential dilutive effects from shares are considered.
For each period presented, a contract to issue a certain number of shares (i.e., stock options and nonemployee warrants) was assessed as potentially dilutive if it was “in the money” (i.e., the exercise or settlement price is lower than the average market price).

Three Months Ended
March 31, 2026March 31, 2025
Net income attributable to shareholders of Criteo S.A.$7,817 $37,928 
Basic shares:
Weighted average number of shares outstanding of Criteo S.A.50,352,465 53,979,157 
Dilutive effect of:
RSUs and PSUs
613,468 3,079,762 
Stock options
— 82,956 
Share warrants— 54,023 
Diluted shares:
Weighted average number of shares outstanding used to determine diluted earnings per share50,965,933 57,195,898 
Diluted earnings per share$0.15 $0.66 
The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows:
Three Months Ended
March 31, 2026March 31, 2025
Restricted share awards1,995,016 33,092 
Weighted average number of anti-dilutive securities excluded from diluted earnings per share1,995,016 33,092 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and contingencies
3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies Commitments and contingencies
From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, results of operations, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
The amount of the provisions represents management’s latest estimate of the expected impact.
Legal and Regulatory matters
Following a complaint from Privacy International against a number of advertising technology companies with certain data protection authorities, including in France, France's Commission Nationale de l'Informatique et des Libertés (the "CNIL") opened a formal investigation in January 2020 against Criteo. In June 2023, the CNIL issued its decision, which retained alleged European Union's General Data Protection Regulation ("GDPR") violations but reduced the financial sanction against Criteo from the original amount of €60 million ($69.0 million) to €40 million ($46.0 million). Criteo issued the required sanction payment during the third quarter of 2023. The decision relates to past matters and does not include any obligation for Criteo to change its current practices. Criteo appealed this decision before the French Council of State (Conseil d’Etat). On March 4, 2026, the Conseil d'État rejected the appeal and affirmed the CNIL's decision in full.
As previously disclosed, the Company is party to a claim (Doe vs. GoodRx Holdings, Inc. et al. in the U.S. District Court for the Northern District of California) alleging violations of various state and federal laws. In the third quarter of 2025, the Company agreed to settle the matter for $7.0 million, subject to court approval. GoodRx agreed to indemnify the Company for $5.5 million, subject to court approval of the settlement with plaintiffs. In January 2026, the court denied approval of the proposed settlement. The Company continues to engage in discussions with the plaintiffs and GoodRx to address the Judge’s requests and re-file the settlement agreement. Based on management's assessment of the underlying facts and circumstances, including the status of settlement discussions and the indemnification arrangement with GoodRx, the Company recorded an estimated probable loss of $7.0 million in 2025. As of March 31, 2026, this amount is presented within “Contingencies-current portion”, and an indemnification receivable of $5.5 million is presented within “Prepaid expenses and other current assets”. The results of legal proceedings are inherently uncertain and it is reasonably possible that the ultimate loss may differ from the Company's estimate.
On July 9, 2025, a putative class action was filed against the Company, CVS and others in the U.S. District Court for the Central District of California, alleging violations of various laws regarding sensitive health and personal information. On October 27, 2025, the action was dismissed with respect to the Company. On November 7, 2025, a second amended putative class action complaint was filed against the Company, CVS and others in the U.S. District Court for the Central District of California, again alleging violations of various laws regarding sensitive health and personal information. The plaintiffs seek damages and injunctive relief. On January 30, 2026, the plaintiff filed a stipulation to dismiss the case, and the parties are currently engaged in mediation. While the Company continues to dispute the allegations of wrongdoing, as of the quarter ended March 31, 2026, the Company has recorded an accrual that reflects management's current best estimate of probable loss related to this matter. The ultimate outcome of this matter may differ from the amount accrued. The Company does not believe the resolution of this matter will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.
On October 17, 2025, AlmondNet, Inc. and Intent IQ, LLC filed a patent-infringement lawsuit in the U.S. District Court for the District of Delaware. The complaint was served to the Company on October 21, 2025. The plaintiffs seek damages and injunctive relief. We dispute the allegations of wrongdoing and intend to defend ourselves vigorously in these matters.
Non-income tax risks
For the three months ended March 31, 2026, the provision related to certain non-income tax matters recognized under ASC 450 – Contingencies, as of March 31, 2026 and December 31, 2025, respectively, was $23.0 million and $22.7 million.
These risks were initially identified and recognized as part of the Iponweb Acquisition in 2022. In accordance with the purchase agreement relating to the acquisition, the Company is indemnified against specific tax risks, and as
such, an indemnification asset has been recorded. The indemnification asset is recorded as part of "Other noncurrent assets" on the consolidated statement of financial position.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.26.1
Breakdown of Revenue and Noncurrent Assets
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Breakdown of Revenue and Noncurrent Assets Segment information
The Company reports segment information based on the management approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company's reportable segments. The Company reports its results of operations through the following two segments: Retail Media and Performance Media.
Retail Media: This segment encompasses revenue generated from brands, agencies and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services.

Performance Media: This segment encompasses our targeting capabilities and supply and AdTech services.

The Company's chief operating decision maker ("CODM"), our Chief Executive Office ("CEO"), allocates resources to and assesses the performance of each operating segment using information about Contribution ex-TAC, which is Criteo's segment profitability measure and reflects our gross profit plus other costs of revenue.
The CODM only reviews revenues and corresponding TAC for each segment, and is not regularly provided any other expense nor financial information for our two segments.
The following table shows revenue by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 
The following table shows TAC by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$682 $708 
Performance Media173,589 186,354 
Total Traffic Acquisition Costs$174,271 $187,062 

The following table shows Contribution ex-TAC by reportable segment and its reconciliation to the Company’s Consolidated Statements of Operation:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Contribution ex-TAC
Retail Media$40,589 $58,790 
Performance Media209,779 205,582 
$250,368 $264,372 
Other cost of revenue
27,626 27,396 
Gross profit$222,742 $236,976 
Operating expenses
Research and development expenses69,683 60,749 
Sales and operations expenses97,501 88,889 
General and administrative expenses45,158 39,171 
Total Operating expenses$212,342 $188,809 
Income from operations$10,400 $48,167 
Financial and other income1,873 2,302 
Income before tax$12,273 $50,469 
Breakdown of Revenue and Noncurrent Assets
The following table presents the Company's revenue disaggregated by major product for the periods presented:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Commerce Growth356,583 365,296 
Other26,785 26,640 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 

The Company operates in three geographical markets:
Americas: North and South America;
Europe, Middle-East and Africa; and
Asia-Pacific.
The following table discloses our consolidated revenue for each geographical area for each of the reported periods. Revenue by geographical area is based mainly on the location of advertisers’ campaigns.
Revenue generated in other significant countries where we operate is presented in the following table:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Americas$158,629 $192,908 
United States140,414 174,499 
EMEA$175,330 $164,861 
Germany50,436 45,983 
France20,250 19,439 
Asia-Pacific$90,680 $93,665 
Japan56,239 54,151 
For each reported period, noncurrent assets (corresponding to the net book value of tangible and intangible assets) are presented in the table below. The geographical information includes such noncurrent assets from the locations of legal entities.
AmericasEMEAAsia-PacificTotal
(in thousands)
March 31, 2026$79,139 $210,336 $14,751 $304,226 
December 31, 2025$69,785 $207,109 $14,289 $291,183 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Subsequent Events
3 Months Ended
Mar. 31, 2026
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events The Company evaluated all subsequent events that occurred after March 31, 2026 through the date of issuance of the unaudited condensed consolidated financial statements and determined there are no significant events that require adjustments or disclosure.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying unaudited condensed consolidated financial statements (the "Unaudited Condensed Consolidated Financial Statements") have been prepared by Criteo in accordance with generally accepted accounting principles in the United States of America ("GAAP") and pursuant to the applicable rules and regulations of the Securities and Exchange Commission ("SEC"), including regarding interim financial reporting. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.

The unaudited condensed consolidated financial statements included herein reflect all normal recurring adjustments that are, in the opinion of management, necessary to state fairly the results for the interim periods presented. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year ending December 31, 2026.
Use of Estimates
Use of Estimates

The preparation of our Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the period. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates.
On an on-going basis, management evaluates its estimates, primarily those related to: (1) revenue recognition (2) income taxes, (3) assumptions used in the valuation of long-lived assets including intangible assets, and goodwill, and (4) assumptions surrounding the recognition and valuation of contingent liabilities and losses.
Significant Accounting Policies
Significant Accounting Policies

There have been no other significant changes to our accounting policies described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Reclassifications
Certain prior year amounts, which are not material, have been reclassified to conform to current year presentation in the consolidated financial statements and notes.
Accounting Pronouncements Not Yet Adopted
Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, which requires disaggregated disclosure of income statement expenses. This standard is effective for annual periods beginning after December 15, 2026, with early adoption permitted. We do not expect the adoption of this standard to have a material impact on our consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software, which simplifies the capitalization guidance by removing the references to project stages, among other changes. The new standard is effective for annual periods beginning after December 15, 2027. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.
In December 2025, the FASB issued ASU 2025-10, Government Grants, Accounting for Government Grants received by Business Entities, which establishes guidance for business entities on how to recognize, measure, present and disclose government grants received. The new standard is effective for annual periods beginning after December 15, 2028. We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring and Other Exit Costs (Tables)
3 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Summary of restructuring activities included in other current liabilities
A summary of our Restructuring and Other Exit costs activity is presented as follows:
Severance Liability
(in thousands)
Restructuring liability as of December 31, 2025
$3,043 
Restructuring charge5,688 
Amounts paid (3,841)
Restructuring liability as of March 31, 2026
$4,890 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Segment information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
The following table shows revenue by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 
The following table shows TAC by reportable segment:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$682 $708 
Performance Media173,589 186,354 
Total Traffic Acquisition Costs$174,271 $187,062 

The following table shows Contribution ex-TAC by reportable segment and its reconciliation to the Company’s Consolidated Statements of Operation:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Contribution ex-TAC
Retail Media$40,589 $58,790 
Performance Media209,779 205,582 
$250,368 $264,372 
Other cost of revenue
27,626 27,396 
Gross profit$222,742 $236,976 
Operating expenses
Research and development expenses69,683 60,749 
Sales and operations expenses97,501 88,889 
General and administrative expenses45,158 39,171 
Total Operating expenses$212,342 $188,809 
Income from operations$10,400 $48,167 
Financial and other income1,873 2,302 
Income before tax$12,273 $50,469 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.26.1
Financial instruments (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis
The following tables summarize our assets measured at fair value on a recurring basis and the classification by level of input within the fair value hierarchy:
March 31, 2026December 31, 2025
(in thousands)
Cash and Cash Equivalents
Level 1
Cash$165,557 $160,252 
Money Market funds103,481 89,157 
Level 2
Commercial paper11,426 35,139 
Term deposits28,745 41,614 
Structured debt securities10,772 15,876 
Total$319,981 $342,038 
Schedule of Investment Securities, Held at Cost
The following table presents for each reporting period, the breakdown of investment securities held at cost basis:
March 31, 2026December 31, 2025
(in thousands)
Securities Held-to-maturity
Commercial paper$22,599 $17,366 
Structured debt securities17,247 17,625 
Corporate debt securities11,498 11,750 
Total$51,344 $46,742 
Schedule of Investment Securities, Held-to-Maturity
The following table classifies our held-to-maturity securities by contractual maturities:
Held-to-maturity
March 31, 2026
(in thousands)
Due in one year$28,348 
Due in one to five years22,996 
Total$51,344 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Trade Receivables (Tables)
3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Schedule of Breakdown in Trade Receivables
The following table shows the breakdown in trade receivables net book value for the presented periods:
March 31, 2026December 31, 2025
(in thousands)
Trade accounts receivables$471,460 $607,983 
(Less) Allowance for doubtful accounts(23,185)(25,881)
Net carrying value at end of period$448,275 $582,102 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill (Tables)
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Goodwill allocated to the two reportable segments and the changes in the carrying amount for the three months ended March 31, 2026 were as follows:
Retail MediaPerformance MediaTotal
(in thousands)
Balance at January 1, 2026
$151,828 $383,933 $535,761 
Currency translation adjustment(547)(2,689)(3,236)
Balance at March 31, 2026
$151,281 $381,244 $532,525 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Assets (Tables)
3 Months Ended
Mar. 31, 2026
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Current Assets
The following table presents the components of prepaid expenses and other current assets, net, for the periods presented:
March 31, 2026December 31, 2025
(in thousands)
Prepayments to suppliers
$52,409 $39,294 
Other current assets
17,188 13,916 
Total
$69,597 $53,210 
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Liabilities (Tables)
3 Months Ended
Mar. 31, 2026
Other Liabilities Disclosure [Abstract]  
Schedule of Other Current Liabilities
Other current liabilities are presented in the following table:
March 31, 2026December 31, 2025
(in thousands)
Rebates$35,369 $36,844 
Customer prepayments and deferred revenue
6,620 8,420 
Accounts payable relating to capital expenditures30,004 18,126 
Other creditors6,032 4,888 
Total$78,025 $68,277 
Schedule of Other Noncurrent Liabilities
Other noncurrent liabilities are presented in the following table:
March 31, 2026December 31, 2025
(in thousands)
Uncertain tax positions$29,205 $28,675 
Other3,198 3,151 
Total$32,403 $31,826 
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Leases (Tables)
3 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Schedule of Components of Lease Expense
The components of lease expense are as follows:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Lease expense
$10,335 $7,993 
Short term lease expense135 69 
Variable lease expense414 493 
Sublease income(154)(300)
Total operating lease expense$10,730 $8,255 
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.26.1
Employee Benefits (Tables)
3 Months Ended
Mar. 31, 2026
Retirement Benefits [Abstract]  
Schedule of Accumulated and Projected Benefit Obligations
The following table summarizes the changes in the projected benefit obligation:
Projected benefit obligation
(in thousands)
Accumulated postretirement benefit obligation at January 1, 2025
$4,709 
Service cost
785 
Interest cost
200 
Actuarial losses (gains)
(622)
Currency translation adjustment
635 
Accumulated postretirement benefit obligation at December 31, 2025
$5,707 
Service cost
198 
Interest cost
64 
Actuarial losses (gains)
(118)
Currency translation adjustment
(126)
Accumulated postretirement benefit obligation at March 31, 2026
$5,725 
Schedule of Assumptions Used for Actuarial Valuations
The main assumptions used for the purposes of the actuarial valuations are listed below:
Three Months EndedYear Ended
March 31, 2026December 31, 2025
Discount rate (Corp AA)
4.6%4.5%
Expected rate of salary increase
7.0%7.0%
Expected rate of social charges
50.0%50.0%
Expected staff turnover
Company age-based tableCompany age-based table
Estimated retirement age
65 years old65 years old
Life table
TH-TF 2000-2002 shiftedTH-TF 2000-2002 shifted
Schedule of Defined Contribution Plan
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Defined contribution plan expenses
$4,832 $4,242 
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share based compensation expense recorded in the consolidated statements of operations was as follows:

Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Research and Development
$6,598 $5,589 
Sales and Operations
2,956 5,421 
General and Administrative
5,505 5,654 
Total Share based compensation expense$15,059 $16,664 
Share based Compensation capitalized as internal-use software costs
(1,712)(1,255)
Total Share based compensation expense net of capitalization$13,347 $15,409 
Schedule of Nonvested Restricted Stock Units Activity
The following table summarizes the activities for our unvested RSUs for the period ended March 31, 2026:

Shares (RSU)Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
4,518,697 $33.15 
Granted692,386 17.93 
Vested(344,695)30.34 
Forfeited(127,651)34.86 
Outstanding as of March 31, 2026
4,738,737 $31.09 
Share-Based Payment Arrangement, Performance Shares, Activity
The following table summarizes the activities for our unvested Financial PSUs for the period ended March 31, 2026 (1):

Shares (Financial PSU)
Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
442,139 $31.89 
Granted
392,985 24.74 
Performance share adjustment
4,658 29.37 
Vested(195,018)32.43 
Forfeited(15,615)31.31 
Outstanding as of March 31, 2026
629,149 $27.25 
Share Based Compensation Performance Shares Award Total Shareholder Return Unvested Activity
The following table summarizes the activities for our unvested TSR PSUs for the period ended March 31, 2026:

Shares
(TSR PSU)
Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2025
313,383 $54.41 
Granted
332,744 27.39 
Vested(23,699)51.28 
Forfeited(121,859)54.57 
Outstanding as of March 31, 2026
500,569 $36.56 


(1) The number of Financial PSUs granted during the three months ended March 31, 2026 includes 60,242 PSUs previously modified from TSR PSUs, for which financial performance targets were established in March 2026 for the 2026 performance tranche.
The grant-date fair value was determined based on a Monte-Carlo valuation model using the following key assumptions:
Expected volatility of the Company39.70 %
Expected volatility of the benchmark81.68 %
Risk-free rate3.71 %
Expected dividend yield— %
Schedule of Stockholders' Equity Note, Warrants or Rights
SharesWeighted-Average Grant date Fair Value Per ShareWeighted-Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2025
159,897 $18.31 2.6$1,300.0 
Granted— 
Exercised— 
Canceled— 
Expired— 
Outstanding as of March 31, 2026
159,897 $18.31 2.4$1,300.0 
Vested and exercisable - March 31, 2026
159,897 
Schedule of Stock Options Roll Forward
Options Outstanding
Number of Shares Underlying Outstanding OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2025
86,715 $17.35 4.0$276.0 
Options granted— 
Options exercised— 
Options forfeited— 
Options canceled— 
Options expired(86,715)
Outstanding as of March 31, 2026
— $— 0.0$— 
Vested and exercisable as of March 31, 2026
— 
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.26.1
Financial and Other Income and Expenses (Tables)
3 Months Ended
Mar. 31, 2026
Other Income and Expenses [Abstract]  
Schedule of Financial and Other Income (Expense)
The condensed consolidated statements of income line item “Financial and Other Income” can be broken down as follows:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Financial income from cash equivalents$2,654 $1,680 
Interest and fees(764)(430)
Foreign exchange income24 1,072 
Other financial expense(41)(20)
Total financial and other income $1,873 $2,302 
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Schedule of Provision for Income Taxes
The following table presents provision for income taxes:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Provision for Income taxes$3,693 $10,458 
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Basic Earnings Per Share
The components of Basic earnings per share ("EPS") for the periods presented were as follows:
Three Months Ended
March 31, 2026March 31, 2025
Net income attributable to shareholders of Criteo S.A.
$7,817 $37,928 
Weighted average number of shares outstanding of Criteo S.A.
50,352,465 53,979,157 
Basic earnings per share$0.16 $0.70 
Schedule of Diluted Earnings Per Share
Three Months Ended
March 31, 2026March 31, 2025
Net income attributable to shareholders of Criteo S.A.$7,817 $37,928 
Basic shares:
Weighted average number of shares outstanding of Criteo S.A.50,352,465 53,979,157 
Dilutive effect of:
RSUs and PSUs
613,468 3,079,762 
Stock options
— 82,956 
Share warrants— 54,023 
Diluted shares:
Weighted average number of shares outstanding used to determine diluted earnings per share50,965,933 57,195,898 
Diluted earnings per share$0.15 $0.66 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows:
Three Months Ended
March 31, 2026March 31, 2025
Restricted share awards1,995,016 33,092 
Weighted average number of anti-dilutive securities excluded from diluted earnings per share1,995,016 33,092 
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.26.1
Breakdown of Revenue and Noncurrent Assets (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Revenue from External Customers by Products and Services
The following table presents the Company's revenue disaggregated by major product for the periods presented:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Retail Media$41,271 $59,498 
Commerce Growth356,583 365,296 
Other26,785 26,640 
Performance Media383,368 391,936 
Total Revenue$424,639 $451,434 
Revenue from External Customers and Long-Lived Assets by Geographical Areas
Revenue generated in other significant countries where we operate is presented in the following table:
Three Months Ended
March 31, 2026March 31, 2025
(in thousands)
Americas$158,629 $192,908 
United States140,414 174,499 
EMEA$175,330 $164,861 
Germany50,436 45,983 
France20,250 19,439 
Asia-Pacific$90,680 $93,665 
Japan56,239 54,151 
For each reported period, noncurrent assets (corresponding to the net book value of tangible and intangible assets) are presented in the table below. The geographical information includes such noncurrent assets from the locations of legal entities.
AmericasEMEAAsia-PacificTotal
(in thousands)
March 31, 2026$79,139 $210,336 $14,751 $304,226 
December 31, 2025$69,785 $207,109 $14,289 $291,183 
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring and Other Exit Costs - Summary of restructuring activities included in other current liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Restructuring Reserve [Roll Forward]    
Restructuring liability, beginning balance $ 3,043  
Restructuring charge 5,688 $ 3,000
Amounts paid (3,841)  
Restructuring liability, ending balance $ 4,890 $ 3,043
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring and Other Exit Costs - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Restructuring and Related Activities [Abstract]    
Restructuring charge $ 5,688 $ 3,000
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Sales and operations expenses Sales and operations expenses
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Segment information - Narrative (Details)
3 Months Ended
Mar. 31, 2026
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
Number of operating segments 2
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.26.1
Segment information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Revenue $ 424,639 $ 451,434
Traffic acquisition costs 174,271 187,062
Contribution ex-TAC 250,368 264,372
Other cost of revenue 27,626 27,396
Gross profit 222,742 236,976
Operating expenses    
Research and development expenses 69,683 60,749
Sales and operations expenses 97,501 88,889
General and administrative expenses 45,158 39,171
Total operating expenses 212,342 188,809
Income from operations 10,400 48,167
Financial and other income 1,873 2,302
Income before taxes 12,273 50,469
Retail Media    
Segment Reporting Information [Line Items]    
Revenue 41,271 59,498
Traffic acquisition costs 682 708
Contribution ex-TAC 40,589 58,790
Performance Media    
Segment Reporting Information [Line Items]    
Revenue 383,368 391,936
Traffic acquisition costs 173,589 186,354
Contribution ex-TAC $ 209,779 $ 205,582
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.26.1
Financial instruments - Fair Value Assets Measured on a Recurring Basis (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and Cash Equivalents, Fair Value Disclosure $ 319,981 $ 342,038
Level 1 | Cash    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and Cash Equivalents, Fair Value Disclosure 165,557 160,252
Level 1 | Money Market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and Cash Equivalents, Fair Value Disclosure 103,481 89,157
Level 2 | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and Cash Equivalents, Fair Value Disclosure 11,426 35,139
Level 2 | Term deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and Cash Equivalents, Fair Value Disclosure 28,745 41,614
Level 2 | Structured debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and Cash Equivalents, Fair Value Disclosure $ 10,772 $ 15,876
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.26.1
Financial instruments - Schedule of Breakdown of Marketable Securities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Securities Held-to-maturity $ 51,344 $ 46,742
Commercial paper    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Securities Held-to-maturity 22,599 17,366
Structured debt securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Securities Held-to-maturity 17,247 17,625
Corporate debt securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Securities Held-to-maturity $ 11,498 $ 11,750
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.26.1
Financial instruments - Schedule of Marketable Securities by Contractual Maturity (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Fair Value Disclosures [Abstract]    
Due in one year $ 28,348  
Due in one to five years 22,996  
Total $ 51,344 $ 46,742
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.26.1
Trade Receivables (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Receivables [Abstract]    
Trade accounts receivables $ 471,460 $ 607,983
(Less) Allowance for doubtful accounts (23,185) (25,881)
Net carrying value at end of period $ 448,275 $ 582,102
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
segment
Goodwill [Line Items]  
Number of reportable segments | segment 2
Goodwill [Roll Forward]  
Goodwill balance, beginning of the period $ 535,761
Currency translation adjustment (3,236)
Goodwill balance, end of the period 532,525
Retail Media  
Goodwill [Roll Forward]  
Goodwill balance, beginning of the period 151,828
Currency translation adjustment (547)
Goodwill balance, end of the period 151,281
Performance Media  
Goodwill [Roll Forward]  
Goodwill balance, beginning of the period 383,933
Currency translation adjustment (2,689)
Goodwill balance, end of the period $ 381,244
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Assets - Breakdown in other current assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepayments to suppliers $ 52,409 $ 39,294
Other current assets 17,188 13,916
Total $ 69,597 $ 53,210
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Assets - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Sep. 30, 2025
Other Non-current Assets [Line Items]        
Capitalized stock-based compensation relating to internally developed software $ 24,700   $ 25,600  
Capitalized computer software, amortization 2,100 $ 2,000    
Restricted cash, included in other current assets 321 $ 321 300  
Other noncurrent assets 46,777   45,680  
Doe vs. GoodRx Holdings, Inc.        
Other Non-current Assets [Line Items]        
Loss contingency, receivable 5,500   5,500 $ 5,500
Iponweb        
Other Non-current Assets [Line Items]        
Indemnification asset $ 37,200   $ 37,200  
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Liabilities - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Other Liabilities Disclosure [Abstract]    
Rebates $ 35,369 $ 36,844
Customer prepayments and deferred revenue 6,620 8,420
Accounts payable relating to capital expenditures 30,004 18,126
Other creditors 6,032 4,888
Total $ 78,025 $ 68,277
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.26.1
Other Current and Noncurrent Liabilities - Schedule of Other Noncurrent Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Other Liabilities Disclosure [Abstract]    
Uncertain tax positions $ 29,205 $ 28,675
Other 3,198 3,151
Total $ 32,403 $ 31,826
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.26.1
Leases (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Leases [Abstract]    
Lease expense $ 10,335 $ 7,993
Short term lease expense 135 69
Variable lease expense 414 493
Sublease income (154) (300)
Total operating lease expense $ 10,730 $ 8,255
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.26.1
Employee Benefits - Schedule of Accumulated and Projected Benefit Obligations (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]    
Accumulated postretirement benefit obligation at beginning of period $ 5,707 $ 4,709
Service cost 198 785
Interest cost 64 200
Actuarial losses (gains) (118) (622)
Currency translation adjustment (126) 635
Accumulated postretirement benefit obligation at end of period $ 5,725 $ 5,707
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Operating Expenses  
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.26.1
Employee Benefits - Schedule of Assumptions Used for Actuarial Valuations (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Retirement Benefits [Abstract]    
Discount rate (Corp AA) 4.60% 4.50%
Expected rate of salary increase 7.00% 7.00%
Expected rate of social charges 50.00% 50.00%
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.26.1
Employee Benefits - Schedule of Defined Contribution Plans (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Retirement Benefits [Abstract]    
Defined contribution plan expenses $ 4,832 $ 4,242
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation - Equity Awards Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total Share based compensation expense $ 13,347 $ 15,409
Share based Compensation capitalized as internal-use software costs (1,712) (1,255)
Total Share based compensation expense net of capitalization 15,059 16,664
Research and Development    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total Share based compensation expense net of capitalization 6,598 5,589
Sales and Operations    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total Share based compensation expense net of capitalization 2,956 5,421
General and Administrative    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total Share based compensation expense net of capitalization $ 5,505 $ 5,654
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
tranche
shares
Dec. 31, 2025
USD ($)
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Warrants term (in years) 4 years  
Employees warrants exercised (in shares) | shares 0  
Granted (in shares) | shares 0  
Aggregate intrinsic value of the share options exercised $ 0.0 $ 0.9
Granted, options (in shares) | shares 0  
Restricted stock units (RSUs)    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Award vesting period 4 years  
Unrecognized stock-based compensation, nonvested awards $ 76.6  
Stock-based compensation, recognition period 3 years 1 month 6 days  
Financial PSU (PSUs)    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Award vesting period 3 years  
Unrecognized stock-based compensation, nonvested awards $ 11.1  
Stock-based compensation, recognition period 3 years 4 months 24 days  
Minimum percentage increase to target shares 0  
Maximum percentage increase to target shares 2  
TSR Performance Shares Units (TSR PSU)    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Unrecognized stock-based compensation, nonvested awards $ 13.6  
Stock-based compensation, recognition period 2 years 7 months 6 days  
Minimum percentage increase to target shares 0  
Maximum percentage increase to target shares 2  
Number of tranches | tranche 2  
Total share-based payment expense $ 9.1  
TSR Performance Shares Units (TSR PSU) | Tranche 1    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Award vesting period 2 years  
TSR Performance Shares Units (TSR PSU) | Tranche 2    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Award vesting period 3 years  
Employee Stock Option    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Award vesting period 4 years  
Expiration period 10 years  
Unrecognized stock-based compensation, stock options $ 0.0  
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation - RSU Activity (Details) - Restricted stock units (RSUs)
3 Months Ended
Mar. 31, 2026
$ / shares
shares
Shares (RSU)  
Beginning balance (in shares) | shares 4,518,697
Granted (in shares) | shares 692,386
Vested (in shares) | shares (344,695)
Forfeited (in shares) | shares (127,651)
Ending balance (in shares) | shares 4,738,737
Weighted-Average Grant date Fair Value Per Share  
Outstanding at beginning of period (in USD per share) | $ / shares $ 33.15
Granted (in USD per share) | $ / shares 17.93
Vested (in USD per share) | $ / shares 30.34
Forfeited (in USD per share) | $ / shares 34.86
Outstanding at end of period (in USD per share) | $ / shares $ 31.09
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation - PSU Activity (Details) - Financial PSU
3 Months Ended
Mar. 31, 2026
$ / shares
shares
Shares (Financial PSU)  
Beginning balance (in shares) | shares 442,139
Granted (in shares) | shares 392,985
Performance share adjustment (in shares) | shares 4,658
Vested (in shares) | shares (195,018)
Forfeited (in shares) | shares (15,615)
Ending balance (in shares) | shares 629,149
Weighted-Average Grant date Fair Value Per Share  
Outstanding at beginning of period (in USD per share) | $ / shares $ 31.89
Granted (in USD per share) | $ / shares 24.74
Performance share adjustment (in USD per share) | $ / shares 29.37
Vested (in USD per share) | $ / shares 32.43
Forfeited (in USD per share) | $ / shares 31.31
Outstanding at end of period (in USD per share) | $ / shares $ 27.25
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation - Performance Stock Units Total Shareholder Return Activity (Details)
3 Months Ended
Mar. 31, 2026
$ / shares
shares
TSR Performance Shares Units (TSR PSU)  
Shares (Financial PSU)  
Beginning balance (in shares) 313,383
Granted (in shares) 332,744
Vested (in shares) (23,699)
Forfeited (in shares) (121,859)
Ending balance (in shares) 500,569
Weighted-Average Grant date Fair Value Per Share  
Outstanding at beginning of period (in USD per share) | $ / shares $ 54.41
Granted (in USD per share) | $ / shares 27.39
Vested (in USD per share) | $ / shares 51.28
Forfeited (in USD per share) | $ / shares 54.57
Outstanding at end of period (in USD per share) | $ / shares $ 36.56
Expected volatility of the Company 0.3970
Expected volatility of the benchmark 0.8168
Risk-free rate 3.71%
Expected dividend yield 0.00%
Financial Performance Shares Units Previously Modified TSR PSUs  
Shares (Financial PSU)  
Granted (in shares) 60,242
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation - Warrants (Details) - USD ($)
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Shares    
Beginning balance (in shares) 159,897  
Granted (in shares) 0  
Exercised (in shares) 0  
Canceled (in shares) 0  
Expired (in shares) 0  
Ending balance (in shares) 159,897  
Vested and exercisable (in shares) 159,897  
Weighted-Average Grant date Fair Value Per Share    
Weighted-average exercise price (in US dollar per share) $ 18.31 $ 18.31
Weighted-Average Remaining Contractual Term (Years)    
Weighted-average remaining contractual term outstanding 2 years 4 months 24 days 2 years 7 months 6 days
Aggregate Intrinsic Value (in thousands)    
Aggregate intrinsic value $ 1,300,000 $ 1,300,000
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation - Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]    
Beginning balance, options (in shares) 86,715  
Granted, options (in shares) 0  
Exercised, options (in shares) 0  
Forfeited, options (in shares) 0  
Canceled, options (in shares) 0  
Expired, options (in shares) (86,715)  
Ending balance, options (in shares) 0 86,715
Vested and exercisable, options (in shares) 0  
Weighted-Average Exercise Price    
Weighted-average exercise price, options outstanding (in US dollar per share) $ 0 $ 17.35
Weighted-Average Remaining Contractual Term (Years)    
Weighted-average remaining contractual term, options outstanding (years) 0 years 4 years
Aggregate Intrinsic Value (in thousands)    
Aggregate intrinsic value, options outstanding $ 0 $ 276
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.26.1
Financial and Other Income and Expenses - Schedule of Financial Income (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Other Income and Expenses [Abstract]    
Financial income from cash equivalents $ 2,654 $ 1,680
Interest and fees (764) (430)
Foreign exchange income 24 1,072
Other financial expense (41) (20)
Total financial and other income $ 1,873 $ 2,302
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Tax Disclosure [Abstract]    
Provision for Income taxes $ 3,693 $ 10,458
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share - Schedule of Basic Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Earnings Per Share [Abstract]    
Net income attributable to shareholders of Criteo S.A. $ 7,817 $ 37,928
Weighted average number of shares outstanding of Criteo S.A. (in shares) 50,352,465 53,979,157
Basic earnings per share (in USD per share) $ 0.16 $ 0.70
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share - Schedule of Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Earnings Per Share [Abstract]    
Net income attributable to shareholders of Criteo S.A. $ 7,817 $ 37,928
Basic shares:    
Weighted average number of shares outstanding of Criteo S.A. (in shares) 50,352,465 53,979,157
Dilutive effect of:    
RSUs and PSUs (in shares) 613,468 3,079,762
Share options (in shares) 0 82,956
Share warrants (in shares) 0 54,023
Diluted shares:    
Weighted average number of shares outstanding used to determine diluted earnings per share (in shares) 50,965,933 57,195,898
Diluted earnings per share (in USD per share) $ 0.15 $ 0.66
XML 80 R70.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share - Anti-Dilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares) 1,995,016 33,092
Restricted share awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares) 1,995,016 33,092
XML 81 R71.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and contingencies (Details)
€ in Millions, $ in Millions
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
Sep. 30, 2025
USD ($)
Jun. 21, 2023
USD ($)
Jun. 21, 2023
EUR (€)
Aug. 03, 2022
USD ($)
Aug. 03, 2022
EUR (€)
Commission Nationale de l'Informatique et des Libertés (CNIL)              
Loss Contingencies [Line Items]              
Loss contingency, estimate of possible loss       $ 46.0 € 40 $ 69.0 € 60
Doe vs. GoodRx Holdings, Inc.              
Loss Contingencies [Line Items]              
Loss contingency accrual   $ 7.0 $ 7.0        
Loss contingency, receivable $ 5.5 5.5 $ 5.5        
Iponweb              
Loss Contingencies [Line Items]              
Loss contingency accrual $ 22.7 $ 23.0          
XML 82 R72.htm IDEA: XBRL DOCUMENT v3.26.1
Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue by Product and Services (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total Revenue $ 424,639 $ 451,434
Retail Media    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total Revenue 41,271 59,498
Performance Media    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total Revenue 383,368 391,936
Commerce Growth | Retail Media    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total Revenue 356,583 365,296
Other | Retail Media    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total Revenue $ 26,785 $ 26,640
XML 83 R73.htm IDEA: XBRL DOCUMENT v3.26.1
Breakdown of Revenue and Noncurrent Assets - Narrative (Details)
Mar. 31, 2026
market
Segment Reporting [Abstract]  
Number of geographical markets in which entity operates 3
XML 84 R74.htm IDEA: XBRL DOCUMENT v3.26.1
Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue Generated in Other Significant Countries (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue $ 424,639 $ 451,434
Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue 158,629 192,908
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue 140,414 174,499
EMEA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue 175,330 164,861
Germany    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue 50,436 45,983
France    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue 20,250 19,439
Asia-Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue 90,680 93,665
Japan    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue $ 56,239 $ 54,151
XML 85 R75.htm IDEA: XBRL DOCUMENT v3.26.1
Breakdown of Revenue and Noncurrent Assets - Schedule of Non-Current Assets by Geographical Area and Country (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 304,226 $ 291,183
Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 79,139 69,785
EMEA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 210,336 207,109
Asia-Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 14,751 $ 14,289
XML 86 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 87 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 89 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 134 294 1 true 44 0 false 9 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.criteo.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) Sheet http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) Statements 2 false false R3.htm 9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) (Parenthetical) Sheet http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE OPERATIONS (UNAUDITED) Sheet http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE OPERATIONS (UNAUDITED) Statements 5 false false R6.htm 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) Sheet http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) Statements 6 false false R7.htm 9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) Sheet http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) Statements 7 false false R8.htm 9952157 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 8 false false R9.htm 9952158 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.criteo.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 9952159 - Disclosure - Restructuring and Other Exit Costs Sheet http://www.criteo.com/role/RestructuringandOtherExitCosts Restructuring and Other Exit Costs Notes 10 false false R11.htm 9952160 - Disclosure - Segment information Sheet http://www.criteo.com/role/Segmentinformation Segment information Notes 11 false false R12.htm 9952161 - Disclosure - Financial instruments Sheet http://www.criteo.com/role/Financialinstruments Financial instruments Notes 12 false false R13.htm 9952162 - Disclosure - Trade Receivables Sheet http://www.criteo.com/role/TradeReceivables Trade Receivables Notes 13 false false R14.htm 9952163 - Disclosure - Goodwill Sheet http://www.criteo.com/role/Goodwill Goodwill Notes 14 false false R15.htm 9952164 - Disclosure - Other Current and Noncurrent Assets Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentAssets Other Current and Noncurrent Assets Notes 15 false false R16.htm 9952165 - Disclosure - Other Current and Noncurrent Liabilities Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilities Other Current and Noncurrent Liabilities Notes 16 false false R17.htm 9952166 - Disclosure - Leases Sheet http://www.criteo.com/role/Leases Leases Notes 17 false false R18.htm 9952167 - Disclosure - Employee Benefits Sheet http://www.criteo.com/role/EmployeeBenefits Employee Benefits Notes 18 false false R19.htm 9952168 - Disclosure - Share-based Compensation Sheet http://www.criteo.com/role/SharebasedCompensation Share-based Compensation Notes 19 false false R20.htm 9952169 - Disclosure - Financial and Other Income and Expenses Sheet http://www.criteo.com/role/FinancialandOtherIncomeandExpenses Financial and Other Income and Expenses Notes 20 false false R21.htm 9952170 - Disclosure - Income Taxes Sheet http://www.criteo.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 9952171 - Disclosure - Earnings Per Share Sheet http://www.criteo.com/role/EarningsPerShare Earnings Per Share Notes 22 false false R23.htm 9952172 - Disclosure - Commitments and contingencies Sheet http://www.criteo.com/role/Commitmentsandcontingencies Commitments and contingencies Notes 23 false false R24.htm 9952173 - Disclosure - Breakdown of Revenue and Noncurrent Assets Sheet http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssets Breakdown of Revenue and Noncurrent Assets Notes 24 false false R25.htm 9952174 - Disclosure - Subsequent Events Sheet http://www.criteo.com/role/SubsequentEvents Subsequent Events Notes 25 false false R26.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 26 false false R27.htm 9955511 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.criteo.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.criteo.com/role/SummaryofSignificantAccountingPolicies 27 false false R28.htm 9955512 - Disclosure - Restructuring and Other Exit Costs (Tables) Sheet http://www.criteo.com/role/RestructuringandOtherExitCostsTables Restructuring and Other Exit Costs (Tables) Tables http://www.criteo.com/role/RestructuringandOtherExitCosts 28 false false R29.htm 9955513 - Disclosure - Segment information (Tables) Sheet http://www.criteo.com/role/SegmentinformationTables Segment information (Tables) Tables http://www.criteo.com/role/Segmentinformation 29 false false R30.htm 9955514 - Disclosure - Financial instruments (Tables) Sheet http://www.criteo.com/role/FinancialinstrumentsTables Financial instruments (Tables) Tables http://www.criteo.com/role/Financialinstruments 30 false false R31.htm 9955515 - Disclosure - Trade Receivables (Tables) Sheet http://www.criteo.com/role/TradeReceivablesTables Trade Receivables (Tables) Tables http://www.criteo.com/role/TradeReceivables 31 false false R32.htm 9955516 - Disclosure - Goodwill (Tables) Sheet http://www.criteo.com/role/GoodwillTables Goodwill (Tables) Tables http://www.criteo.com/role/Goodwill 32 false false R33.htm 9955517 - Disclosure - Other Current and Noncurrent Assets (Tables) Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsTables Other Current and Noncurrent Assets (Tables) Tables http://www.criteo.com/role/OtherCurrentandNoncurrentAssets 33 false false R34.htm 9955518 - Disclosure - Other Current and Noncurrent Liabilities (Tables) Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesTables Other Current and Noncurrent Liabilities (Tables) Tables http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilities 34 false false R35.htm 9955519 - Disclosure - Leases (Tables) Sheet http://www.criteo.com/role/LeasesTables Leases (Tables) Tables http://www.criteo.com/role/Leases 35 false false R36.htm 9955520 - Disclosure - Employee Benefits (Tables) Sheet http://www.criteo.com/role/EmployeeBenefitsTables Employee Benefits (Tables) Tables http://www.criteo.com/role/EmployeeBenefits 36 false false R37.htm 9955521 - Disclosure - Share-based Compensation (Tables) Sheet http://www.criteo.com/role/SharebasedCompensationTables Share-based Compensation (Tables) Tables http://www.criteo.com/role/SharebasedCompensation 37 false false R38.htm 9955522 - Disclosure - Financial and Other Income and Expenses (Tables) Sheet http://www.criteo.com/role/FinancialandOtherIncomeandExpensesTables Financial and Other Income and Expenses (Tables) Tables http://www.criteo.com/role/FinancialandOtherIncomeandExpenses 38 false false R39.htm 9955523 - Disclosure - Income Taxes (Tables) Sheet http://www.criteo.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.criteo.com/role/IncomeTaxes 39 false false R40.htm 9955524 - Disclosure - Earnings Per Share (Tables) Sheet http://www.criteo.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.criteo.com/role/EarningsPerShare 40 false false R41.htm 9955525 - Disclosure - Breakdown of Revenue and Noncurrent Assets (Tables) Sheet http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsTables Breakdown of Revenue and Noncurrent Assets (Tables) Tables http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssets 41 false false R42.htm 9955526 - Disclosure - Restructuring and Other Exit Costs - Summary of restructuring activities included in other current liabilities (Details) Sheet http://www.criteo.com/role/RestructuringandOtherExitCostsSummaryofrestructuringactivitiesincludedinothercurrentliabilitiesDetails Restructuring and Other Exit Costs - Summary of restructuring activities included in other current liabilities (Details) Details 42 false false R43.htm 9955527 - Disclosure - Restructuring and Other Exit Costs - Narrative (Details) Sheet http://www.criteo.com/role/RestructuringandOtherExitCostsNarrativeDetails Restructuring and Other Exit Costs - Narrative (Details) Details 43 false false R44.htm 9955528 - Disclosure - Segment information - Narrative (Details) Sheet http://www.criteo.com/role/SegmentinformationNarrativeDetails Segment information - Narrative (Details) Details 44 false false R45.htm 9955529 - Disclosure - Segment information - Schedule of Segment Reporting Information (Details) Sheet http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails Segment information - Schedule of Segment Reporting Information (Details) Details 45 false false R46.htm 9955530 - Disclosure - Financial instruments - Fair Value Assets Measured on a Recurring Basis (Details) Sheet http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails Financial instruments - Fair Value Assets Measured on a Recurring Basis (Details) Details 46 false false R47.htm 9955531 - Disclosure - Financial instruments - Schedule of Breakdown of Marketable Securities (Details) Sheet http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails Financial instruments - Schedule of Breakdown of Marketable Securities (Details) Details 47 false false R48.htm 9955532 - Disclosure - Financial instruments - Schedule of Marketable Securities by Contractual Maturity (Details) Sheet http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails Financial instruments - Schedule of Marketable Securities by Contractual Maturity (Details) Details 48 false false R49.htm 9955533 - Disclosure - Trade Receivables (Details) Sheet http://www.criteo.com/role/TradeReceivablesDetails Trade Receivables (Details) Details http://www.criteo.com/role/TradeReceivablesTables 49 false false R50.htm 9955534 - Disclosure - Goodwill (Details) Sheet http://www.criteo.com/role/GoodwillDetails Goodwill (Details) Details http://www.criteo.com/role/GoodwillTables 50 false false R51.htm 9955535 - Disclosure - Other Current and Noncurrent Assets - Breakdown in other current assets (Details) Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails Other Current and Noncurrent Assets - Breakdown in other current assets (Details) Details 51 false false R52.htm 9955536 - Disclosure - Other Current and Noncurrent Assets - Narrative (Details) Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails Other Current and Noncurrent Assets - Narrative (Details) Details 52 false false R53.htm 9955537 - Disclosure - Other Current and Noncurrent Liabilities - Schedule of Other Current Liabilities (Details) Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails Other Current and Noncurrent Liabilities - Schedule of Other Current Liabilities (Details) Details 53 false false R54.htm 9955538 - Disclosure - Other Current and Noncurrent Liabilities - Schedule of Other Noncurrent Liabilities (Details) Sheet http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails Other Current and Noncurrent Liabilities - Schedule of Other Noncurrent Liabilities (Details) Details 54 false false R55.htm 9955539 - Disclosure - Leases (Details) Sheet http://www.criteo.com/role/LeasesDetails Leases (Details) Details http://www.criteo.com/role/LeasesTables 55 false false R56.htm 9955540 - Disclosure - Employee Benefits - Schedule of Accumulated and Projected Benefit Obligations (Details) Sheet http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails Employee Benefits - Schedule of Accumulated and Projected Benefit Obligations (Details) Details 56 false false R57.htm 9955541 - Disclosure - Employee Benefits - Schedule of Assumptions Used for Actuarial Valuations (Details) Sheet http://www.criteo.com/role/EmployeeBenefitsScheduleofAssumptionsUsedforActuarialValuationsDetails Employee Benefits - Schedule of Assumptions Used for Actuarial Valuations (Details) Details 57 false false R58.htm 9955542 - Disclosure - Employee Benefits - Schedule of Defined Contribution Plans (Details) Sheet http://www.criteo.com/role/EmployeeBenefitsScheduleofDefinedContributionPlansDetails Employee Benefits - Schedule of Defined Contribution Plans (Details) Details 58 false false R59.htm 9955543 - Disclosure - Share-based Compensation - Equity Awards Compensation Expense (Details) Sheet http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails Share-based Compensation - Equity Awards Compensation Expense (Details) Details 59 false false R60.htm 9955544 - Disclosure - Share-based Compensation - Narrative (Details) Sheet http://www.criteo.com/role/SharebasedCompensationNarrativeDetails Share-based Compensation - Narrative (Details) Details 60 false false R61.htm 9955545 - Disclosure - Share-based Compensation - RSU Activity (Details) Sheet http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails Share-based Compensation - RSU Activity (Details) Details 61 false false R62.htm 9955546 - Disclosure - Share-based Compensation - PSU Activity (Details) Sheet http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails Share-based Compensation - PSU Activity (Details) Details 62 false false R63.htm 9955547 - Disclosure - Share-based Compensation - Performance Stock Units Total Shareholder Return Activity (Details) Sheet http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails Share-based Compensation - Performance Stock Units Total Shareholder Return Activity (Details) Details 63 false false R64.htm 9955548 - Disclosure - Share-based Compensation - Warrants (Details) Sheet http://www.criteo.com/role/SharebasedCompensationWarrantsDetails Share-based Compensation - Warrants (Details) Details 64 false false R65.htm 9955549 - Disclosure - Share-based Compensation - Options Activity (Details) Sheet http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails Share-based Compensation - Options Activity (Details) Details 65 false false R66.htm 9955550 - Disclosure - Financial and Other Income and Expenses - Schedule of Financial Income (Details) Sheet http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails Financial and Other Income and Expenses - Schedule of Financial Income (Details) Details 66 false false R67.htm 9955551 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details) Sheet http://www.criteo.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails Income Taxes - Schedule of Provision for Income Taxes (Details) Details 67 false false R68.htm 9955552 - Disclosure - Earnings Per Share - Schedule of Basic Earnings (Loss) Per Share (Details) Sheet http://www.criteo.com/role/EarningsPerShareScheduleofBasicEarningsLossPerShareDetails Earnings Per Share - Schedule of Basic Earnings (Loss) Per Share (Details) Details 68 false false R69.htm 9955553 - Disclosure - Earnings Per Share - Schedule of Diluted Earnings Per Share (Details) Sheet http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails Earnings Per Share - Schedule of Diluted Earnings Per Share (Details) Details 69 false false R70.htm 9955554 - Disclosure - Earnings Per Share - Anti-Dilutive Securities (Details) Sheet http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails Earnings Per Share - Anti-Dilutive Securities (Details) Details 70 false false R71.htm 9955555 - Disclosure - Commitments and contingencies (Details) Sheet http://www.criteo.com/role/CommitmentsandcontingenciesDetails Commitments and contingencies (Details) Details http://www.criteo.com/role/Commitmentsandcontingencies 71 false false R72.htm 9955556 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue by Product and Services (Details) Sheet http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue by Product and Services (Details) Details 72 false false R73.htm 9955557 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Narrative (Details) Sheet http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsNarrativeDetails Breakdown of Revenue and Noncurrent Assets - Narrative (Details) Details 73 false false R74.htm 9955558 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue Generated in Other Significant Countries (Details) Sheet http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue Generated in Other Significant Countries (Details) Details 74 false false R75.htm 9955559 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Non-Current Assets by Geographical Area and Country (Details) Sheet http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails Breakdown of Revenue and Noncurrent Assets - Schedule of Non-Current Assets by Geographical Area and Country (Details) Details 75 false false All Reports Book All Reports crto-20260331.htm crto-20260331.xsd crto-20260331_cal.xml crto-20260331_def.xml crto-20260331_lab.xml crto-20260331_pre.xml http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true JSON 92 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "crto-20260331.htm": { "nsprefix": "crto", "nsuri": "http://www.criteo.com/20260331", "dts": { "inline": { "local": [ "crto-20260331.htm" ] }, "schema": { "local": [ "crto-20260331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "crto-20260331_cal.xml" ] }, "definitionLink": { "local": [ "crto-20260331_def.xml" ] }, "labelLink": { "local": [ "crto-20260331_lab.xml" ] }, "presentationLink": { "local": [ "crto-20260331_pre.xml" ] } }, "keyStandard": 261, "keyCustom": 33, "axisStandard": 14, "axisCustom": 0, "memberStandard": 29, "memberCustom": 13, "hidden": { "total": 9, "http://fasb.org/us-gaap/2025": 3, "http://xbrl.sec.gov/dei/2025": 6 }, "contextCount": 134, "entityCount": 1, "segmentCount": 44, "elementCount": 542, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2025": 638, "http://xbrl.sec.gov/dei/2025": 32, "http://xbrl.sec.gov/ecd/2025": 4, "http://fasb.org/srt/2025": 2 }, "report": { "R1": { "role": "http://www.criteo.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "longName": "9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "crto:PrepaidIncomeTaxes", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R3": { "role": "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical", "longName": "9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "eurPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R4": { "role": "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "longName": "9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R5": { "role": "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED", "longName": "9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE OPERATIONS (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE OPERATIONS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R6": { "role": "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "longName": "9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-8", "name": "us-gaap:SharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "us-gaap:SharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical", "longName": "9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-54", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-54", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "longName": "9952157 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R9": { "role": "http://www.criteo.com/role/SummaryofSignificantAccountingPolicies", "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.criteo.com/role/RestructuringandOtherExitCosts", "longName": "9952159 - Disclosure - Restructuring and Other Exit Costs", "shortName": "Restructuring and Other Exit Costs", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.criteo.com/role/Segmentinformation", "longName": "9952160 - Disclosure - Segment information", "shortName": "Segment information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": null }, "R12": { "role": "http://www.criteo.com/role/Financialinstruments", "longName": "9952161 - Disclosure - Financial instruments", "shortName": "Financial instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.criteo.com/role/TradeReceivables", "longName": "9952162 - Disclosure - Trade Receivables", "shortName": "Trade Receivables", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.criteo.com/role/Goodwill", "longName": "9952163 - Disclosure - Goodwill", "shortName": "Goodwill", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentAssets", "longName": "9952164 - Disclosure - Other Current and Noncurrent Assets", "shortName": "Other Current and Noncurrent Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilities", "longName": "9952165 - Disclosure - Other Current and Noncurrent Liabilities", "shortName": "Other Current and Noncurrent Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.criteo.com/role/Leases", "longName": "9952166 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.criteo.com/role/EmployeeBenefits", "longName": "9952167 - Disclosure - Employee Benefits", "shortName": "Employee Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.criteo.com/role/SharebasedCompensation", "longName": "9952168 - Disclosure - Share-based Compensation", "shortName": "Share-based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.criteo.com/role/FinancialandOtherIncomeandExpenses", "longName": "9952169 - Disclosure - Financial and Other Income and Expenses", "shortName": "Financial and Other Income and Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.criteo.com/role/IncomeTaxes", "longName": "9952170 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.criteo.com/role/EarningsPerShare", "longName": "9952171 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.criteo.com/role/Commitmentsandcontingencies", "longName": "9952172 - Disclosure - Commitments and contingencies", "shortName": "Commitments and contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssets", "longName": "9952173 - Disclosure - Breakdown of Revenue and Noncurrent Assets", "shortName": "Breakdown of Revenue and Noncurrent Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": null }, "R25": { "role": "http://www.criteo.com/role/SubsequentEvents", "longName": "9952174 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.criteo.com/role/SummaryofSignificantAccountingPoliciesPolicies", "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.criteo.com/role/RestructuringandOtherExitCostsTables", "longName": "9955512 - Disclosure - Restructuring and Other Exit Costs (Tables)", "shortName": "Restructuring and Other Exit Costs (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.criteo.com/role/SegmentinformationTables", "longName": "9955513 - Disclosure - Segment information (Tables)", "shortName": "Segment information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.criteo.com/role/FinancialinstrumentsTables", "longName": "9955514 - Disclosure - Financial instruments (Tables)", "shortName": "Financial instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.criteo.com/role/TradeReceivablesTables", "longName": "9955515 - Disclosure - Trade Receivables (Tables)", "shortName": "Trade Receivables (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.criteo.com/role/GoodwillTables", "longName": "9955516 - Disclosure - Goodwill (Tables)", "shortName": "Goodwill (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsTables", "longName": "9955517 - Disclosure - Other Current and Noncurrent Assets (Tables)", "shortName": "Other Current and Noncurrent Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesTables", "longName": "9955518 - Disclosure - Other Current and Noncurrent Liabilities (Tables)", "shortName": "Other Current and Noncurrent Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.criteo.com/role/LeasesTables", "longName": "9955519 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.criteo.com/role/EmployeeBenefitsTables", "longName": "9955520 - Disclosure - Employee Benefits (Tables)", "shortName": "Employee Benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.criteo.com/role/SharebasedCompensationTables", "longName": "9955521 - Disclosure - Share-based Compensation (Tables)", "shortName": "Share-based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesTables", "longName": "9955522 - Disclosure - Financial and Other Income and Expenses (Tables)", "shortName": "Financial and Other Income and Expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.criteo.com/role/IncomeTaxesTables", "longName": "9955523 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.criteo.com/role/EarningsPerShareTables", "longName": "9955524 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "crto:ScheduleOfEarningsPerShareBasicTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "crto:ScheduleOfEarningsPerShareBasicTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsTables", "longName": "9955525 - Disclosure - Breakdown of Revenue and Noncurrent Assets (Tables)", "shortName": "Breakdown of Revenue and Noncurrent Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.criteo.com/role/RestructuringandOtherExitCostsSummaryofrestructuringactivitiesincludedinothercurrentliabilitiesDetails", "longName": "9955526 - Disclosure - Restructuring and Other Exit Costs - Summary of restructuring activities included in other current liabilities (Details)", "shortName": "Restructuring and Other Exit Costs - Summary of restructuring activities included in other current liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PaymentsForRestructuring", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R43": { "role": "http://www.criteo.com/role/RestructuringandOtherExitCostsNarrativeDetails", "longName": "9955527 - Disclosure - Restructuring and Other Exit Costs - Narrative (Details)", "shortName": "Restructuring and Other Exit Costs - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": null }, "R44": { "role": "http://www.criteo.com/role/SegmentinformationNarrativeDetails", "longName": "9955528 - Disclosure - Segment information - Narrative (Details)", "shortName": "Segment information - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:NumberOfOperatingSegments", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R45": { "role": "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails", "longName": "9955529 - Disclosure - Segment information - Schedule of Segment Reporting Information (Details)", "shortName": "Segment information - Schedule of Segment Reporting Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "crto:GrossProfitAndOtherCostsOfRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R46": { "role": "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails", "longName": "9955530 - Disclosure - Financial instruments - Fair Value Assets Measured on a Recurring Basis (Details)", "shortName": "Financial instruments - Fair Value Assets Measured on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails", "longName": "9955531 - Disclosure - Financial instruments - Schedule of Breakdown of Marketable Securities (Details)", "shortName": "Financial instruments - Schedule of Breakdown of Marketable Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-72", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R48": { "role": "http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails", "longName": "9955532 - Disclosure - Financial instruments - Schedule of Marketable Securities by Contractual Maturity (Details)", "shortName": "Financial instruments - Schedule of Marketable Securities by Contractual Maturity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.criteo.com/role/TradeReceivablesDetails", "longName": "9955533 - Disclosure - Trade Receivables (Details)", "shortName": "Trade Receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.criteo.com/role/GoodwillDetails", "longName": "9955534 - Disclosure - Goodwill (Details)", "shortName": "Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:NumberOfOperatingSegments", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfGoodwillTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R51": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails", "longName": "9955535 - Disclosure - Other Current and Noncurrent Assets - Breakdown in other current assets (Details)", "shortName": "Other Current and Noncurrent Assets - Breakdown in other current assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-5", "name": "crto:PrepaymentsToSuppliers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "crto:PrepaymentsToSuppliers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails", "longName": "9955536 - Disclosure - Other Current and Noncurrent Assets - Narrative (Details)", "shortName": "Other Current and Noncurrent Assets - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CapitalizedComputerSoftwareGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CapitalizedComputerSoftwareGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails", "longName": "9955537 - Disclosure - Other Current and Noncurrent Liabilities - Schedule of Other Current Liabilities (Details)", "shortName": "Other Current and Noncurrent Liabilities - Schedule of Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NotesPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:NotesPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails", "longName": "9955538 - Disclosure - Other Current and Noncurrent Liabilities - Schedule of Other Noncurrent Liabilities (Details)", "shortName": "Other Current and Noncurrent Liabilities - Schedule of Other Noncurrent Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-5", "name": "crto:UncertainTaxLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "crto:UncertainTaxLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.criteo.com/role/LeasesDetails", "longName": "9955539 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:LeaseCostTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:LeaseCostTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails", "longName": "9955540 - Disclosure - Employee Benefits - Schedule of Accumulated and Projected Benefit Obligations (Details)", "shortName": "Employee Benefits - Schedule of Accumulated and Projected Benefit Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-15", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R57": { "role": "http://www.criteo.com/role/EmployeeBenefitsScheduleofAssumptionsUsedforActuarialValuationsDetails", "longName": "9955541 - Disclosure - Employee Benefits - Schedule of Assumptions Used for Actuarial Valuations (Details)", "shortName": "Employee Benefits - Schedule of Assumptions Used for Actuarial Valuations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.criteo.com/role/EmployeeBenefitsScheduleofDefinedContributionPlansDetails", "longName": "9955542 - Disclosure - Employee Benefits - Schedule of Defined Contribution Plans (Details)", "shortName": "Employee Benefits - Schedule of Defined Contribution Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedContributionPlanCostRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedContributionPlanCostRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails", "longName": "9955543 - Disclosure - Share-based Compensation - Equity Awards Compensation Expense (Details)", "shortName": "Share-based Compensation - Equity Awards Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "longName": "9955544 - Disclosure - Share-based Compensation - Narrative (Details)", "shortName": "Share-based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails", "longName": "9955545 - Disclosure - Share-based Compensation - RSU Activity (Details)", "shortName": "Share-based Compensation - RSU Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-92", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-92", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "longName": "9955546 - Disclosure - Share-based Compensation - PSU Activity (Details)", "shortName": "Share-based Compensation - PSU Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-95", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-95", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "longName": "9955547 - Disclosure - Share-based Compensation - Performance Stock Units Total Shareholder Return Activity (Details)", "shortName": "Share-based Compensation - Performance Stock Units Total Shareholder Return Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-100", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "crto:ShareBasedCompensationPerformanceSharesAwardTotalShareholderReturnUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-100", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "crto:ShareBasedCompensationPerformanceSharesAwardTotalShareholderReturnUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails", "longName": "9955548 - Disclosure - Share-based Compensation - Warrants (Details)", "shortName": "Share-based Compensation - Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails", "longName": "9955549 - Disclosure - Share-based Compensation - Options Activity (Details)", "shortName": "Share-based Compensation - Options Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R66": { "role": "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails", "longName": "9955550 - Disclosure - Financial and Other Income and Expenses - Schedule of Financial Income (Details)", "shortName": "Financial and Other Income and Expenses - Schedule of Financial Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentIncomeInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentIncomeInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.criteo.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails", "longName": "9955551 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)", "shortName": "Income Taxes - Schedule of Provision for Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": null }, "R68": { "role": "http://www.criteo.com/role/EarningsPerShareScheduleofBasicEarningsLossPerShareDetails", "longName": "9955552 - Disclosure - Earnings Per Share - Schedule of Basic Earnings (Loss) Per Share (Details)", "shortName": "Earnings Per Share - Schedule of Basic Earnings (Loss) Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "crto:ScheduleOfEarningsPerShareBasicTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": null }, "R69": { "role": "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails", "longName": "9955553 - Disclosure - Earnings Per Share - Schedule of Diluted Earnings Per Share (Details)", "shortName": "Earnings Per Share - Schedule of Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "crto:ScheduleOfEarningsPerShareBasicTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "crto:ScheduleOfEarningsPerShareDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R70": { "role": "http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails", "longName": "9955554 - Disclosure - Earnings Per Share - Anti-Dilutive Securities (Details)", "shortName": "Earnings Per Share - Anti-Dilutive Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "longName": "9955555 - Disclosure - Commitments and contingencies (Details)", "shortName": "Commitments and contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-108", "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-108", "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails", "longName": "9955556 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue by Product and Services (Details)", "shortName": "Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue by Product and Services (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-111", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R73": { "role": "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsNarrativeDetails", "longName": "9955557 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Narrative (Details)", "shortName": "Breakdown of Revenue and Noncurrent Assets - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "unitRef": "market", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "unitRef": "market", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails", "longName": "9955558 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue Generated in Other Significant Countries (Details)", "shortName": "Breakdown of Revenue and Noncurrent Assets - Schedule of Revenue Generated in Other Significant Countries (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-115", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "unique": true } }, "R75": { "role": "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "longName": "9955559 - Disclosure - Breakdown of Revenue and Noncurrent Assets - Schedule of Non-Current Assets by Geographical Area and Country (Details)", "shortName": "Breakdown of Revenue and Noncurrent Assets - Schedule of Non-Current Assets by Geographical Area and Country (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NoncurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:NoncurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "crto-20260331.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "crto_AccountsPayableCapitalExpenditures": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "AccountsPayableCapitalExpenditures", "crdr": "credit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable relating to capital expenditures", "label": "Accounts Payable, Capital Expenditures", "documentation": "Accounts Payable, Capital Expenditures" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableTradeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableTradeCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables", "label": "Accounts Payable, Trade, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17", "r47" ] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/TradeReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/TradeReceivablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade accounts receivables", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r153", "r266", "r860" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://www.criteo.com/role/TradeReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "http://www.criteo.com/role/TradeReceivablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables, net of allowances of $23.2 million and $25.9 million at March\u00a031, 2026 and December\u00a031, 2025, respectively.", "totalLabel": "Net carrying value at end of period", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1134" ] }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Other taxes", "label": "Accrual for Taxes Other than Income Taxes, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r49", "r861", "r1221" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r49", "r93" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r18", "r19", "r65", "r154", "r712", "r752", "r753", "r1232" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r11", "r19", "r561", "r564", "r624", "r748", "r749", "r1063", "r1064", "r1065", "r1121", "r1122", "r1123", "r1124" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r990" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r58" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r765", "r1121", "r1122", "r1123", "r1124", "r1233", "r1285" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r1003" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r1003" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r1003" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r1003" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Noncash and nonoperating items", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item", "documentation": "Amount of expense (income) and loss (gain) in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied." } } }, "auth_ref": [ "r1113" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r426" ] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1036" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r962", "r972", "r982", "r1014" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r965", "r975", "r985", "r1017" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1037" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r1003" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r1010" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r966", "r976", "r986", "r1010", "r1018", "r1022", "r1030" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r1028" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails": { "parentTag": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Share based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r458", "r465", "r466" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/TradeReceivablesDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical", "http://www.criteo.com/role/TradeReceivablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables, allowances", "negatedTerseLabel": "(Less) Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r155", "r267", "r301" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "crto_AmericanDepositarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "AmericanDepositarySharesMember", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "American Depositary Shares", "label": "American Depositary Shares [Member]", "documentation": "American Depositary Shares [Member]" } } }, "auth_ref": [] }, "srt_AmericasMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "AmericasMember", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas", "label": "Americas [Member]", "documentation": "Continents of North and South America." } } }, "auth_ref": [ "r1053", "r1054", "r1055", "r1056", "r1287", "r1289", "r1290", "r1291" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r218" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r218" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r218" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r218" ] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "AsiaPacificMember", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia-Pacific", "label": "Asia Pacific [Member]", "documentation": "Region of Asia Pacific." } } }, "auth_ref": [ "r1053", "r1054", "r1055", "r1056", "r1287", "r1289", "r1290", "r1291" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r92", "r102", "r149", "r184", "r185", "r186", "r222", "r235", "r253", "r257", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r549", "r553", "r595", "r699", "r700", "r709", "r800", "r876", "r877", "r886", "r923", "r939", "r940", "r953", "r1181", "r1182", "r1247" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r144", "r156", "r184", "r185", "r186", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r549", "r553", "r595", "r923", "r1181", "r1182", "r1247" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total noncurrent assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r184", "r185", "r186", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r549", "r553", "r595", "r1181", "r1182", "r1247" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r1025" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r1026" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r1021" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r1021" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r1021" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r1021" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r1021" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r1021" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r452", "r453", "r454", "r455", "r456" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r1024" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r1023" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r1022" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r1022" ] }, "us-gaap_BankTimeDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BankTimeDepositsMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term deposits", "label": "Bank Time Deposits [Member]", "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest." } } }, "auth_ref": [ "r98" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.criteo.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r1115" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination [Domain]", "label": "Business Combination [Domain]", "documentation": "Business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r326", "r331", "r332", "r333", "r334", "r335", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r755", "r896", "r897", "r1224", "r1226", "r1227" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination [Axis]", "label": "Business Combination [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r326", "r331", "r332", "r333", "r334", "r335", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r755", "r896", "r897", "r1224", "r1226", "r1227" ] }, "us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification asset", "label": "Business Combination, Indemnification Asset, Acquisition Date, Amount", "documentation": "Amount of indemnification asset recognized at acquisition date in business combination." } } }, "auth_ref": [ "r512", "r523" ] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, property and equipment acquired through payables", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r23", "r24", "r25" ] }, "us-gaap_CapitalizedComputerSoftwareAmortization1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CapitalizedComputerSoftwareAmortization1", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized computer software, amortization", "label": "Capitalized Computer Software, Amortization", "documentation": "Amount of expense for amortization of capitalized computer software costs." } } }, "auth_ref": [ "r854", "r855" ] }, "us-gaap_CapitalizedComputerSoftwareGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CapitalizedComputerSoftwareGross", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized stock-based compensation relating to internally developed software", "label": "Capitalized Computer Software, Gross", "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software." } } }, "auth_ref": [ "r336", "r855" ] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash to the consolidated statement of financial position", "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r21", "r146", "r859" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Axis]", "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r146" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and Cash Equivalents, Fair Value Disclosure", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r588", "r590", "r591", "r1235", "r1236" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "periodStartLabel": "Net cash and cash equivalents and restricted cash at the beginning of the period", "periodEndLabel": "Net cash and cash equivalents and restricted cash at the end of the period", "totalLabel": "Total cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r21", "r77", "r181" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash and cash equivalents and restricted cash", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r77" ] }, "us-gaap_CashMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits." } } }, "auth_ref": [ "r146" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r1001" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r998" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r996" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockDomain", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r114", "r150", "r151", "r152", "r184", "r186", "r208", "r213", "r215", "r217", "r224", "r225", "r298", "r361", "r363", "r364", "r365", "r368", "r369", "r374", "r375", "r377", "r378", "r380", "r382", "r384", "r385", "r386", "r387", "r389", "r595", "r757", "r758", "r759", "r760", "r765", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r788", "r808", "r827", "r834", "r835", "r836", "r837", "r838", "r1040", "r1117", "r1118", "r1125" ] }, "crto_ClassOfWarrantOrRightAggregateInstrinsicValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightAggregateInstrinsicValueAbstract", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value (in thousands)", "label": "Class Of Warrant Or Right, Aggregate Instrinsic Value [Abstract]", "documentation": "Class Of Warrant Or Right, Aggregate Instrinsic Value" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value", "label": "Class Of Warrant Or Right, Aggregate Intrinsic Value", "documentation": "Class Of Warrant Or Right, Aggregate Intrinsic Value" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightCanceledDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightCanceledDuringPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Canceled (in shares)", "label": "Class Of Warrant Or Right, Canceled During Period", "documentation": "Class Of Warrant Or Right, Canceled During Period" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightExercisedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightExercisedDuringPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employees warrants exercised (in shares)", "negatedLabel": "Exercised (in shares)", "label": "Class Of Warrant Or Right, Exercised During Period", "documentation": "Class Of Warrant Or Right, Exercised During Period" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightExpiredDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightExpiredDuringPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expired (in shares)", "label": "Class Of Warrant Or Right, Expired During Period", "documentation": "Class Of Warrant Or Right, Expired During Period" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightGrantedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightGrantedDuringPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Class Of Warrant Or Right, Granted During Period", "documentation": "Class Of Warrant Or Right, Granted During Period" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightOutstandingWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageGrantDateFairValue", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average exercise price (in US dollar per share)", "label": "Class Of Warrant Or Right, Outstanding, Weighted Average Grant Date Fair Value", "documentation": "Class Of Warrant Or Right, Outstanding, Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightRollForward", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares", "label": "Class Of Warrant Or Right [Roll Forward]", "documentation": "Class Of Warrant Or Right" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightVestedAndExercisableWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightVestedAndExercisableWeightedAverageRemainingContractualTerm", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining contractual term outstanding", "label": "Class Of Warrant Or Right, Vested And Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Class Of Warrant Or Right, Vested And Exercisable, Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and exercisable (in shares)", "label": "Class Of Warrant Or Right, Vested And Expected to Vest, Exercisable, Number", "documentation": "Class Of Warrant Or Right, Vested And Expected to Vest, Exercisable, Number" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightWeightedAverageGrantDateFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightWeightedAverageGrantDateFairValueAbstract", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant date Fair Value Per Share", "label": "Class Of Warrant Or Right, Weighted Average Grant Date Fair Value [Abstract]", "documentation": "Class Of Warrant Or Right, Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "crto_ClassOfWarrantOrRightWeightedAverageRemainingContractualTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ClassOfWarrantOrRightWeightedAverageRemainingContractualTermAbstract", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Remaining Contractual Term (Years)", "label": "Class Of Warrant Or Right, Weighted Average Remaining Contractual Term [Abstract]", "documentation": "Class Of Warrant Or Right, Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1002" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r1002" ] }, "crto_CommerceGrowthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "CommerceGrowthMember", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commerce Growth", "label": "Commerce Growth [Member]", "documentation": "Commerce Growth" } } }, "auth_ref": [] }, "us-gaap_CommercialPaperMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommercialPaperMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails", "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial paper", "label": "Commercial Paper [Member]", "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds." } } }, "auth_ref": [ "r84", "r360", "r947", "r948", "r949", "r950" ] }, "crto_CommissionNationaleDeLInformatiqueEtDesLibertesCNILMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "CommissionNationaleDeLInformatiqueEtDesLibertesCNILMember", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commission Nationale de l'Informatique et des Libert\u00e9s (CNIL)", "label": "Commission Nationale De l'Informatique Et Des Libert\u00e9s (CNIL) [Member]", "documentation": "Commission Nationale De l'Informatique Et Des Libert\u00e9s (CNIL)" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/Commitmentsandcontingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r83", "r353", "r354", "r844", "r1173", "r1175" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "verboseLabel": "Ordinary Shares", "terseLabel": "Share capital", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r943", "r944", "r945", "r947", "r948", "r949", "r950", "r1121", "r1122", "r1124", "r1233", "r1283", "r1285" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares par value (in euro per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r56" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r56", "r788" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r56" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r12", "r56", "r788", "r806", "r1285", "r1286" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares, \u20ac0.025 par value, 55,659,895 and 55,659,895 shares authorized and issued, and 50,098,139 and 51,151,866 outstanding at March\u00a031, 2026 and December\u00a031, 2025, respectively.", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r56", "r375", "r381", "r711", "r923" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r1007" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r1006" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r1008" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r1005" ] }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "presentation": [ "http://www.criteo.com/role/EmployeeBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Benefits", "label": "Compensation and Employee Benefit Plans [Text Block]", "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans." } } }, "auth_ref": [ "r1186", "r1187", "r1188", "r1191" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Attributable to shareholders of Criteo S.A.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r20", "r159", "r161", "r168", "r697", "r723", "r725" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Attributable to noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r6", "r43", "r46", "r159", "r161", "r167", "r696", "r723", "r724" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income (loss)", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r46", "r90", "r159", "r161", "r166", "r695", "r723" ] }, "us-gaap_ContractWithCustomerRefundLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerRefundLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer prepayments and deferred revenue", "label": "Contract with Customer, Refund Liability, Current", "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current." } } }, "auth_ref": [ "r1185" ] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate debt securities", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r890", "r892", "r894", "r910", "r924", "r941", "r1280" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Traffic acquisition costs", "label": "Cost of Product and Service Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r68", "r69", "r657", "r862", "r866", "r907", "r1105" ] }, "us-gaap_CostOfRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfRevenueAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue:", "label": "Cost of Revenue [Abstract]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Country Region", "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "country_DE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "DE", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Germany", "label": "GERMANY" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtSecuritiesMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Structured debt securities", "label": "Debt Securities [Member]", "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions." } } }, "auth_ref": [ "r32", "r945", "r1288" ] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r470", "r471" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Change in deferred taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r8", "r112", "r1116", "r1120" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r470", "r471", "r710" ] }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Defined benefit plans", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan." } } }, "auth_ref": [ "r37", "r38", "r52", "r86" ] }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanActuarialGainLoss", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Actuarial losses (gains)", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan." } } }, "auth_ref": [ "r398" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAssumptionsUsedforActuarialValuationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate (Corp AA)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan." } } }, "auth_ref": [ "r410", "r417" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAssumptionsUsedforActuarialValuationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected rate of salary increase", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan." } } }, "auth_ref": [ "r411", "r418" ] }, "crto_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateofSocialCharges": { "xbrltype": "percentItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateofSocialCharges", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAssumptionsUsedforActuarialValuationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected rate of social charges", "label": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate of Social Charges", "documentation": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate of Social Charges" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanBenefitObligation", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accumulated postretirement benefit obligation at beginning of period", "periodEndLabel": "Accumulated postretirement benefit obligation at end of period", "label": "Defined Benefit Plan, Benefit Obligation", "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r395", "r412" ] }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Currency translation adjustment", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan." } } }, "auth_ref": [ "r399" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r394", "r397", "r408", "r422", "r894", "r895" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r406", "r419", "r420" ] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofAccumulatedandProjectedBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r396", "r407", "r421", "r894", "r895" ] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsScheduleofDefinedContributionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan expenses", "label": "Defined Contribution Plan, Cost", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r423" ] }, "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedContributionPlanDisclosuresTableTextBlock", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Contribution Plan", "label": "Defined Contribution Plan Disclosures [Table Text Block]", "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r10" ] }, "crto_DepreciationDepletionAmortizationAndProvisionsForVarious": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "DepreciationDepletionAmortizationAndProvisionsForVarious", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization and provisions", "label": "Depreciation, Depletion, Amortization And Provisions For Various", "documentation": "Depreciation, Depletion, Amortization And Provisions For Various" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.criteo.com/role/SharebasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r424", "r429", "r460", "r461", "r463", "r898" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationTable", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r957" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r989" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "crto_DoeVs.GoodRxHoldingsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "DoeVs.GoodRxHoldingsInc.Member", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Doe vs. GoodRx Holdings, Inc.", "label": "Doe Vs. GoodRx Holdings, Inc. [Member]", "documentation": "Doe Vs. GoodRx Holdings, Inc." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r1000" ] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EMEAMember", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EMEA", "label": "EMEA [Member]", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r1287", "r1289", "r1290", "r1291" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Net income allocated to shareholders per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/EarningsPerShareScheduleofBasicEarningsLossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic (in USD per share)", "terseLabel": "Basic earnings per share (in USD per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r141", "r169", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r206", "r208", "r215", "r216", "r217", "r221", "r373", "r464", "r491", "r547", "r572", "r573", "r698", "r726", "r867" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted (in USD per share)", "terseLabel": "Diluted earnings per share (in USD per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r141", "r169", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r208", "r215", "r216", "r217", "r221", "r373", "r464", "r491", "r547", "r572", "r573", "r698", "r726", "r867" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.criteo.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r205", "r218", "r219", "r220" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rates changes on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r603" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee - related payables", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r49" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "crdr": "debit", "calculation": { "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails": { "parentTag": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Share based Compensation capitalized as internal-use software costs", "label": "Share-Based Payment Arrangement, Amount Capitalized", "documentation": "Amount of cost capitalized for award under share-based payment arrangement." } } }, "auth_ref": [ "r459" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails", "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1219" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation, recognition period", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r462" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation, nonvested awards", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r1220" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation, stock options", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1220" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r955" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r955" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r955" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1039" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r955" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r955" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r955" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r994" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r1035" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r1035" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1035" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityComponentDomain", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r12", "r138", "r140", "r141", "r162", "r163", "r164", "r189", "r190", "r191", "r193", "r200", "r202", "r204", "r223", "r299", "r300", "r338", "r372", "r390", "r464", "r481", "r482", "r488", "r489", "r490", "r492", "r546", "r547", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r571", "r604", "r606", "r607", "r608", "r609", "r610", "r612", "r615", "r624", "r721", "r748", "r749", "r750", "r765", "r827" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r1004" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r962", "r972", "r982", "r1014" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r959", "r969", "r979", "r1011" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r1010" ] }, "country_FR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "FR", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "France", "label": "FRANCE" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r575", "r576", "r583", "r910" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r575", "r576", "r583", "r910" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets Measured on Recurring Basis", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r1235", "r1236" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r588", "r590", "r591", "r856", "r921", "r1244" ] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r588", "r591", "r856", "r921", "r1243", "r1244" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investment Securities, Held at Cost", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r589", "r592", "r856", "r921", "r1244" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r370", "r400", "r401", "r402", "r403", "r404", "r405", "r413", "r414", "r574", "r576", "r577", "r578", "r579", "r582", "r583", "r585", "r588", "r630", "r631", "r632", "r856", "r884", "r885", "r890", "r891", "r892", "r893", "r894", "r910", "r914", "r921" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r370", "r400", "r405", "r413", "r576", "r583", "r588", "r630", "r856", "r890", "r891", "r892", "r893", "r894", "r910", "r921" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r370", "r400", "r405", "r413", "r415", "r576", "r577", "r583", "r588", "r631", "r856", "r884", "r885", "r890", "r891", "r892", "r893", "r894", "r910", "r921" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r370", "r400", "r401", "r402", "r403", "r404", "r405", "r413", "r414", "r574", "r576", "r577", "r578", "r579", "r582", "r583", "r585", "r588", "r630", "r631", "r632", "r856", "r884", "r885", "r890", "r891", "r892", "r893", "r894", "r910", "r914", "r921" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r371", "r388", "r559", "r570", "r586", "r594", "r597", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r707", "r722", "r881", "r910", "r912", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r924", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1154", "r1155", "r1156", "r1157", "r1234", "r1237", "r1238", "r1239", "r1240", "r1241", "r1242", "r1243" ] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/Financialinstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Financial instruments", "label": "Financial Instruments Disclosure [Text Block]", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [ "r587" ] }, "crto_FinancialLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "FinancialLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Financial liabilities - current portion", "label": "Financial Liabilities, Current", "documentation": "Financial Liabilities, Current" } } }, "auth_ref": [] }, "crto_FinancialPerformanceSharesUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "FinancialPerformanceSharesUnitsMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Financial PSU (PSUs)", "terseLabel": "Financial PSU", "label": "Financial Performance Shares Units [Member]", "documentation": "Financial Performance Shares Units" } } }, "auth_ref": [] }, "crto_FinancialPerformanceSharesUnitsPreviouslyModifiedTSRPSUsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "FinancialPerformanceSharesUnitsPreviouslyModifiedTSRPSUsMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Performance Shares Units Previously Modified TSR PSUs", "label": "Financial Performance Shares Units Previously Modified TSR PSUs [Member]", "documentation": "Financial Performance Shares Units Previously Modified TSR PSUs" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange income", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r173", "r599", "r600", "r601", "r602", "r824" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r966", "r976", "r986", "r1018" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r966", "r976", "r986", "r1018" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r966", "r976", "r986", "r1018" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r966", "r976", "r986", "r1018" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r966", "r976", "r986", "r1018" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r999" ] }, "crto_GainLossOnDisposalOfAndImpairmentOfLongLivedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "GainLossOnDisposalOfAndImpairmentOfLongLivedAssets", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain (loss) on disposal of and impairment of long-lived assets", "label": "Gain (Loss) on Disposal of and Impairment of Long-Lived Assets", "documentation": "Gain (Loss) on Disposal of and Impairment of Long-Lived Assets" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r72", "r810" ] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and Administrative", "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r72" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "http://www.criteo.com/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Goodwill balance, beginning of the period", "periodEndLabel": "Goodwill balance, end of the period", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r147", "r311", "r692", "r877", "r882", "r901", "r902", "r903", "r904", "r911", "r923", "r1160", "r1167", "r1228" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/Goodwill" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill." } } }, "auth_ref": [ "r310", "r312", "r322", "r324", "r325", "r327", "r328", "r329", "r882" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustment", "label": "Goodwill, Foreign Currency Translation, Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r318", "r545" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillLineItems", "presentation": [ "http://www.criteo.com/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r882" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillRollForward", "presentation": [ "http://www.criteo.com/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r66", "r70", "r101", "r184", "r185", "r186", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r595", "r871", "r876", "r1127", "r1129", "r1130", "r1131", "r1132", "r1181" ] }, "crto_GrossProfitAndOtherCostsOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "GrossProfitAndOtherCostsOfRevenue", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contribution ex-TAC", "label": "Gross Profit And Other Costs Of Revenue", "documentation": "Gross Profit And Other Costs Of Revenue" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "crdr": "debit", "calculation": { "http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in one to five years", "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r105", "r107", "r295", "r704" ] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue", "crdr": "debit", "calculation": { "http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in one year", "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r104", "r106", "r294", "r703" ] }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HeldToMaturitySecuritiesFairValue", "crdr": "debit", "calculation": { "http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails", "http://www.criteo.com/role/FinancialinstrumentsScheduleofMarketableSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Securities Held-to-maturity", "totalLabel": "Total", "label": "Debt Securities, Held-to-Maturity, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r103", "r290", "r576", "r582", "r590", "r591", "r593", "r693", "r708" ] }, "us-gaap_HeldToMaturitySecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HeldToMaturitySecuritiesTextBlock", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investment Securities, Held-to-Maturity", "label": "Debt Securities, Held-to-Maturity [Table Text Block]", "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r1136", "r1137", "r1138", "r1139", "r1140", "r1141", "r1142", "r1143", "r1144", "r1145", "r1146", "r1147", "r1148", "r1149", "r1150", "r1151", "r1152", "r1153" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income before taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r67", "r96", "r101", "r699", "r701", "r717", "r863", "r865", "r866", "r871", "r876", "r1127", "r1129", "r1130", "r1131", "r1132" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount is reported." } } }, "auth_ref": [ "r339", "r341", "r345", "r555", "r556", "r557", "r558", "r580", "r581", "r584", "r596", "r597", "r598", "r746", "r747", "r811", "r855", "r856", "r901", "r903", "r908", "r909", "r913", "r921", "r1223", "r1225", "r1253" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount is reported." } } }, "auth_ref": [ "r341", "r345", "r555", "r556", "r557", "r558", "r580", "r581", "r584", "r596", "r597", "r598", "r746", "r747", "r811", "r855", "r856", "r901", "r903", "r908", "r909", "r913", "r921", "r1223", "r1225", "r1253" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r184", "r187", "r469", "r473", "r474", "r475", "r476", "r477", "r478", "r483", "r485", "r486", "r487", "r706", "r754", "r762", "r900" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Provision for income taxes", "terseLabel": "Provision for Income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r109", "r113", "r184", "r203", "r204", "r222", "r243", "r257", "r472", "r473", "r484", "r727", "r863", "r865", "r866", "r900" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash paid for taxes, net of refunds", "label": "Income Taxes Paid, Net", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r22", "r180", "r479", "r480" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccountsPayableTrade", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables", "label": "Increase (Decrease) in Accounts Payable, Trade", "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Trade receivables", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInIncomeTaxes", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Change in income taxes", "label": "Increase (Decrease) in Income Taxes", "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets." } } }, "auth_ref": [ "r1112" ] }, "us-gaap_IncreaseDecreaseInOperatingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOperatingCapital", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Changes in assets and liabilities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital", "documentation": "Amount of increase (decrease) in asset and (increase) decrease in liability, used in operating activity in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied." } } }, "auth_ref": [ "r7" ] }, "crto_IncreaseDecreaseInOperatingLeaseLiabilitiesAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "IncreaseDecreaseInOperatingLeaseLiabilitiesAssets", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities and right of use assets", "label": "Increase (Decrease) In Operating Lease Liabilities (Assets)", "documentation": "Increase (Decrease) In Operating Lease Liabilities (Assets)" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r1112" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Current Liabilities", "documentation": "Amount of increase (decrease) in current liabilities classified as other." } } }, "auth_ref": [ "r1112" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "crto_IncreaseDecreaseInUnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "IncreaseDecreaseInUnrecognizedTaxBenefits", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Change in uncertain tax positions", "label": "Increase (Decrease) In Unrecognized Tax Benefits", "documentation": "Increase (Decrease) In Unrecognized Tax Benefits" } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "calculation": { "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share warrants (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method." } } }, "auth_ref": [ "r209", "r210", "r211", "r217" ] }, "crto_IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptions": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptions", "calculation": { "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share options (in shares)", "label": "Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Options", "documentation": "Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Options" } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs and PSUs (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r209", "r210", "r212", "r217", "r428" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r966", "r976", "r986", "r1010", "r1018", "r1022", "r1030" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r1028" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r958", "r1034" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r958", "r1034" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r958", "r1034" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r330", "r1170", "r1171" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest and fees", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r239", "r863", "r866", "r1067" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash paid for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r175", "r178", "r179" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial income from cash equivalents", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r222", "r238", "r257", "r876", "r1066" ] }, "crto_IponwebMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "IponwebMember", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Iponweb", "label": "Iponweb [Member]", "documentation": "Iponweb" } } }, "auth_ref": [] }, "country_JP": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "JP", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japan", "label": "JAPAN" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.criteo.com/role/LeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease expense", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r618", "r922" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.criteo.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Lease Expense", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1246" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.criteo.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r614" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r16", "r48", "r49", "r50", "r51", "r52", "r53", "r54", "r184", "r185", "r186", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r550", "r553", "r554", "r595", "r787", "r870", "r886", "r953", "r1181", "r1247", "r1248" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity and liabilities", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r62", "r95", "r715", "r923", "r939", "r940", "r1116", "r1119", "r1158", "r1245" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and shareholders' equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r50", "r145", "r184", "r185", "r186", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r550", "r553", "r554", "r595", "r923", "r1181", "r1247", "r1248" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total noncurrent liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r16", "r51", "r52", "r53", "r54", "r184", "r185", "r186", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r550", "r553", "r554", "r595", "r1181", "r1247", "r1248" ] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "LitigationCaseAxis", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Axis]", "label": "Litigation Case [Axis]", "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim." } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Domain]", "label": "Litigation Case [Domain]", "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information." } } }, "auth_ref": [] }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/TradeReceivables" ], "lang": { "en-us": { "role": { "terseLabel": "Trade Receivables", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses." } } }, "auth_ref": [ "r611", "r1133" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r230", "r355", "r356", "r357", "r359", "r467", "r883", "r1176", "r1177" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingenciesTable", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r230", "r355", "r356", "r357", "r359", "r467", "r883", "r1176", "r1177" ] }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingencyAccrualAtCarryingValue", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency accrual", "label": "Loss Contingency Accrual", "documentation": "Amount of loss contingency liability." } } }, "auth_ref": [ "r355", "r1043" ] }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingencyAccrualCarryingValueCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Contingencies - current portion", "label": "Loss Contingency, Accrual, Current", "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r355" ] }, "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingencyAccrualCarryingValueNoncurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Contingencies - noncurrent portion", "label": "Loss Contingency, Accrual, Noncurrent", "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r355" ] }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingencyEstimateOfPossibleLoss", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, estimate of possible loss", "label": "Loss Contingency, Estimate of Possible Loss", "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date." } } }, "auth_ref": [ "r230", "r356", "r357", "r358", "r359", "r467", "r883" ] }, "us-gaap_LossContingencyReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingencyReceivable", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/CommitmentsandcontingenciesDetails", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, receivable", "label": "Loss Contingency, Receivable", "documentation": "Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable." } } }, "auth_ref": [ "r1180" ] }, "us-gaap_MarketableSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesCurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities - current portion", "label": "Marketable Securities, Current", "documentation": "Amount of investment in marketable security, classified as current." } } }, "auth_ref": [ "r1061" ] }, "us-gaap_MarketableSecuritiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesNoncurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities - noncurrent portion", "label": "Marketable Securities, Noncurrent", "documentation": "Amount of investment in marketable security, classified as noncurrent." } } }, "auth_ref": [ "r1061" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r1002" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r1002" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interests", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r61", "r94", "r184", "r185", "r186", "r298", "r361", "r363", "r364", "r365", "r368", "r369", "r714", "r790", "r1245" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r1021" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money Market funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r1189", "r1190" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r1029" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r1003" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r177" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r177" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r77", "r78", "r79" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash flows from operating activities", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/EarningsPerShareScheduleofBasicEarningsLossPerShareDetails", "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to shareholders of Criteo S.A.", "terseLabel": "Net income attributable to shareholders of Criteo S.A.", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r71", "r79", "r97", "r141", "r143", "r157", "r160", "r164", "r184", "r185", "r186", "r188", "r192", "r196", "r197", "r198", "r199", "r200", "r203", "r204", "r214", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r373", "r376", "r379", "r383", "r464", "r491", "r547", "r573", "r595", "r720", "r807", "r825", "r826", "r863", "r865", "r866", "r951", "r1181" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Net income available to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r45", "r91", "r157", "r160", "r200", "r203", "r204", "r719", "r1065" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.criteo.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Pronouncements Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoTradingSymbolFlag", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "No Trading Symbol Flag", "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r1002" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r966", "r976", "r986", "r1010", "r1018" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r993" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r992" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r1010" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1029" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1029" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Noncash investing and financing activities", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Non controlling interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r41", "r390", "r1121", "r1122", "r1123", "r1124", "r1285" ] }, "us-gaap_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncurrentAssets", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-lived assets", "label": "Long-Lived Assets", "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets." } } }, "auth_ref": [ "r263" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial and other income", "verboseLabel": "Financial and other income", "totalLabel": "Total financial and other income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r73" ] }, "us-gaap_NontradeReceivablesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NontradeReceivablesNoncurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Noncurrent financial assets", "label": "Nontrade Receivables, Noncurrent", "documentation": "The noncurrent portion of the receivable other than from customers, that is amounts expected to be collected after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1060" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rebates", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfCountriesInWhichEntityOperates", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of geographical markets in which entity operates", "label": "Number of Countries in which Entity Operates", "documentation": "The number of countries in which the entity operates as of balance sheet date." } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.criteo.com/role/SegmentinformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r877", "r1128" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.criteo.com/role/GoodwillDetails", "http://www.criteo.com/role/SegmentinformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r872", "r880", "r1128" ] }, "crto_NumberOfTranches": { "xbrltype": "integerItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "NumberOfTranches", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of tranches", "label": "Number of Tranches", "documentation": "Number of Tranches" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [ "r866" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "verboseLabel": "Operating expenses", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r101", "r863", "r866", "r871", "r1127", "r1129", "r1130", "r1131", "r1132" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.criteo.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r619", "r922" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liability - operating - current portion", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r617" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liability - operating - noncurrent portion", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r617" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use assets - operating leases", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r616" ] }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAccruedLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Other Accrued Liabilities, Noncurrent", "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r52" ] }, "us-gaap_OtherAssetsMiscellaneousCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsMiscellaneousCurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Miscellaneous, Current", "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other noncurrent assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r148" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation differences, net of taxes", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2", "r721" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive income (loss)", "terseLabel": "Other comprehensive income (loss)", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r12", "r15", "r158", "r161", "r165", "r200", "r604", "r605", "r610", "r694", "r721", "r1063", "r1064" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Actuarial gains on employee benefits, net of taxes", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r3", "r4", "r64", "r65", "r721" ] }, "us-gaap_OtherCostOfOperatingRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherCostOfOperatingRevenue", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other cost of revenue", "label": "Other Cost of Operating Revenue", "documentation": "Other costs incurred during the reporting period related to other revenue generating activities." } } }, "auth_ref": [ "r70" ] }, "us-gaap_OtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherCurrentAssetsTextBlock", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current and Noncurrent Assets", "label": "Other Current Assets [Text Block]", "documentation": "The entire disclosure for other current assets." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Current Liabilities", "label": "Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherIncomeAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherIncomeAndExpensesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Other Income and Expenses [Abstract]", "label": "Other Income and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 }, "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "totalLabel": "Total", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r49", "r923" ] }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherLiabilitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Other Liabilities Disclosure [Abstract]", "label": "Other Liabilities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current and Noncurrent Liabilities", "label": "Other Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for other liabilities." } } }, "auth_ref": [ "r49", "r52", "r1172" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 5.0 }, "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other noncurrent liabilities", "totalLabel": "Total", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r52" ] }, "crto_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "OtherMember", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other [Member]", "documentation": "Other" } } }, "auth_ref": [] }, "crto_OtherNonCurrentAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "OtherNonCurrentAssetsLineItems", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-current Assets [Line Items]", "label": "Other Non-current Assets [Line Items]", "documentation": "Other Non-current Assets" } } }, "auth_ref": [] }, "crto_OtherNonCurrentAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "OtherNonCurrentAssetsTable", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-current Assets [Table]", "label": "Other Non-current Assets [Table]", "documentation": "Other Non-current Assets" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r79" ] }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Noncurrent Liabilities", "label": "Other Noncurrent Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeAndExpenseTextBlock", "presentation": [ "http://www.criteo.com/role/FinancialandOtherIncomeandExpenses" ], "lang": { "en-us": { "role": { "terseLabel": "Financial and Other Income and Expenses", "label": "Other Nonoperating Income and Expense [Text Block]", "documentation": "The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [ "r170", "r171" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesScheduleofFinancialIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other financial expense", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r74", "r907" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1002" ] }, "us-gaap_OtherSundryLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherSundryLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other creditors", "label": "Other Sundry Liabilities, Current", "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date." } } }, "auth_ref": [ "r34", "r49" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r964", "r974", "r984", "r1016" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r967", "r977", "r987", "r1019" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r967", "r977", "r987", "r1019" ] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ParentMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Equity - attributable to shareholders of Criteo S.A.", "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r991" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchase of treasury stocks", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r76" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/RestructuringandOtherExitCostsSummaryofrestructuringactivitiesincludedinothercurrentliabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts paid", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r344", "r1111" ] }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireMarketableSecurities", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of investment securities", "label": "Payments to Acquire Marketable Securities", "documentation": "Amount of cash outflow for purchase of marketable security." } } }, "auth_ref": [ "r1135" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Acquisition of intangible assets, property and equipment", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r108", "r1229", "r1230", "r1231" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r1001" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1001" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r993" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r1010" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r1003" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r992" ] }, "crto_PerformanceMediaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "PerformanceMediaMember", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails", "http://www.criteo.com/role/GoodwillDetails", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Media", "label": "Performance Media [Member]", "documentation": "Performance Media" } } }, "auth_ref": [] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r994" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1038" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r993" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 }, "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1062" ] }, "crto_PrepaidIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "PrepaidIncomeTaxes", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Prepaid Income Taxes", "documentation": "Prepaid Income Taxes" } } }, "auth_ref": [] }, "crto_PrepaidOtherTaxesAndOtherTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "PrepaidOtherTaxesAndOtherTaxesReceivable", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Other taxes", "label": "Prepaid Other Taxes And Other Taxes Receivable", "documentation": "Prepaid Other Taxes And Other Taxes Receivable" } } }, "auth_ref": [] }, "crto_PrepaymentsToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "PrepaymentsToSuppliers", "crdr": "debit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsBreakdowninothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayments to suppliers", "label": "Prepayments To Suppliers", "documentation": "Prepayments To Suppliers" } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.criteo.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Accounting Policies", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r1058" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Change in other financing activities", "label": "Proceeds from (Payment for) Other Financing Activity", "documentation": "Amount of cash inflow (outflow) from financing activity, classified as other." } } }, "auth_ref": [ "r1044", "r1110" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Maturities and sales of investment securities", "label": "Proceeds from Sale and Maturity of Marketable Securities", "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal of intangible assets, property and equipment", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r75" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r5", "r13" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r119", "r120", "r121", "r122", "r123", "r124", "r137", "r260", "r657", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r857", "r862", "r865", "r866", "r887", "r888", "r933", "r934", "r935", "r938", "r942", "r1045", "r1057", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1106", "r1107", "r1108", "r1109", "r1178", "r1179", "r1252", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1281", "r1282" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r119", "r120", "r121", "r122", "r123", "r124", "r137", "r260", "r657", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r857", "r862", "r865", "r866", "r887", "r888", "r933", "r934", "r935", "r938", "r942", "r1045", "r1057", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1106", "r1107", "r1108", "r1109", "r1178", "r1179", "r1252", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1281", "r1282" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEOPERATIONSUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net Income", "terseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r141", "r143", "r157", "r160", "r176", "r184", "r185", "r186", "r188", "r192", "r200", "r203", "r204", "r298", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r373", "r464", "r491", "r547", "r548", "r551", "r552", "r573", "r595", "r699", "r701", "r718", "r764", "r807", "r825", "r826", "r905", "r906", "r952", "r1065", "r1181" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r9", "r623", "r705", "r716", "r923" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r991" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r991" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Receivables [Abstract]", "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r959", "r969", "r979", "r1011" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r468", "r855", "r863", "r864", "r876", "r1249" ] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r960", "r970", "r980", "r1012" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r961", "r971", "r981", "r1013" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r968", "r978", "r988", "r1020" ] }, "us-gaap_RestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCash", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash, included in other current assets", "label": "Restricted Cash", "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r1059", "r1114", "r1250", "r1251" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsFairValueAssetsMeasuredonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Domain]", "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r146" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedStockMember", "presentation": [ "http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted share awards", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r1126", "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [ "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/RestructuringandOtherExitCosts" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Other Exit Costs", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r342", "r343", "r344", "r347", "r352" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/RestructuringandOtherExitCostsNarrativeDetails", "http://www.criteo.com/role/RestructuringandOtherExitCostsSummaryofrestructuringactivitiesincludedinothercurrentliabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restructuring charge", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r8", "r172", "r174", "r348", "r349", "r864", "r1174" ] }, "us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.criteo.com/role/RestructuringandOtherExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes restructuring charges." } } }, "auth_ref": [ "r1041", "r1042" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/RestructuringandOtherExitCostsSummaryofrestructuringactivitiesincludedinothercurrentliabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Restructuring liability, beginning balance", "periodEndLabel": "Restructuring liability, ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r344", "r350" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.criteo.com/role/RestructuringandOtherExitCostsSummaryofrestructuringactivitiesincludedinothercurrentliabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "crto_RetailMediaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "RetailMediaMember", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails", "http://www.criteo.com/role/GoodwillDetails", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retail Media", "label": "Retail Media [Member]", "documentation": "Retail Media" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r59", "r85", "r713", "r751", "r753", "r761", "r789", "r923" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r138", "r140", "r141", "r189", "r190", "r191", "r193", "r200", "r202", "r204", "r299", "r300", "r338", "r372", "r464", "r481", "r482", "r488", "r489", "r490", "r492", "r546", "r547", "r560", "r562", "r563", "r565", "r571", "r612", "r615", "r748", "r750", "r765", "r1285" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "verboseLabel": "Total Revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r99", "r100", "r222", "r236", "r237", "r251", "r257", "r260", "r262", "r264", "r391", "r392", "r393", "r657", "r863", "r866" ] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1029" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1029" ] }, "crto_SalesAndOperationsExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "SalesAndOperationsExpenseMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and Operations", "label": "Sales And Operations Expense [Member]", "documentation": "Sales And Operations Expense [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://www.criteo.com/role/TradeReceivablesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Breakdown in Trade Receivables", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r57", "r63" ] }, "us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated and Projected Benefit Obligations", "label": "Schedule of Accumulated and Projected Benefit Obligations [Table Text Block]", "documentation": "Tabular disclosure of benefit obligations including accumulated benefit obligation and projected benefit obligation." } } }, "auth_ref": [ "r87" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.criteo.com/role/EarningsPerShareAntiDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r218" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.criteo.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "presentation": [ "http://www.criteo.com/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assumptions Used for Actuarial Valuations", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate." } } }, "auth_ref": [ "r409", "r416" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.criteo.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Provision for Income Taxes", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r1222" ] }, "crto_ScheduleOfEarningsPerShareBasicTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ScheduleOfEarningsPerShareBasicTableTextBlock", "presentation": [ "http://www.criteo.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Basic Earnings Per Share", "label": "Schedule Of Earnings Per Share, Basic [Table Text Block]", "documentation": "Schedule Of Earnings Per Share, Basic [Table Text Block]" } } }, "auth_ref": [] }, "crto_ScheduleOfEarningsPerShareDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ScheduleOfEarningsPerShareDilutedTableTextBlock", "presentation": [ "http://www.criteo.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Diluted Earnings Per Share", "label": "Schedule Of Earnings Per Share, Diluted [Table Text Block]", "documentation": "Schedule Of Earnings Per Share, Diluted [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails", "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from External Customers by Products and Services", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.criteo.com/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Goodwill [Table]", "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason." } } }, "auth_ref": [ "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r882" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.criteo.com/role/GoodwillTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r882", "r1159", "r1160", "r1161", "r1162", "r1163", "r1164", "r1165", "r1166", "r1167", "r1168", "r1169" ] }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Nonvested Restricted Stock Units Activity", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units." } } }, "auth_ref": [ "r88" ] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Current Assets", "label": "Schedule of Other Current Assets [Table Text Block]", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "presentation": [ "http://www.criteo.com/role/FinancialandOtherIncomeandExpensesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Financial and Other Income (Expense)", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.criteo.com/role/RestructuringandOtherExitCostsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of restructuring activities included in other current liabilities", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r33", "r81", "r82" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from External Customers and Long-Lived Assets by Geographical Areas", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r31", "r66" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset." } } }, "auth_ref": [ "r31", "r66" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r27", "r28", "r29" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.criteo.com/role/SegmentinformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r27", "r28", "r29" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r425", "r427", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r463" ] }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Options Roll Forward", "label": "Schedule of Stock Options Roll Forward [Table Text Block]", "documentation": "Tabular disclosure of the change in stock options." } } }, "auth_ref": [ "r1195" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stockholders' Equity Note, Warrants or Rights", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r1183" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r954" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r956" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentDomain", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails", "http://www.criteo.com/role/GoodwillDetails", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r99", "r100", "r101", "r102", "r222", "r232", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r257", "r258", "r259", "r264", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r337", "r346", "r351", "r539", "r542", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r873", "r876", "r877", "r882", "r937", "r1252", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1281", "r1282" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r115", "r116", "r117", "r118", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r227", "r262", "r263", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r699", "r700", "r701", "r702", "r778", "r779", "r780", "r830", "r831", "r832", "r833", "r840", "r841", "r842", "r843", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r858", "r868", "r887", "r889", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r936", "r945", "r1252", "r1254", "r1255", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1281", "r1282" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssets", "http://www.criteo.com/role/Segmentinformation" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment information", "terseLabel": "Breakdown of Revenue and Noncurrent Assets", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r102", "r222", "r231", "r232", "r233", "r234", "r235", "r247", "r249", "r250", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r872", "r874", "r875", "r876", "r878", "r879", "r880" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and operations expenses", "label": "Selling and Marketing Expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r898" ] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustment", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance share adjustment (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment" } } }, "auth_ref": [] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentWeightedAverageGrantDateFairValue", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance share adjustment (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment, Weighted Average Grant Date Fair Value", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustment, Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r444" ] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total share-based payment expense", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r444" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r441", "r442" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares (RSU)", "terseLabel": "Shares (Financial PSU)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in USD per share)", "periodEndLabel": "Outstanding at end of period (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r441", "r442" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant date Fair Value Per Share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r445" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r445" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r454" ] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateBenchmark": { "xbrltype": "pureItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateBenchmark", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility of the benchmark", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Benchmark", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Benchmark" } } }, "auth_ref": [] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateCompany": { "xbrltype": "pureItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateCompany", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility of the Company", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Company", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Company" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r425", "r427", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r463" ] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageIncreaseToTargetShares": { "xbrltype": "pureItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageIncreaseToTargetShares", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum percentage increase to target shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Percentage Increase To Target Shares", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Percentage Increase To Target Shares" } } }, "auth_ref": [] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageIncreaseToTargetShares": { "xbrltype": "pureItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageIncreaseToTargetShares", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum percentage increase to target shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Percentage Increase To Target Shares", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Percentage Increase To Target Shares" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Remaining Contractual Term (Years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "auth_ref": [] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value (in thousands)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract]", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value" } } }, "auth_ref": [] }, "crto_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Canceled, options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Cancellations in Period", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Cancellations in Period" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and exercisable, options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r435" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value of the share options exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r448" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expired, options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r440" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited, options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r439" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted, options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r437" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value, options outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r39" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, options (in shares)", "periodEndLabel": "Ending balance, options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r433", "r434" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average exercise price, options outstanding (in US dollar per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r433", "r434" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationPSUActivityDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails", "http://www.criteo.com/role/SharebasedCompensationRSUActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r452", "r453", "r454", "r455", "r456" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tranche 1", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [ "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tranche 2", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [ "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "crto_ShareBasedCompensationPerformanceSharesAwardTotalShareholderReturnUnvestedActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "ShareBasedCompensationPerformanceSharesAwardTotalShareholderReturnUnvestedActivityTableTextBlock", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Share Based Compensation Performance Shares Award Total Shareholder Return Unvested Activity", "label": "Share Based Compensation Performance Shares Award Total Shareholder Return Unvested Activity [Table Text Block]", "documentation": "Share Based Compensation Performance Shares Award Total Shareholder Return Unvested Activity" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Performance Shares, Activity", "label": "Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]", "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares." } } }, "auth_ref": [ "r14" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1", "crdr": "debit", "calculation": { "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/SharebasedCompensationEquityAwardsCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Share based compensation expense net of capitalization", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount", "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement." } } }, "auth_ref": [ "r457" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r899" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining contractual term, options outstanding (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r89" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharesOutstanding", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://www.criteo.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short term lease expense", "label": "Short-Term Lease, Cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r620", "r922" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.criteo.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r182", "r183" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenuebyProductandServicesDetails", "http://www.criteo.com/role/GoodwillDetails", "http://www.criteo.com/role/SegmentinformationScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r99", "r100", "r101", "r102", "r142", "r222", "r232", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r257", "r258", "r259", "r264", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r337", "r340", "r346", "r351", "r539", "r542", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r873", "r876", "r877", "r882", "r937", "r1252", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1281", "r1282" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r114", "r150", "r151", "r152", "r184", "r186", "r208", "r213", "r215", "r217", "r224", "r225", "r298", "r361", "r363", "r364", "r365", "r368", "r369", "r374", "r375", "r377", "r378", "r380", "r382", "r384", "r385", "r386", "r387", "r389", "r595", "r757", "r758", "r759", "r760", "r765", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r788", "r808", "r827", "r834", "r835", "r836", "r837", "r838", "r1040", "r1117", "r1118", "r1125" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r12", "r56", "r60", "r61", "r138", "r140", "r141", "r162", "r163", "r164", "r189", "r190", "r191", "r193", "r200", "r202", "r204", "r223", "r299", "r300", "r338", "r372", "r390", "r464", "r481", "r482", "r488", "r489", "r490", "r492", "r546", "r547", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r571", "r604", "r606", "r607", "r608", "r609", "r610", "r612", "r615", "r624", "r721", "r748", "r749", "r750", "r765", "r827" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofNonCurrentAssetsbyGeographicalAreaandCountryDetails", "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r115", "r116", "r117", "r118", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r227", "r262", "r263", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r699", "r700", "r701", "r702", "r778", "r779", "r780", "r830", "r831", "r832", "r833", "r840", "r841", "r842", "r843", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r858", "r868", "r887", "r889", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r936", "r945", "r1252", "r1254", "r1255", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1281", "r1282" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementLineItems", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r189", "r190", "r191", "r223", "r374", "r375", "r377", "r380", "r615", "r657", "r756", "r766", "r777", "r781", "r782", "r783", "r784", "r785", "r786", "r788", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r801", "r802", "r803", "r804", "r805", "r809", "r810", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r827", "r865", "r866", "r946", "r1284" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementTable", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r189", "r190", "r191", "r223", "r265", "r374", "r375", "r377", "r380", "r615", "r657", "r756", "r766", "r777", "r781", "r782", "r783", "r784", "r785", "r786", "r788", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r801", "r802", "r803", "r804", "r805", "r809", "r810", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r827", "r865", "r866", "r946", "r1284" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r963", "r973", "r983", "r1015" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [ "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r12", "r55", "r56", "r85", "r757", "r827", "r835" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury shares used for vesting (in shares)", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r12", "r55", "r56", "r85" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationOptionsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exercised, options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r12", "r55", "r56", "r85", "r438" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r12", "r55", "r56", "r85", "r765", "r827", "r835", "r952" ] }, "srt_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Authorized amount of share repurchase program", "label": "Share Repurchase Program, Authorized, Amount", "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r1184" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Equity attributable to the shareholders of Criteo S.A.", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r56", "r60", "r61", "r80", "r790", "r806", "r828", "r829", "r923", "r953", "r1116", "r1118", "r1119", "r1158", "r1245", "r1285" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r41", "r42", "r44", "r138", "r139", "r140", "r141", "r163", "r189", "r190", "r191", "r193", "r200", "r202", "r299", "r300", "r338", "r372", "r390", "r464", "r481", "r482", "r488", "r489", "r490", "r492", "r546", "r547", "r560", "r561", "r562", "r563", "r564", "r565", "r571", "r604", "r606", "r610", "r613", "r624", "r749", "r750", "r763", "r790", "r806", "r828", "r829", "r839", "r939", "r940", "r952", "r1116", "r1118", "r1119", "r1158", "r1245", "r1285" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' equity:", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityOther", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other changes in equity", "label": "Stockholders' Equity, Other", "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy." } } }, "auth_ref": [] }, "crto_StructuredDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "StructuredDebtSecuritiesMember", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Structured debt securities", "label": "Structured Debt Securities [Member]", "documentation": "Structured Debt Securities" } } }, "auth_ref": [] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubleaseIncome", "crdr": "credit", "calculation": { "http://www.criteo.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.criteo.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Sublease income", "label": "Sublease Income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r622", "r922" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events [Abstract]", "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.criteo.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r625", "r626" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "crto_TSRPerformanceSharesUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "TSRPerformanceSharesUnitsMember", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails", "http://www.criteo.com/role/SharebasedCompensationPerformanceStockUnitsTotalShareholderReturnActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "TSR Performance Shares Units (TSR PSU)", "label": "TSR Performance Shares Units [Member]", "documentation": "TSR Performance Shares Units" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r1009" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1001" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r1008" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r1028" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1030" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.criteo.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.criteo.com/role/FinancialinstrumentsScheduleofBreakdownofMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r371", "r388", "r559", "r570", "r586", "r594", "r597", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r707", "r722", "r910", "r912", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r924", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1154", "r1155", "r1156", "r1157", "r1234", "r1237", "r1238", "r1239", "r1240", "r1241", "r1242", "r1243" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1031" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1032" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r1032" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1030" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1030" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1033" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1031" ] }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockAcquiredAverageCostPerShare", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock acquired, average cost per share (in dollars per share)", "label": "Shares Acquired, Average Cost Per Share", "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased." } } }, "auth_ref": [ "r35" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r35" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITEDParenthetical", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock (in shares)", "negatedPeriodStartLabel": "Treasury stock, beginning balance (in shares)", "negatedPeriodEndLabel": "Treasury stock, ending balance (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r35" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITEDParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in treasury stocks (in shares)", "terseLabel": "Change in treasury stocks (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r12", "r56", "r85" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock, 5,561,756 and 4,508,029 shares at cost as of March\u00a031, 2026 and December\u00a031, 2025, respectively.", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r35", "r36", "r56", "r60" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in treasury stocks", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r12", "r35", "r85" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "US", "presentation": [ "http://www.criteo.com/role/BreakdownofRevenueandNoncurrentAssetsScheduleofRevenueGeneratedinOtherSignificantCountriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "UNITED STATES" } } }, "auth_ref": [] }, "crto_UncertainTaxLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.criteo.com/20260331", "localname": "UncertainTaxLiability", "crdr": "credit", "calculation": { "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.criteo.com/role/OtherCurrentandNoncurrentLiabilitiesScheduleofOtherNoncurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions", "label": "Uncertain Tax Liability", "documentation": "Uncertain Tax Liability" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r1027" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UseOfEstimates", "presentation": [ "http://www.criteo.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r110", "r111", "r226", "r228", "r229", "r230", "r699", "r701", "r869" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableLeaseCost", "crdr": "debit", "calculation": { "http://www.criteo.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.criteo.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable lease expense", "label": "Variable Lease, Cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r621", "r922" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VestingAxis", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Axis]", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VestingDomain", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Domain]", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1192", "r1193", "r1194", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r997" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://www.criteo.com/role/SharebasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants term (in years)", "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1237", "r1238", "r1239" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "presentation": [ "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of:", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of shares outstanding used to determine diluted earnings per share (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r207", "r217" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted shares:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.criteo.com/role/EarningsPerShareScheduleofBasicEarningsLossPerShareDetails", "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of shares outstanding of Criteo S.A. (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r206", "r217" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "presentation": [ "http://www.criteo.com/role/EarningsPerShareScheduleofDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic shares:", "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.criteo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares outstanding used in computing per share amounts:", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r995" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "70", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org/320/tableOfContent" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-10" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(e)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479024/942-230-45-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column C", "Footnote": "5", "Publisher": "SEC" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column C", "Footnote": "4", "Publisher": "SEC" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column C", "Footnote": "2", "Publisher": "SEC" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column F", "Footnote": "7", "Publisher": "SEC" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "4", "Publisher": "SEC" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column B", "Publisher": "SEC" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column C", "Publisher": "SEC" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147